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ABSTRACT
Mutations are important in the study of gene function. Until recently mouse
mutants available for study were spontaneous mutations and those derived from
chemical or X-ray mutagenesis. Transgenic technology brought about the creation of
more mouse mutants through insertional mutagenesis by retroviral agent or
microinjected recombinant DNA. The insert may be used as a tag to molecularly
clone and characterise the mutated gene. With the advent of embryonic stem (ES) cell
technology the number of mutations available for study should grow - both specific
and random mutations.
ES cells are pluripotent stem cells, that may be manipulated genetically in
culture, and yet retain the ability to contribute to normal development and the germ
line of a host blastocyst. Thus the phenotypic effects of the introduced mutation may
be studied in vivo. Random mutations may be introduced into the ES cell genome by
insertional mutagenesis by retroviral agent or by promoter or enhancer trap vectors.
Gene targeting by homologous recombination may be used to introduce specific
mutations.
Hox-2.1 is a mouse homeobox-containing gene, belonging to the family of Hox
genes. It has been cloned and mapped to the Hox-2 cluster on chromosome 11. Hox
genes are thought to play important roles in mouse development. They may act as
regulatory genes, controlling the expression of structural genes at different positions
in the developing embryo. In order to study the function of Hox-2.1 in development it
would be useful to have a mouse mutant for Hox-2.1.
It was the aim of this project to produce a mouse mutant for Hox-2.1. The first
step towards this aim is the targeting/knock-out of the gene in ES cells. During this
project various Hox-2.1 targeting constructs have been designed and built.
Replacement vectors, incorporating a promoterless neo or employing the positive-
negative selection strategy, were designed to enrich for targeting events. These and
two insertion vectors were transfected separately into ES cells. Over 200 selected
clones have been screened for disruption of the Hox-2.1 locus. No homologous
recombinants were identified. One clone, known as a "pick-up" clone, was identified.
It is thought that the targeting vector has found homology with the target sequence,
picked up DNA from the locus (in this case 3' to sequence within the construct) and
integrated elsewhere in the genome.
An integration site, which the promoterless Hox-2.1-neo targeting vector has
integrated into twice, despite non-homology, has been characterised. It is suggested
that this locus may be a site of frequent integration. The sequence flanking the
construct was amplified by inverse PCR, cloned and sequenced. The properties which
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Recent technical advances have widened the scope of knowledge that may be
gleaned from the mouse model.
This chapter will introduce the mouse as a genetic model; discuss the power
of embryonic stem (ES) cell technology in the manipulation of the mouse genome
and outline the potential application of this technology to the study of development,
with specific reference to the Hox-2.1 gene.
1.1 The mouse as a genetic and developmental model.
More than 1300 genetic loci have been described in the mouse (catalogued by
Green in Lyon and Searle, 1989). Initially most were discovered due to visible
phenotype alteration such as coat colour changes, physical or behavioural effects.
Subsequently by experimental determination of strain differences in enzyme activity,
antigenic determinants were used and more recently DNA sequence variations were
detected. Over a thousand of these loci have been assigned to the mouse
chromosome linkage map by the use of biochemical or DNA polymorphisms or
chromosomal rearrangements.
Mutations in mouse genetic loci are useful in the study of mammalian
development and may also serve as models for human disease. Until recently the
mouse mutations available for study arose from natural variation or spontaneous
mutation and induction by X-irradiation (Russel, 1951), chemical mutagenesis
(Peters, 1985) or retroviral insertion (Jaenisch et al., 1985).
However, large numbers of genetic loci have been cloned and mapped which
show no variation between mouse strains and whose functions are unknown. Several
mouse genes have been cloned due to homology to known developmental genes of
Drosophila e.g.. the homeobox-containing family of genes (to be described in
section 1.7). Function may be surmised from DNA/protein sequence motifs and
expression patterns may be determined by in situ hybridisation.
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To some extent gene function may be determined by over- or ectopic
expression. Overexpression may be regarded as a dominant gain of function
mutation, similar to those observed in Drosophila melanogaster e.g. Antennpedia
(Antp). Genes may be introduced into the genome of transgenic mice by
microinjection into pronuclei of fertilised eggs. Transgenic mice, in which Hox-1.4
is overexpressed, exhibit a megacolon phenotype (Wolgemuth et al., 1989).
Transgenic mice, in which Hox-1.1 is ectopically expressed, exhibit multiple
craniofacial abnormalities (Balling et al., 1989) and variations of cervical vertebra -
"transformed" structures and an additional vertebra have more posterior-like
characteristics (Kessel et al., 1990).
Function may be determined absolutely by the disruption of the normal
process i.e. mutation of the gene. It is difficult to mutate specific genes of interest by
the above mentioned methods.
1.2 Pluripotent stem cells.
A more recent technology which allows the mutation of a large number of
genes either randomly or specifically has been facilitated by the culturing of mouse
pluripotent stem cells. Embryonal carcinoma (EC) cells derived from
teratocarcinomas and embryonic stem (ES) cells derived from the normal mouse
embryo may differentiate into a number of diverse cell types both in culture and in
vivo under the influence of environmental signals.
The technique for the derivation of EC cells is described by Damjanov et al.
in Robertson (1987). Teratocarcinomas are established by transplanting 6-7 day old
(post implantation egg cylinder) embryos to an ectopic site, such as the kidney
capsule of a recipient mouse. Foci of EC cells comprise 20-40% of 8 week old post¬
transplantation tumours. EC cells (resembling blastocyst cells) may be established as
permanent cell lines by explanting onto a layer of feeder cells in tissue culture
medium. Under defined culture conditions (removal of feeders) EC cells form a
structure known as an embryoid body (EC cells surrounded by endodermal cells)
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from which a variety of cell types are observed to proliferate e.g.. fibroblasts,
cartilage, beating heart muscles, pigmented cells and neural cells (Martin and Evans,
1975). Upon injection of EC cells into a host blastocyst and transfer of that
blastocyst into a surrogate mother, EC cells may contribute to normal development
(Brinster, 1974 and Mintz and Illmensee, 1975) and may sometimes populate the
germ line of the resulting host-EC cell chimaeric mouse (Stewart and Mintz, 1981).
The derivation of ES cells was first described independently in two papers:
Evans and Kaufman (1981) and Martin (1981). The technique is described in Hogan
(1986) and by Robertson in Robertson (1987). The ES cells are derived from the
inner cell mass of 3.5 day blastocysts explanted into culture conditions which
prevent differentiation. The cells are maintained under the same culture conditions
once established as cell lines.
ES cells were originally derived and cultured on mitomycin-treated STO
fibroblast or embryo-derived fibroblast feeders. Subsequently it was discovered by
Smith and Hooper (1987) that ES cells cultured on Buffalo rat liver (BRL) cells
retain pluripotency. Cells may also be derived in BRL cell conditioned medium in
the presence of feeders (Handyside et al., 1989). More recently a glycoprotein of Mr
43000 (generated through extensive glycosylation of a Mr=20000 polypeptide),
termed differentiation inhibitory factor (DIA) was isolated from BRL cell
conditioned medium and found to inhibit ES cell differentiation in vitro (Smith et
al., 1988). This factor had been previously partially purified from STO feeder
conditioned medium and shown to act as a differentiation retarding factor (Koopman
and Cotton, 1984). Purified DIA is identical to the haemopoetic regulatory factors,
leukaemia inhibitory factor (LIF) (Williams et al., 1988) and human interleukin for
DA cells (HILDA) (Moreau et al., 1988). DIA/LIF may control the differentiation of
embryonic ectoderm during normal embryogenesis. ES cell differentiation is
inhibited by 0.2 ng/ml (10 pM) DIA (Heath and Smith, 1989). Its action is probably
hormonal via interaction with cell surface receptors. ES cells capable of germ-line
transmission have been derived in medium supplemented only with DIA (Nichols et
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al., 1990). Removal of feeders, conditioned medium or DIA/LIF allows
differentiation of ES cells. Culturing ES cells in suspension, without conditioned
medium, results in the formation of embryoid bodies which upon attachment give
rise to an array of cell phenotypes, e.g.. nerve, cartilage and muscle (Robertson in
Robertson, 1987). Photographs of ES cells in the undifferentiated state and their
subsequent differentiated state upon removal of LIF from the medium are presented
in Figure 1.1.
ES cells have a number of advantages over EC cells as an experimental tool -
the euploid number of chromosomes is more stable, the chimaerism obtained upon
injection into host blastocysts is higher and most importantly they are more able to
contribute to the germ line of the chimaeric animal.
Upon microinjection of ES cells into a host blastocyst and replacement of that
blastocyst into a surrogate mother, the blastocyst will continue normal development.
Well maintained ES cells will contribute to all the tissues of the developing embryo,
including the germ line (Bradley et al., 1984) and a chimaeric mouse will result.
Differing coat colour markers or glucose phosphate isomerase isozyme (GPI)
analysis distinguish the ES cell derivitives from the host cell derivitives. If XY ES
cells contribute widely to an XX host the phenomenon of sex conversion may occur,
giving rise to a male animal that can transmit only ES cell derived sperm (since XX
cells cannot undergo spermatogenesis). Sex is determined by the number of XY cells
residing in the developing genital ridge. Sex conversion results in a sex distortion
effect such that more that 50% of the chimaeras produced will be male (Robertson,
1986). Extent of chimaerism and efficiency of germ-line transmission is affected by
the choice of mouse strain used as the host blastocyst (Schwartzberg et al., 1989).
C57B/6 was found to be a good host strain for 129-derived ES cell germ-line
transmission when compared to strains CD-I and MF1.
It has now been shown that ES cells selected on 6-thioguanine (6-TG), FIAT
(hypoxanthine aminopterin thymidine) medium, G418 and gancyclovir are capable
of germ-line transmission. Germ-line chimaeras may be bred to produce offspring
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heterozygous for the genetic alteration. Breeding of two heterozygous mice will
result in offspring homozygous for the alteration.
ES cells may be genetically manipulated and yet retain full pluripotency and
potential to form germ-line chimaeras. Genetic manipulation in culture may be
carried out through the introduction of DNA by microinjection, calcium phosphate
precipitation, electroporation or retroviral infection, followed by clonal selection of
altered genetic make-up. Large numbers of cells may be screened for the desired
genotype before microinjection into the mouse - thus ES cell technology offers a
tremendous advantage over microinjection of DNA into fertilised eggs to produce
transgenics. Although there is one reported case of the targeted correction of a
mutation by DNA microinjection into mouse eggs (Brinster et al., 1989), it is very
inefficient. Of 506 transgenics among 1841 mice born, only one had the targeted
correction of the MHC class II Ea gene.
One of the first experiments to show the usefulness of ES cells in the
generation of new mouse mutations was the generation of hypoxanthine
phosphoribosyl transferase (Hprt) deficient mice as a model for the human disease,
Lesch-Nyan syndrome. This experiment was carried out independently in two
laboratories: Hooper et al. (1987) and Kuehn et al. (1987). Hooper et al. selected for
spontaneous Hprt loss of function by selection of ES cells on 6-TG. 6-TG is toxic to
cells upon metabolism by the Hprt enzyme. Kuehn et al. retrovirally infected ES
cells and selected for Hprt' variants.
Since Hprt is X-linked, females born to a germ-line chimaera and with the
ES cell coat colour marker phenotype will be heterozygous for the Hprt defect and
all males born wild-type. Upon breeding of the heterozygous females, males
hemizygous for the Hprt' mutation were born. No defect was observed at the time of
publication. However, on recent examination Hprt' mice have been observed to
show behavioural defects (Hooper, personal communication).
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1.3 Insertional mutagenesis.
Mutations resulting from spontaneous loss of function, X-irradiation or
chemical mutagenesis are difficult to characterise genetically. Cloning of the genes
responsible for the mutant phenotype requires the use of laborious reverse genetic
techniques.
Mouse mutations may arise or may be created by the insertion of a DNA
element into the genome such that gene sequence or expression is disrupted. The
inserting element is useful as a tag for mapping and cloning of the disrupted DNA
sequence.
A number of well characterised mouse mutations may have arisen as a result
of movement of a naturally occurring transposable element (Jenkins et al., 1981 and
Stoye et al., 1988). 500-1000 endogenous retroviral sequences are present in the
mouse genome. No two strains have an identical set. Differences in proviral
locations may be detected by hybridisation of a viral sequence probe to genomic
DNA digests. It was found that an endogenous murine leukaemia virus (MuLV)
proviral copy was linked to the dilute (d) coat colour mutation locus (Jenkins et al.,
1981). Spontaneous revertants of the d phenotype no longer have the associated
proviral sequence. It was found that the hairless (hr) mutation of mice was
associated with the presence of a unique proviral copy (Stoye et al., 1988). Sequence
cloned from the site was found to be strongly linked to the mutation. Spontaneous
excision of the provirus results in reversion of the mutation. The data strongly
suggest the hr mutation is caused by the proviral insertion. The insertion is into
intronic sequence and proviral sequence may provide a splice acceptor site (Dr.
Jonathon Stoye, communication).
Viral insertion has also been used in the generation of new mutations
(reviewed by Jaenisch, 1988 and Palmiter and Brinster, 1985). Developing embryos
may be exposed to retroviral infection. Stable integration of the provirus into the
mouse genome may disrupt gene function. Lines of transgenic mice may be
generated. Jaenisch et al. (1983) and Schnieke et al, (1983) have shown that a
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recessive embryonic lethal mutation (strain Movl3) is caused by the insertion of the
infecting agent Moloney leukemia virus (Mo-MLV) into the a 1(1) collagen gene.
Movl3 has been useful in studying the role of collagen in development.
Many integration sites from transgenics generated by microinjection of
recombinant DNA into fertilised eggs have been cloned (Jaenisch, 1988). However,
these sites are often associated with sequence duplication and rearrangement so that
determination of the molecular defect causing the mutant phenotype is made
difficult. One mutation, H{558, resulting from integration of 10-20 copies of human
(3-globin gene causes a recessive lethal mutation (Radice et al., 1991). Homozygotes
for the integration show defective postimplantation development at day 7.5 p.c.. The
integration site was mapped to chromosome 10 by in situ hybridisation. A probe,
from within a 3 kb deletion of endogenous sequence, detects a transcript from 8.5
days p.c. embryos and represents a strong candidate for the gene responsible for the
mutant phenotype.
ES cell technology allows another route for the generation of new mutations
by insertional mutagenesis. Random mutations may be generated in the ES cells in
culture, characterised at the molecular level and the cells used to generate mutant
mice for the study ofmutant phenotype.
Robertson et al. (1986) exposed ES cells to infection by the replication
defective MPSVneo retroviral vector. Clones derived were found to have an average
of 5 integrations. Chimaeric mice were generated from uncloned, infected cells.
Chimaeras were bred to generate lines. The viral integration, designated 413.d, was
found to cause a recessive lethal mutation (Conlon et al., 1991). Homozygotes for
this mutation show disrupted post-implantation development. ES cells derived from
the homozygous 413.d mutant embryos were found to have full differentiation
potential in vitro and were able to carry out normal development in a chimaeric
embryo. It may be concluded that the gene mutated does not code for a cell
autonomous product.
Gossler et al. (1989) describe the use of promoter or enhancer trap vectors to
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mutate or detect expressing genes in ES cells. It is believed that a number of
important developmental genes will be expressed in ES cells. The vectors used by
Gossler et al. contain the reporter gene lacZ either attached to a weak promoter
(enhancer trap) or promoterless (promoter trap). Upon integration next to an
enhancer or active promoter, respectively, the lacZ is expressed and the product, (3-
galactosidase, easily detected by X-gal staining. Chimaeras were generated from
lacZ expressing clones and the pattern of expression during development determined
by whole embryo X-gal staining. Several of the cell lines generated were shown to
have a time and space specific expression in the developing embryo, indicating that
developmental gene enhancer or promoters had been "targeted". Phenotypic affects
may be observed upon breeding of the chimaeras and cloning of the disrupted genes
facilitated by the presence of known DNA sequence at the site.
A promoter trap vector has been shown by Macleod et al. (1991) to integrate
into sites with CpG islands. CpG islands occur at the 5' ends of housekeeping genes
and some tissue specific genes. Two integration sites were cloned and shown to
detect transcription of endogenous genes.
1.4 Gene targeting by homologous recombination.
Gene targeting by homologous recombination is the process by which
introduced DNA integrates into or replaces endogenous sequence due to sequence
identity. Specific genes may be targeted to introduce a subtle or null mutation.
Uptake of introduced DNA by homologous recombination into the cell
genome was first demonstrated by transformation of the yeast, Saccharomyces
cerevisiae (Hinnen et al., 1978). Most transformants (revertants of the Leu2~
mutation) were generated as a result of integration of the selectable Leu2 gene-
plasmid construct at the Leu2 site due to homology. 20% of the revertants were
generated as a result of a double cross-over event at the site of homology. Orr-
Weaver et al. (1981) demonstrated that transformation efficiency was increased by
10-1000 fold upon linearisation of the incoming DNA. This may enhance the
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recombination by allowing strand invasion or by reducing topological constraints
(Mansour et al., 1988). Rothstein (1983) demonstrated, using yeast, how gene
disruption may be brought about by homologous recombination. A selectable yeast
gene, such as His3 or Leu2 is inserted into the target gene sequence in the targeting
vector. Upon transformation and selection for presence of the marker gene, the target
gene function is lost.
The enzymes necessary to undertake the homologous recombination process
are present in mammalian cells. This was shown by a number of experiments
involving the correction of defective input DNA molecules such as selectable genes
or viral genomes (Wake et al., 1985). Wake et al. showed that a double strand break
in the region of homology greatly enhanced the rate of homologous recombination
between defective SV40 virus genomes in monkey cells. Lin et al. (1984) showed
that homologous recombination rate between two introduced but defective thymidine
kinase (tk) genes in mouse Ltk- cells was increased by increasing the amount of
DNA homology or by linearisation of the DNA.
In contrast to yeast, homologous recombination in mammalian cells is a rare
event, occurring against a large background of random integration events. Random
integration events have been characterised (Roth et al., 1985 and Macleod et al.,
1991) and have been found to be not dependant on large regions of homology and
are therefore termed "non-homologous" events. The processes involved in non¬
homologous recombination are favoured over the processes involved in homologous
recombination in mammalian cells.
Different studies show variable frequencies of homologous recombination to
random integration: 1/1000 (Smithies et al., 1985 and Thomas and Capecchi, 1987),
1/100 (Thomas et al., 1986) and 1/100000 (Lin et al., 1985). These differences may
arise due to differences in mode of DNA introduction or in target sequence.
Gene targeting by homologous recombination into an endogenous gene in
mammalian cells was first demonstrated by Smithies et al. (1985). Sequence was
integrated into the (3-globin gene of human EJ bladder carcinoma cells or human
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chromosome 11 hybrid cells. No direct selection method was available to detect
homologous integration, therefore a sensitive screening method was used. The
targeting vector contained 4.6 kb of homology to the (3-globin gene, a neo gene for
selection of construct uptake by the cells, supF for the plasmid rescue of integration
site sequence and a unique Xba I restriction site to allow the identification of
correctly targeted events. Targeting frequency of 1/300-1/1100 selected clones was
obtained upon targeting expressing or non-expressing p-globin.
Lin et al. (1985) corrected a defective endogenous tk gene by introduction of
a second, differently defective exogenous tk gene. One homologous recombinant
occurred for every 100000 cells integrating DNA.
Thomas et al. (1986) corrected mutant copies of integrated neomycin
phosphotransferase APH(3') II enzyme (neo) gene by microinjection of a different
mutant copy and selection for homologous recombination or restoration to correct
neo function by resistance to G418. Since 1/10 microinjected cells integrate DNA
and 1/1000 microinjected cells are G418 resistant (G418r) the overall targeting
frequency is 1/100.
Early studies in gene targeting were carried out on the Hprt gene. Hprt has
two advantages which make it a suitable gene for the study of factors influencing
homologous recombination in mammalian cells. Firstly, loss ofHprt may be selected
for by resistance to 6-TG. Secondly, it is located on the X-chromosome and thus in
male ES cells only one inactivation event is required to produce the selectable
phenotype. Hprt spans 33 kb of genomic DNA and contains 9 exons coded by 1307
kb DNA (Melton et al., 1984).
Thomas and Capecchi (1987) compared the rate of homologous recombination
into Hprt obtained using two types of targeting vector: replacement and insertion.
These vectors are analogous to the vectors used in yeast (Rothstein, 1983 and Orr-
Weaver et al., 1981). The replacement vector contains sequence homologous to the
target sequence which is colinear with the endogenous gene. It is designed to replace
endogenous sequence (Figure 1.2a) by a double cross-over event at the ends of
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homology. The insertion vector contains a double strand break in the region of target
homology and is designed to insert into the endogenous sequence (Figure 1.2b) by a
single cross-over event. Insertion brings about the duplication of target sequence.
Thomas and Capecchi (1987) included sequence from exon 8 of the Hprt
gene in the targeting vectors. The neo gene performs two functions: 1. insertion into
the coding sequence to mutate the Hprt gene and 2. acts as a selectable marker to
confer G418r on cells stably integrating the construct (only 0.1 % cells integrate
DNA after electroporation). Homologous recombinants were identified as 6-TG
resistant clones and confirmed by Southern blot hybridisation. Homologous
recombinants give rise to a diagnostic restriction band pattern at the target locus.
On varying the length of homology to target sequence the targeting
frequency varied. The most efficient targeting frequency obtained was 1 correctly
targeted clone per 950 G418r clones upon electroporation of the replacement vector
containing 9.1 kb of homology. Comparable frequencies of 1/1100 to 1/1400 was
obtained from the insertion vector with 9.3 kb homology. Replacement vectors with
4 and 5.4 kb homology had targeting frequencies of 1/40000, 1/12000 and 1/7000
respectively. The smaller insertion vector, with 3.7 kb homology, gave a targeting
frequency of 1/20000. A five-fold increase in target homology (2.9-14.3 kb) results
in a 100-fold increase in targeting frequency (Capecchi, 1989). Expressing
homologous recombinants as a fraction of the number of electroporated cells, the
targeting frequencies vary between 0.02-0.3 x 10 6 (3 x 10 4 for 14.3 kb homology).
However, in a separate study by Doetschman et al. (1988) an overall
targeting frequency of 0.4-1.6 x 10"6 per cells electroporated was obtained when 1.3
kb of Hprt exon 3 was targeted using a replacement vector. The comparable
frequencies obtained, despite the smaller target sequence than Thomas and Capecchi
may be due to the choice of gene sequence to be targeted. Sequences, even from
within the same gene, may have different inherent targeting properties.
Doetschman et al. (1987) were able to correct a 10 kb deletion in the Hprt
gene in ES cells (created by Hooper et al., 1987) by homologous recombination
12
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Figure 1.2
Schematic representation of disruption of the Hprt gene by gene targeting using a replacement
vector (a) and an insertion vector (b). Closed boxes represent exons and hatched boxes
represent the neo gene. These diagrams were reproduced from Thomas and Capecchi (1987).
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using an insertion vector. Hprt revertants are selectable on HAT medium. The
deletion in the ES cells was found to span exons 1 and 2. The targeting vector
contained the Hprt promoter and exons 1 and 2 to replace deleted sequence. 2.5-5 kb
homology (size not known exactly since 3' deletion end-point had not been mapped)
was present in the vector. Upon integration, exon 3 is duplicated. A targeting
frequency of 1.4 x lO6 per electroporated cell was obtained. Since the G418r
frequency was 1 x 105, the targeting frequency may also be stated as 14/100
G418r clones.
Thompson et al. (1989) were the first to show that homologous
recombination could be used to introduce a targeted alteration in ES cells which
could be transmitted to mice, in vivo. Hprt deleted ES cells were corrected as above
(Doetshman et al., 1987) and injected into mouse blastocysts to generate germ-line
chimaeras. Heterozygous females born as a result of crossing the male chimaera to
Hprt' homozygous females show the normal expression pattern of Hprt from the
corrected locus. More of the corrected clones have since been introduced into the
mouse via germ-line chimaeras (Koller et al., 1989).
Recently the Hprt system has been used to show that the length of non¬
homologous DNA sequence included in the replacement targeting vector has no
effect on targeting frequency (Mansour et al., 1990). 8 bp, 1 kb or 3.4 kb
heterologous DNA sequence inserted into 9.1 kb of Hprt sequence gave similar
targeting frequencies; as did 4.3 kb and 12 kb of sequence inserted into Hprt exon 3.
Homologous recombinants were selected on 6-TG and checked by Southern blot
hybridisation.
As stated earlier, Hprt has the advantage of a selectable phenotype to identify
correctly targeted clones. Another gene, which has a selectable phenotype and is X-
linked, has been targeted - the adenine phosphoribosyltransferase locus (Adair et al.,
1989). Other genes of interest are present in two copies and do not have a selectable
phenotype upon disruption. Since the targeting frequency of a given locus is
unpredictable and since even with the largest region of homology the most efficient
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targeting frequency obtained upon targeting of Hprt was 1/300 G418r clones
(Capecchi, 1989), it is not always feasible to screen for homologous recombinants by
Southern blot hybridisation alone.
The polymerase chain reaction (PCR) (Saiki et al., 1988) may be used as a
rapid and sensitive screening method to identify homologous recombination events
by amplification of the recombinant DNA or novel junction fragment (Kim and
Smithies, 1988). PCR amplification between a primer specific for the targeting
vector sequence (e.g.. neo) and a primer specific for the targeted endogenous
sequence, within 2 kb of the first primer but not within targeting vector sequence,
results in a PCR product of predictable size only if the vector has integrated by
homologous recombination. The PCR is able to detect small numbers of homologous
recombinant cells in pools of thousands of non-recombinant cells. PCR amplification
may be used to identify pools of clones containing homologous recombinants,
which may be further analysed by a process of sib-selection to identify single
homologous recombinant clones. PCR amplification may be subject to artifact from
random integration events if the polymerase fails to amplify neo primer through to
flanking random DNA. The partially extended product may hybridise to target locus
and amplify sequence to the second primer to give a band size similar to that
predicted for homologous recombination (Mansour, 1990). Also false positives may
arise due to contamination or if the endogenous sequence primer has similarity to
and hybridises to sequence near a non-homologous targeting vector insert (Kim et
al., 1991)
PCR amplification was used by Joyner et al. (1989) to successfully identify
targeted events in the En-2 gene of ES cells. Upon positive identification of a pool of
ten clones, cells from individual clones were analysed. DNA from a positive clone
was checked by Southern blot hybridisation. A targeting frequency of 1/260 G418r
clones was obtained.
Zijlstra et al. (1989) used PCR to identify homologous recombinants upon
targeting (32-microglobulin ((32-m) with a replacement vector, containing 10 kb of
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homology. Thirty independent pools of ES cells were grown to the 8 cell stage and
each clone divided in half - one half was grown in a pool for PCR analysis, the
second half was grown in an individual well for analysis upon positive identification
of a pool. The high targeting frequency obtained (1/25 G418r clones) may be due to
a recombination hotspot or because of enrichment for targeted clones by omitting the
polyadenylation signal from the neo selectable marker (strategies for enrichment are
discussed below). Koller and Smithies (1989) also report the targeting of (32-m (8.4
kb homology included in the vector) and screening for homologous recombinants by
PCR. 1/117 G418r clones were correctly targeted.
Zimmer and Gruss (1989) used PCR detection without prior selection after
microinjection of ES cells with a Hox-1.1 targeting construct. Non-homologous
DNA in the vector was limited to a 20 bp oligonucleotide, which inserts a stop codon
inframe to disrupt the Hox-1.1 coding sequence and acts as a priming site for PCR
amplification. 719 ES cells were microinjected and analysed for homologous
recombination by PCR in 12 pools. At least 5 independent homologous
recombination events were identified giving a targeting frequency of 1/150
microinjected cells. Since 20% of cells are estimated to stably integrate DNA (this
reduces the need for a selectable marker), a frequency of 1 homologous to 30 non¬
homologous events is estimated. The authors suggest that microinjection may
increase targeting frequency by providing DNA substrate suitable for homologous
recombination as opposed to non-homologous recombination. However,
microinjection of ES cells is technically difficult and lower frequencies for some
genes may mean large numbers would have to be microinjected. A similar strategy
was used recently by Kim et al. (1991) in an attempt to correct the human sickle-cell
(3 globin gene in a mouse-human cell hybrid. No homologous recombinants were
detected after screening 18000 (1800 to 3600 transformants) microinjected cells.
Upon electroporation of a targeting vector containing similar sequence and a neo
selectable marker gene a targeting frequency of 1/9700 G418r clones was obtained
(Shesely et al., 1991).
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The background of non-homologous events may be lowered by addition of
dideoxynucleotides to the 3' hydroxyls of the targeting vector (Chang and Wilson,
1987). Dideoxynucleotides prevent end-joining and since end-joining is thought to
be involved in non-homologous recombination, these events are reduced. Free DNA
ends probably play a different role in homologous recombination events, that of
strand invasion, and this process will be unaffected by dideoxynucleotide ends.
Homologous recombination events may also be enriched for by selecting
against non-homologous recombination events and the number of clones required for
screening thus reduced. There are two enrichment procedures that may be used: 1.
the use of cis-acting regulatory elements of the target gene for the expression of the
selectable marker or 2. the positive-negative selection (PNS) strategy (Mansour et
al., 1988). These strategies have been used to target a number of genes successfully
at high targeting frequencies.
Use of a promoterless gene as a selectable marker in the targeting vector is
expected to reduce the number of selected clones generated by random integration
and enrich for homologous recombination into the expressed target locus gene
(Doetschman et al., 1988). Use of this strategy requires target gene expression in the
experimental cells. Requirement for enhancer sequence (Jasin and Berg, 1988) or
polyadenylation signal (Zijlstra et al., 1989) by the selectable marker may also
enrich for integration into the target locus.
Dorin et al. (1989) report a targeting frequency of 3/11 G418r clones upon
targeting of SV40 sequence in human-mouse cell hybrid C121 cells using a
replacement vector in which a promoterless neo gene is fused inframe with the SV40
sequence. Sedivy and Sharpe (1989) claim an 100-fold enrichment for disruption of
the polyoma middle T antigen in NIH 3T3 cells upon targeting with a replacement
vector in which a promoterless neo is fused inframe to chloroamphenical
acetyltransferase gene amino-terminal portion sequence (to ensure correct neo
function) and T antigen target sequence. A targeting frequency of ~ 1/100 G418r
clones was obtained. A similar construct design was used to target c-abl in ES cells
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(Schwartzberg et al., 1989 and 1990) at a targeting frequency of 1/34 G418r clones.
Clones carrying the c-abl base substitution mutation were subsequently introduced
into blastocysts to derive germ-line chimaeric mice. A promoterless neo vector was
used to target N-myc in ES cells at a frequency of 1/5 (Charron et al., 1990) and a
promoterless/AUG" neo vector used to target pirn in ES cells at a frequency of 34/40
G418r clones (te Riele et al., 1990).
As an alternative to the generation of a target gent-neo fusion protein, the
termination-reinitiation strategy (Peabody and Berg, 1986) has been suggested. A
stop site is inserted immediately 5' to the neo AUG start site. However, Schwarzberg
et al. (1990) found the latter mechanism to be relatively ineffective. Doetschman et
al. (1988) found the neo gene was not expressed sufficiently to protect targeted cells
from G418 at 400 Jig/ml.
Jasin and Berg (1988) showed an ~ 100-fold enrichment upon deletion of the
transcriptional enhancer from a SV40 sequence targeting vector, to obtain a targeting
frequency of 25/57 selected clones. Use of a neo gene lacking the polyadenylation
signal reduced the number of G418r clones 4-fold upon targeting of (32-
microglobulin (Zijlstra et al., 1990). A targeting frequency of 1/25 G418r clones was
obtained.
The second strategy for the enrichment of homologous recombinants is that
of PNS (Mansour et al., 1988). PNS uses a positive selectable marker, such as neo,
to select for integration events, and a negative selectable marker gene, such as herpes
simplex virus thymidine kinase (HSV-r&), to select against random integration
events. Metabolism of base analogues, gancyclovir (ganc), acyclovir or FIAU,
recognised by HSV-r& but not cellular tk, leads to cytotoxicity and cell death. The
PNS vector design is illustrated in Figure 1.3. Neo is inserted into target sequence
and HSN-tk is placed adjacent to target sequence. Upon replacement of endogenous
sequence in an homologous recombination event, HSV-r& does not integrate, and cell
lines derived will be doubly G418r and ganc resistant (gancr). Upon random
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Figure 1.3
Schematic representation of the disruption of Gene X using the positive-negative selection
strategy.
a. Homologous recombination between the targeting vector and genomic X DNA results in the
disruption of the Gene X and loss of HSV-t& sequence. Such cells will be X",G418r and gancr.
b. Random integration of the targeting vector results in insertion of both neo and HSW-tk
genes. Such cells will be X+, G418r and ganc sensitive.
Closed boxes represent exons and cross-hatch boxes represent neo or HSV-t£ genes.
This diagram is reproduced from Mansour et al. (1988).
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integration via the ends of the targeting vector, HS\-tk sequence is integrated, and
non-homologous recombinant cell lines derived will be G418r but ganc sensitive.
Random integration events, in which HSY-tk is impaired upon integration, are G418r
and gancr.
Mansour et al. (1988) report a 2000-fold enrichment factor upon application
of ganc, such that 1 in 2000 G418r clones is also gancr. Targeting of Hprt resulted in
a targeting frequency of 19/24 double resistant clones and targeting of int-2 gave a
targeting frequency of 4/81. These frequencies may be expressed as a fraction of
G418r clones: 1/2500 for Hprt and 1/40000 for int-2. It is suggested that lower
accessibility of target locus lowers targeting frequency for some genes.
Johnson et al. (1989) report a 300-2000-fold enrichment with ganc selection
and targeting frequencies of 1/16 for c-fos, 2/22 for adipsin and 12/142 for aP2,
when the frequency is expressed as a fraction of doubly resistant clones. Adipsin and
aP2 are not detectably expressed on Northern blots of ES cell RNA. This
demonstrates that the open chromatin structure of expressing genes is not essential
for recombination. This was also shown for the targeting of insulin-like growth
factor II (DeChiara et al., 1990) and |3-globin in EJ bladder carcinoma cells
(Smithies et al., 1985). However, elevated recombination rates may be observed in
transcriptionally active DNA. This was shown in the experiments of Thomas and
Rothstein (1989), in which recombination at the GAL10 locus of S. cerevisiae was
found to be 15 X higher when constitutively expressed in ga/80 mutants than in the
repressed state of gal4 mutants.
Many other genes have been targeted successfully using the PNS strategy.
However, reports vary on the enrichment factor obtained through negative selection
with ganc. Enrichment varies from 8-fold for the targeting of the immunoglobulin p.
gene (Kitamura et al., 1991); 13-fold for the insulin-like growth factor II (DeChiara
et al., 1990); 23-fold for the transcription factor GATA-1 (Pevny et al., 1991) to 70-
fold for the insulin receptor gene (Accili et al., 1991). Targeting frequencies were
1/38, 3/100, 6/79 and 2/24 double resistant clones, respectively. These frequencies
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may be expressed as 1/304, 1/429, 1/302 and 1/804 G418r clones.
Use of two tk genes in the targeting vector - one at either end of the target
sequence - may be expected to enrich for homologous recombinants still further.
Different tk gene sequences are used to reduce the potential for intraplasmid
recombination. Mombaerts et al. (1991) report an enrichment of only 2-fold upon
targeting T-cell antigen receptor and McMahon and Bradley (1990) report
enrichment of 26-fold upon targeting of Wnt-1. Targeting frequencies were 1/500
and 1/275 double resistant clones, respectively or 1/1000 and 1/7500 G418r clones.
These reported enrichment factors may not be "true" enrichment factors.
Tybulewicz et al. (1991) report an apparent 5.2-19.6 fold enrichment upon ganc
selection. However, upon transfection of cells with a neo vector and subsequent
selection on G418 or G418+ganc, two times as many G418r as G418r gancr clones
were generated. 50% of apparent enrichment is therefore due to non-specific
cytotoxicity of ganc rather than the presence of HSW-tk.
ES cells selected on ganc or FIAU (McMahon and Bradley, 1990) are able to
populate the germ line of chimaeric mice. However, ganc has the potential to cause
random mutations. A negative selectable marker gene which does not require drug
selection may be used to decrease the likelihood of adverse effect on the cells. One
such gene is that encoding the cytotoxic Diptheria toxin A-fragment (DT-A). When
used in a PNS vector to target c-fyn, DT-A gave an enrichment factor of 10-fold and
a targeting frequency of 8/16 selected clones (Yagi et al., 1990). Germ-line
chimaeras were obtained.
A novel method for enrichment and selection, epitope addition, is used by
Jasin et al. (1990). The murine cell surface marker Thy-1 is used as a positive
selectable marker. Since the Thy-1 marker used requires promoter activity, AUG and
a leader sequence for proper expression on the cell surface, homologous
recombination events are highly enriched for. Flow cytometry was used to detect
Thy-1 marker on the cell surface. 70% of expressing clones were correctly targeted
at the human CD4 locus in the human T-cell line, JM. A similar strategy is used by
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Itzhaki et al. (1991) to target an interferon inducible gene, 6-16 in HeLa cells. A
promoterless human growth hormone (hGH) is used as positive selectable marker.
An antibody assay was used to detect hGH in the growth medium of pooled clones.
9/10 interferon inducible hGH secreting cell lines were homologous recombinants.
The factors affecting homologous recombination in mammalian cells are not
yet fully understood. Different genes or experiments show tremendous variation in
targeting frequency. Vector design may be optimised by incorporating large regions
of target sequence homology and a strongly expressed neo. An enrichment strategy
may be employed to reduce non-homologous recombination events. It has been
suggested that use of isogenic DNA in vector and cells enhances targeting frequency
by ensuring complete homology (Hein te Riele and Anton Berns, personal
communication). It is also apparent that the DNA sequences vary in their inherent
targetability. DNA sequence, chromatin structure, enhancers or inhibitors of neo
expression may affect frequency of homologous recombination or detection.
It must be noted that comparison of gene targeting frequencies is
complicated. Frequencies expressed as a fraction of the number of cells
electroporated may be complicated by cell death, electroporation conditions or
plating efficiencies. Frequencies expressed as a fraction of the number of G418r
colonies is complicated by the different neo genes used in the targeting construct -
weak promoters or enrichment strategies may reduce numbers.
1.5 Mutant mice generated from targeted ES cells.
In the last two years mice heterozygous and homozygous for targeted
mutations have been generated from ES cells. Phenotypes have been studied in the
hope of gaining some insight into the function of the mutated genes.
Heterozygous mice, born to male chimaeras of ES cells, carrying a null
mutation in the insulin-like growth factor II (IGF-II) gene were found to be 60%
normal size (DeChiara et al., 1990). Homozygotes were also 60% normal size, while
heterozygotes born to female heterozygotes were normal size (DeChiara et al.,
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1991). This study demonstrates that IGF-II is indispensable for normal embryonic
growth and is subject to parental imprinting.
Mutation in the immunoglobulin p. gene leads to abnormal B-cell
development (Kitamura et al., 1991) and mutation in the (32-m gene leads to absence
of certain T-cell populations due to lack of MHC I presentation (Zijlstra et al.,
1990). The importance of the transcription factor GATA-1 in erythrocyte
development was demonstrated in ES cell derived chimaeric mice. Erythrocytes
failed to develop from the ES cells, in which the X-linked GATA-1 had been
mutated by homologous recombination (Pevny et al., 1991).
Homozygotes for a null mutation in c-abl (Tybulewicz et al., 1991) and for a
deletion of the c-terminus of c-abl (Schwartzberg et al., 1991) have been generated.
Both mutations result in similar phenotypes demonstrating the c-terminus (involved
in subcellular localisation) is very important for c-abl function. Homozygotes die 2-
3 weeks after birth. The immune system, thymus and B-cell population are severely
affected.
Homozygotes for the disrupted Hox-1.5 gene die neonatally due to
pulmanory defects (Chisaka and Capecchi, 1991). Absence of thymus and
parathyroid, coronary defects and throat region abnormalities may be due to the lack
of Hox-1.5 in branchial arches and pharyngeal pouches prior to migration or mixing
of cell derivitives.
Homozygotes for Wnt-1 (int-1) mutations have been generated independently
by Thomas and Capecchi (1990) and McMahon and Bradley (1990). The majority of
homozygotes die neonatally, though one mouse surviving to adulthood suffered
severe ataxia (Thomas and Capecchi, 1990). Degrees of penetrance may vary due to
mouse strain background. The dorsal and ventral caudal midbrain were found to be
absent at 9.5 days p.c. (McMahon and Bradley, 1990). This correlates with a broad
band of Wnt-1 expression observed on in situ hybridisation. CNS development,
especially of the cerebellum, is defective.
The Hox-1.5 and Wnt-\ mutants show severe phenotypes in regions that
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would be predicted to be affected because of the previously observed pattern of gene
expression. However, these genes are also expressed in regions which appear
unaffected by the mutation. The gene product may have no role in these areas
despite its expression. A more likely explanation is that of redundancy of function -
the gene function may be replaced by similar or related proteins.
Functional redundancy between En-1 and En-2 in shared regions of
expression is the probable explanation for the normal development of En-2 null
mutation homozygotes (Joyner et al., 1991). A subtle phenotype is observed in the
cerebellum - the only region in the developing mouse embryo where En-2 is
expressed and En-1 is not. En-2 may have developed a special function in this
region. If redundancy is operating, it may be predicted that upon breeding of En-1
mutant with En-2 mutant mice to generate mice homozygous for both mutations, that
a more severe phenotype than either mutation alone would be observed. The En-1
gene has not yet been targeted.
Overlap in function between other protein kinases may also explain why a
null mutation in c-src does not lead to a more extensive phenotype (Soriano et al.,
1991). c-src is expressed widely in the mouse and yet the mutant phenotype is
limited to bone. Other widely expressed protein kinases are being targeted.
1.6 ES cells and new approaches to gene function analysis.
Cell lines carrying null alleles of normally expressed genes may be
instrumental in assessing the function of that gene in vitro or in vivo. Cell lines may
be particularly useful in the study of gene mutations causing early developmental
lethality. Cell lines may be derived from mutant embryos or by the consecutive
inactivation of both alleles by homologous recombination in cultured cells, te Riele
et al. (1990) describe the consecutive inactivation of both pim-1 alleles in ES cells.
The first disruption was achieved by integration of a neo gene using a pim-1
replacement vector and the second disruption made by integration of a different
selectable marker gene, hygromycin (hyg). The bacterial hyg gene confers resistance
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to hygromycin B. Both selectable markers were promoterless. 21/34 hygromycin B
resistant clones, from the second targeting, were correct homologous recombination
events. In six of these the hyg had replaced neo sequence and in the remaining 15
cell lines the hyg had integrated into the second pim-l allele. Double knock-out cells
show no difference from wild-type cells in morphology, growth or differentiation.
Double knock-out cells may also be introduced into blastocysts to form chimaeras.
Otherwise developmentally lethal mutant cells may thus be rescued by normal cells
and the ES cell contribution to developing tissues monitored. Modulation of gene
activity by consecutive gene targeting of the creatine kinase M allele in ES cells is
reported by van Deursen et al. (1991). One allele was knocked out and then was
modulated by an insertion vector to give altered expression of the gene.
Subtle mutations in a gene locus may be introduced by the hit and run
procedure (Hasty et al., 1991). This is achieved by a two-step process and exploits
the locus duplication produced by integration of an insertion vector. A subtle
mutation, such as a missense mutation, is introduced into a duplicated copy of the
gene upon insertion of the targeting vector. The plasmid backbone of the targeting
vector carries a neo marker for positive selection and a tk marker for selection of a
reversion event. Upon reversion, duplicated DNA sequence resolves by intra-
chromosomal recombination and the plasmid sequence, along with the tk gene, is
lost. Reversion events are selectable in FIAU. Hasty et al. demonstrated the efficacy
of this procedure on the Hprt and Hox-2.6 loci of ES cells. Duplication reversion
rates were 4.3 x 106 and 3.8 x lO3 per cell generation, respectively. A proportion of
the revertants were found to carry the introduced mutation.
Replacement of target gene in ES cells with reporter gene, lacZ, allows the
fate of the mutated cells to be followed in the developing chimaeric embryo (Le
Moulliec et al., 1990 and Mansour et al., 1990). Cell ablation studies, similar to
those carried out by Palmiter et al. (1987), would be possible if the target gene in ES
cells was replaced with reporter genes encoding toxin. Timed ablation, in mouse
chimaeras, of the cells expressing the reporter gene would be useful in the study of
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genes functional through various stages of development.
Pavan et al. (1990) and Craig Barton et al. (1990) demonstrate the feasibility
of targeting specific mammalian loci using the recombination abilities of S.
cerivisiae. Large DNA fragments cloned into yeast artificial chromosomes (YAC)
may be targeted efficiently. Homologous recombination in yeast could be used to
introduce mutations rapidly into a cloned locus which then could be used to make
conventional targeting vectors. It has been shown that YACs could be transfected
and integrated into EC cells (Pavan et al., 1990). If ES cells could be transformed in
a similar manner, YAC DNA could be introduced into mice. Correction of mutations
in ES cells and eventually in vivo, by an integrating YAC, may be possible. YAC
integration into ES cells would offer an advantage over microinjection transgenic
technology, because of the DNA locus size that may be introduced. It may also be
possible to target genes in ES cells by homologous recombination of YACs - this
may prove to be highly efficient because of the large region of homology.
1.7 Homeobox genes and mouse development.
The genetics of Drosophila melanogaster development has been extensively
studied through mutant analysis (Nusslein-Volhard et al., 1987; reviewed by Akam,
1987 and Ingham, 1988). At least three groups of genes have been identified which
form a hierarchical network of control throughout the different stages of the fly's
development - the maternal effect genes, the segmentation genes and the homeotic
genes. Cloning and characterisation of the Drosophila developmental genes has had
a spin-off in the study of mammalian development. Drosophila genes contain
functional domains which are highly conserved within gene families across a number
of species, including mouse and man (reviewed by Kessel and Gruss, 1990). One
such domain is the homeobox: a region of 183 bp DNA coding for 61 amino acids
(McGinnis et al., 1984b and reviewed by Gehring, 1987). The homeobox is present
in all three Drosophila gene classes, as well as genes of invertebrate and vertebrate
species (Holland and Hogan, 1986).
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More than 30 homeobox-containing (Hox) genes have been located in the
mouse genome, cloned and sequenced (Kessel and Gruss, 1990). Genes were cloned
through cross-hybridisation of Drosophila homeobox sequence. Mo 10 (now named
Hox-1.5) was the first mouse Hox gene to be cloned (McGinnis et al., 1984a). Many
of the Hox genes show greatest similarity to the Drosophila Antp homeobox. Most of
the Antp-like Hox genes are present in 4 clusters (Hox-1,-2, -3 and -5) in the mouse
genome on chromosomes 6, 11, 15 and 2, respectively. It is possible that the
ancestral Hox gene was duplicated successively to form a gene cluster. During
vertebrate evolution the cluster appears to have duplicated and diverged (Graham et
al., 1989, Duboule and Dolle, 1989 and Schugart et al., 1989). Paralogs between
complexes, have greater sequence similarity (in homeobox and other regions) than
neighbouring genes in the same complex and appear to share a common ancestor
with a related Drosophila gene. Relative position in the complex is maintained and is
found to correlate with the domain of expression along the anteroposterior axis in
both Drosophila and mouse (Graham et al., 1989 and Duboule and Dolle, 1989).
Clustered homeobox genes, present before evolutionary divergence of insects and
vertebrates, may function as important systems for controlling development.
There are three further lines of evidence to suggest a developmental role for
murine Hox genes: their likely role as transcription factors, their expression pattern
in the developing embryo and analyses of Hox mutants. It is likely that they
determine the expression of other genes in a compartmental-specific and temporal-
specific manner within the embryo.
1.7.1 Homeobox genes as transcription factors.
The DNA binding helix-turn-helix motif of the homeobox may bind to
promoter or enhancer regions of genes to allow the regulation or autoregulation of
transcription. The homeobox shows homology to the yeast transcription factors
Matal and Mata2 (Shepherd et al., 1984). These proteins control cellular
differentiation into mating-type a or a cells, or into spores, by controlling the
expression of other genes (reviewed by Nasmyth, 1982). a2 protein binds to DNA
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sequence upstream of one target gene (Johnson and Herskowitz, 1985) and it has
been shown that the region encoding DNA binding corresponds to the homeodomain
(Porter and Smith, 1986). The homeodomain shows similarity to prokaryotic gene
regulatory proteins, cro and repressor protein of bacteriophage X (Laughon and
Scott, 1984). The DNA-binding domain is determined to be a helix-turn-helix
structure (Matthews et al., 1982). In vitro analyses of putative homeodomain DNA
recognition sites have been carried out. These studies identify a 10-12 bp sequence
with a central TAAT motif (reviewed by Hayashi and Scott, 1990; Budd and
Jackson, 1991).
Many homeobox proteins are located within the nucleus as detected by
antibody binding (White and Wilcox, 1984 and see review by Gehring, 1987).
Direct evidence of homeodomain transcriptional regulation comes from cell
culture assays, in which activity of a promoter of interest is monitored by expression
of a reporter gene, upon cotransfection with a homeobox protein expression
construct (reviewed by Hayashi and Scott, 1990).
1.7.2 Expression of Hox genes during mouse development.
The expression patterns throughout development are demonstrated by in situ
hybridisation to mRNA (review Holland and Hogan, 1988a; Kessel and Gruss,
1990). Although it was known for some time that Antp-like genes showed spatially
and temporally restricted expression patterns, from gastrulation (7.5 days p.c.) to
mid- to late- organogenesis (12.5 days p.c.-15 days p.c.), the link
between gene expression and body structure was discovered only upon analysis of
Hox gene expression in 9.5 days p.c. embryos (Murphy et al., 1989 and Wilkinson et
al., 1989). These studies showed that members of the Hox-2 cluster had expression
patterns correlating with segmental structures, termed rhombomeres (Lumsden and
Keynes, 1989), present in the developing hindbrain. Hox-2.9 expression is confined
to a single rhombomere (rhombomere 4) (Murphy et al., 1989 and Wilkinson et al.,
1989), while more 5' members of the Hox-2 cluster show expression throughout the
neural tube with anterior boundaries of expression at two rhombomere intervals
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(Wilkinson et al., 1989). It is suggested that overlapping domains of expression
provide positional signals in the embryo and that Hox genes play a role in
determining segment phenotype. Clear boundaries of Hox-2 gene expression are also
observed in neural crest cells in the neural plate at 8.5 days p.c. (Hunt et al., 1991).
Paralogs from the other gene clusters may also show similar domains of expression
along the anteroposterior axis (Gaunt et al., 1991; Murphy and Hill, 1991) but
tissue-specific variations suggest these related genes perform specialised functions in
specifying parts in the complex body plan (reviewed by Gaunt and Singh, 1990).
Expression pattern of Hox genes during development may also be studied in
transgenic mice. Puschel et al. (1990 and 1991) attached the promoter region of
Hox-1.1 to the reporter gene, lacZ, and monitored lacZ expression in transgenic
embryos. LacZ offers a more sensitive detection system than in situ hybridisation.
However, these studies are only reliable if all the promoter function is retained in the
construct.
1.7.3 Hox gene mutants.
Developmental abnormalities are observed in Hox gene gain-of-function or
loss-of-function mutants. Transgenic mice over-expressing the gene Hox 1.4 exhibit
abnormal gut development (Wolgemuth et al. 1989) and those expressing Hox 1.1
ectopically show multiple developmental defects (Balling et al., 1989). Hox-1.5 null
mutants, derived from targeted knock-outs in ES cells (Chisaka and Capecchi, 1991),
display defective development in the regions normally expressing the gene (see
section 1.5).
1.8 Hox-2.1
Hox-2.1 is located within the Hox-2 cluster on chromosome 11. It was
isolated by hybridisation of the Drosophila Antp and Ultrabithorax homeobox
probes to a mouse genomic library (Jackson et al.,1985 and Hart et al., 1985) and
separately cloned by its hybridisation to a human homeobox sequence from the Hu 2
gene, which had itself been isolated by hybridisation to the Antp homeobox probe
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(Joyner et al., 1985 and Levine et al., 1984). The Hox-2.1 cDNA sequence is
published (Krumlauf et al., 1987). It is paralogous with Hox-1.3 and Hox-3.4 and is
homologous to the Drosophila Sex chromosome reduced (Scr) of the Antennapedia
complex (Graham et al., 1989)
The expression of Hox 2.1 has been studied (Jackson et al., 1985, Krumlauf
et al., 1987, Holland and Hogan, 1988b and Wilkinson et al., 1989). mRNA is
shown to be present in embryonal tissues 7.5-16.5 days p.c. by RNase protection
studies and Northern blot hybridisation. The highest expression is in the spinal cord
at 12.5 days p.c. and adult kidney. In situ hybridisation to embryo sections shows
spatial restriction of the mRNA within the central nervous system at 9.5 days p.c.
There is a clear anterior boundary of expression at the hindbrain-spinal cord
boundary, which lies caudal to the hindbrain rhombomere segments; but no clear
posterior boundary. Segmentation is not observed in the spinal cord. There is a
temporal shift in pattern with the anterior boundary remaining but posterior
expression decreasing after 12.5 days p.c. There is also expression in the peripheral
nervous system - dorsal root ganglia (neural crest derived cells) - and mesodermal
derivatives in the lung and stomach. This expression pattern might indicate that Hox
2.1 has a role in position determination in "collaboration" with other homeobox or
developmental genes (e.g. transition between hindbrain segmentation to spinal cord
CNS organisation) and may be involved in organogenesis of the lung and stomach.
1.9 Summary of Thesis.
The study of Hox-2.1 function during mouse development would be greatly
facilitated by the availability of a mouse mutant for Hox-2.1. Alteration in or lack of
structures would indicate the necessity of Hox-2.1 for normal development.
Redundancy of function may also become apparent. Figure 1.4 illustrates the series
of steps involved in the generation of a mouse mutant for Hox-2.1.
The first step in the series is the introduction of a null mutation into Hox-2.1
in ES cells. Chapter 3 describes the attempts at targeting, using different Hox-2.1
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targeting vectors, designed along the principles discussed in Section 1.4. No
correctly targeted cell line was obtained. Thus the in vivo analysis of an Hox-2.1
mutant was not made possible.
Chapter 4 describes the identification and analysis of an integration site,
which a promoterless Hox-2.1-neo replacement targeting vector has integrated into
twice, despite non-homology. It is suggested that properties of this sequence might















Schematic drawing of steps involved in the generation of a mouse mutant for Hox-2.1. ES cells
are transformed to G418r by eletroporation with a Hox-2.1 targeting vector. A targeted clone is
identified by screening and cells introduced into host blastocysts by microinjection. ES cell
germ-line chimaeric mice may be bred to produce mice heterozygous for the Hox-2.1 mutation.




2. MATERIALS AND METHODS.
2.1 Mammalian cell culture.
2.1.1 Cell lines.
The L cell L-M (tkr) cell line is a subline of the L-M mouse fibroblast cell line,
resistant to 5-bromo-2-deoxyuridine (BUdR) and lacking the enzyme thymidine
kinase (Kit et al., 1963).
ES cells cultured throughout the project were of the E14 cell line (Handyside
et al., 1989), kindly provided at an early passage number (14 through to 19) by Dr.
Martin Hooper's laboratory. E14 cells are derived from strain 129/Ola (homozygous
for the cch chinchilla coat colour marker) mouse blastocysts. They have an XY
karyotype.
ES cells of the line CCE (Robertson, 1986; Evans and Kaufman, 1981) were
grown in Dr. Robin Lovell-Badge's laboratory. CCE cells were derived from
129/Sv/Ev (homozygous for the BB AA black agouti coat colour marker) mouse
blastocysts. They have an XY karyotype.
2.1.2 Maintenance of L cells in culture.
L cells were maintained in Dulbecco's modified Eagles medium (DMEM)
(Flow Laboratories) supplemented with heat inactivated 10% foetal calf serum
(FCS) (Gibco). Penicillin and streptomycin (Gibco) were added to cultures at 100
units/ml and 100 (ig/ml respectively. All cultures were grown at 37°C in 25, 75 cm2
(Nunclon) and 175 cm2 (Falcon) tissue culture flasks in a 10% C02 atmosphere.
Cells were washed in Dulbecco's phosphate buffered saline (PBS) before
trypsinisation with 10% trypsin in versene.
Cells were resuspended at a concentration of 106/ml in FCS containing 7-10%
DMSO and aliquotted into ampoules (Nalgene cryotubes) for freezing. The
ampoules were frozen slowly overnight in a polystyrene box at -70°C and
transferred to liquid nitrogen. Cells were recovered from frozen stock by rapidly
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thawing at 37°C and transferring to 10 ml medium. The cells were pelleted at 1000
rpm for 5 mins before plating in fresh medium.
2.1.3 Maintenance of ES cells.
ES cells were cultured in the presence of DIA/LIF (differentiation inhibitory
activity/leukaemia inhibitory factor) (Smith et al., 1988 and Williams et al., 1988) or
on fibroblast feeder layers (Robertson, 1987) to prevent their differentiation.
ES cells which were cultured on feeder layers were seeded onto a monolayer of
fibroblast feeder (STO) cells which had been mitotically inactivated by mitomycin
C. The cells were cultured in DMEM (Flow Labs), with the addition of 20% foetal
calf serum, O.lmM (3-mercaptoethanol and 50 units/ml penicillin and streptomycin.
ES cells which were cultured with LIF were grown in Glasgow's modified
Eagles medium (GMEM) (Flow Labs) supplemented with 1 X non-essential amino
acids (Gibco), 1 mM sodium pyruvate (Flow Labs), 0.3% glutamine, 0.1 mM (3-
mercaptoethanol and 10% heat inactivated FCS (Globepharm Ltd., tested for toxicity
by Dr. Sinead Jones as described by Robertson, 1987)). LIF was harvested by
Wendy Kimber from Cos-7 cells containing the pC10-6R expression plasmid
(Moreau et al., 1988) (obtained from Dr. Austin Smith). The amount of LIF necessary
for culture was determined by the differentiation of ES cells in a dilution series.
Flasks (Costar 25 cm2 and 225 cm2 with vented lids) for the culture of ES cells were
coated with 0.1% gelatin (Sigma, cell culture tested).
Disposable containers and pipettes were used at all times to ensure that the ES
cells did not come into contact with residual detergent.
1 X trypsin/EDTA was bought from Flow Labs for the trypsinisation of the
cells. ES cells were split usually at a factor of 1 in 8. The passage number of the
cells was noted on each flask after splitting.
2.1.4 Electroporation.
Construct DNA was linearised (or whole inserts released) by the appropriate
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restriction enzyme, prior to electroporation. The DNA was extracted once with
phenol, once with chloroform and ethanol precipitated before resuspending in H20 at
a concentration of 1 mg/ml.
L cells were electroporated on a workshop made electroporator. Cells were
suspended in 1 ml PBS at a concentration of 1 x 106 per ml with 20 |ig linearised
DNA.
ES cells were electroporated using a Bio Rad Gene Pulser. Cells were
suspended at a concentration of 5 X106 to 1 X107 per ml in PBS with 20-100 (ig
linearised DNA. For targeting experiments, 0.8 ml cells were pulsed with
capacitance of 3 pF and voltage of 800 V at path length 0.4 cm (Thompson et al.,
1989). For transfection of CAT (chloramphenicol acetyltransferase) constructs, 0.8
ml cells were pulsed at 960 (iF (with capacitance extender) and 200 V at path length
0.4 cm.
Cells were incubated at room temperature before plating in 10 cm diameter
culture dishes (Costar).
2.1.5 Selection.
Cells containing the neomycin phosphotransferase APH(3') II enzyme gene
(,neo) are resistant to the G418 aminoglycoside antibiotic.
G418 (Gibco) was added to the medium 24 hours after electroporation at a
dose of 600 (ig/ml to 1 mg/ml for L cells or 150 |J.g/ml to 400 |ig/ml for ES cells,
depending on batches of G418. Kill curves for batches of G418 were determined on
untransfected cells. G418 selection was maintained for 10-14 days before the picking
of clones.
Cells transfected with the positive-negative selection vectors were selected with
2 (iM gancyclovir (Syntex Pharmaceuticals Ltd.), a base analogue toxic to cells upon
metabolism by the HSV thymidine kinase (HS\-tk) gene, for 5 days on the fourth or
fifth day after electroporation.
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2.1.6 Picking resistant clones.
Medium was aspirated off and replaced by PBS. A colony was observed under
the microscope and scraped from the surface using a drawn out pasteur pipette
(diameter equal to size of colony). The colony was drawn into the tip of the pasteur
by attachment to a mouth pipetter and transferred to a drop of 1 X trypsin/EDTA. 12
foci were picked in this manner at one time. The trypsin drops were incubated at
37°C for 5 minutes. Using a fine drawn out pasteur (diameter half or quarter size of
the colony) a trypsin drop was sucked up and down until the clump of cells was
observed to break up into single cells. The cells were drawn into the pasteur and
transferred to a medium-containing well of a 24 well plate (Flow Labs). All
remaining colonies were broken up and transferred in a similar manner.
2.1.7 Expansion and freezing of clones.
Cells were maintained on G418. Clones were either expanded to 75 cm2 flasks
or frozen in a 2cm2 well of a 24 well plate (Chan and Evans, 1991).
Cells from 75 cm2 flasks were divided into two pellets. One pellet was
resuspended in 2 ml freezing mix (7% DMSO in FCS) and transferred to two
freezing vials for storage in liquid nitrogen. The second pellet was stored at -20°C
until the preparation of DNA.
Alternatively a clone upon reaching confluence in a 2 cm2 well was used to
seed a second 2 cm2 well at a density of 5 X 104 - IX 105 cells per well. Any
remaining cells were used to seed a 25 cm2 flask. 24 hours later the medium in the
plate was replaced with 250 p.1 freezing mix and the plate stored at -70°C in a
polystyrene box. Upon reaching confluence the cells from the 25 cm2 flask were
pelleted and stored as before for the preparation of DNA.
2.2 Preparation of nucleic acid from cultured cells.
2.2.1 Cell lvsate DNA preparation for PCR.
This method was used to prepare crude cell lysate DNA from small quantities
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of cells for PCR analysis (Joyner et al., 1989).
Cells were pelleted in an eppendorf and resuspended in 100 pi H20. The
suspension was incubated on dry ice for up to 2 hrs, then 94°C for 8 mins. 2 pg
Proteinase K was added and the suspension incubated at 94°C for 6 mins to destroy
the proteinase K. The suspension was stored on ice for up to 30 mins before dividing
between two PCR reaction.
2.2.2 Large scale DNA preparation.
Adapted from R. Lovell-Badge's method in Robertson (1987).
Cells were harvested from a 25 cm2 flask, washed in PBS and pelleted at 1000
rpm for 5 minutes. Pellets could be stored at -20°C at this stage. The pellets were
resuspended in 2 ml ice-cold Tris EDTA (50 mM Tris, pH 8 and 100 mM EDTA).
112 pi 4 M NaCl and 30 pi 20 mg/ml Proteinase K was added. The contents were
mixed gently. 0.6 ml 10% SDS was added and the tubes rocked gently. The tubes
were incubated at 50°C for 2 hours or at 37°C overnight. The contents were
transferred to polypropylene tubes for one phenol (equilibrated in TE (10 mM Tris,
pH 8 and 1 mM EDTA, pH 8)), one phenol/chloroform (1:1) and one chloroform
extraction. 2 volumes of ethanol were added to the final aqueous layer and DNA
precipitated by rocking the tube gently. The DNA was looped out using a sealed
glass pasteur pipette and resuspended in TE buffer (pH 8).
The DNA was left to resuspend overnight, shaking at 4°C.
The OD readings at wavelength 260 nm were made to determine DNA
concentration. An OD26o absorbance reading of 1 corresponds to 50 pg/ml double-
stranded DNA.
2.2.3 RNA preparation.
Cells were harvested, washed in PBS and pelleted, as above.
1 ml solution D (4 M guanidium thiocyanate, 25 mM sodium citrate (pH 7),
0.5% sarcosyl and 0.1 ml 2-mercaptoethanol) was added to the pellet, which was
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then homogenised in a glass-teflon homogeniser. The suspension was transferred to a
polypropylene tube and 0.1 ml 2 M sodium acetate (pH 4), 1 ml water saturated
phenol and 0.2 ml chloroform-isoamyl alcohol (49:1) were added sequentially. The
final suspension was shaken vigorously for 10 seconds and cooled on ice for 15
mins. After centrifugation at 10000 rpm for 20 mins at 4°C, the RNA-aqueous phase
was transferred to a fresh tube. The RNA was precipitated by the addition of 1 ml
isopropanol and placing at -20°C for at least 1 hr. The RNA was pelleted by
centrifugation at 10000 rpm for 20 mins. The RNA pellet was dissolved in 0.3 ml
solution D, transferred to an eppendorf and reprecipitated with 0.3 ml isopropanol at
-20°C for 1 hr. After centrifugation for 10 mins at 4°C, the RNA pellet was washed
in 75% ethanol, vacuum dried and resuspended in 0.2 ml DEPC H20 (see Section
2.7.1).
The OD readings at 260 nM were made to determine RNA concentration.
An OD260 absorbance reading of corresponds to 40 (ig/ml.
2.3 Bacterial cell culture.
2.3.1 Media and additives
L-Broth and Agar 10 g tryptone (Difco), 5 g yeast extract (Difco), 10 g NaCl,
2.46 g MgS04 per litre of distilled water.
15 g agar (Oxoid Ltd.) was added per litre of broth for L-agar.
Media was sterilized by autoclaving.
Terrific Broth 12 g tryptone, 24 g yeast extract, 4 ml glycerol per 900 ml
distilled H20, autoclaved. To this was added 100 ml autoclaved phosphate solution
(0.1 M KH2P04 and 0.72 M K2HP04)
Ampicillin Stock solution of ampicillin (Sigma) was made up at a
concentration of 25 mg/ml, filter sterilized and stored at -20°C. Ampicillin was
added to media and agar at a concentration of 50 (ig/ml.
X-gal Stock solution of X-gal (Boehringer Mannheim) was made up at a
concentration of 20 mg/ml in DMSO and stored, protected from light at -20°C.
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2.3.2 Bacterial host strains.
JM83 ara, A (lac-proAB), rspL, FSO, LacZAM15, (rk+mk+)
(Vieira and Messing, 1982). This host strain was used for Bluescribe or pUC
plasmids.
GM161 F thrl, leu6, thil, supE44, lacYl, tonA21, dam.4, hss2(r-m-)
The bacterial dam gene encodes an enzyme that methylates the N6 position of
the sequence 5'GATC3' (Hattman et al., 1978) The restriction enzyme Bel I will not
cut DNA when this sequence is methylated. Plasmid to be cut at the Bel I site was
grown in dam' GM161.
The stock of GM161 was obtained from Dr. Robin Allshire who had obtained
the strain from Dr. J. Bishop, Department of Genetics, University of Edinburgh.
2.3.3 Vectors and/or clones available for cloning constructs in bacteria.
Bluescribe (Stratagene) is one of the pUC series of plasmid vectors based on
pBR322 (Bolivar et al., 1977). The bacterial origin of replication allows replication
in bacteria to a high copy number and the ampicillin resistance (AmpT) gene ((3-
lactamase) (Vieira and Messing, 1982) allows for selection of plasmid
transformation. The polylinker is inserted into the (3-galactosidase gene (lac Z).
Transformants containing non-recombinant plasmid grew as blue colonies on X-gal
plates due to the enzymatic action of lac Z on X-gal to produce a blue indolyl
derivative. Transformants containing recombinant plasmid in which the insert has
inserted into the polycloning site, and therefore disrupted the lac Z gene, grow as
white colonies. Sequencing of insert is facilitated by the presence of sequence
homologous to the forward and reverse sequencing primers (Section 2.15).
pUC 13/18 (Kay and McPherson, 1987) is a vector containing a symmetric
polylinker (constructed by fusion of Xmn I-Hind III of pUC13 to Hind III-Xmn I of
pUC18) with unique Hind III site in the centre which enables the insertion of DNA
into a site to become flanked by pairs of sites. This vector retains the lac Z gene,
origin of replication and AmpT gene.
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pMClneo PolvA (Thomas and Capecchi, 1987) (Stratagene) contains the
bacterial transposan Tn5 neo gene (with synthetic sequence to substitute the weak
native translation initiation signal) attached to the HS\-tk gene promoter, including
duplication of a synthetic 65 bp fragment from the Polyoma virus enhancer and a
polyadenylation signal. This neo vector is found to be highly efficient at
transforming ES cells to G418 resistance. The plasmid retains an origin of
replication and Ampx gene for amplification in bacterial cells.
SDM Blueneo (Dorin et al., 1989) contains a promoterless neo gene attached to
the HSW-tk polyadenylation signal in bluescribe. The stop codon immediately 5' to
the initiating codon has been removed to allow translational readthrough from
sequence placed in-frame with the neo sequence.
pSV2neo contains the neo gene attached to the SV40 early region promoter and
polyadenylation signal along with the small t intron of SV40.
plJC18HSV-ffc contains the Herpes simplex virus type 1 thymidine kinase gene
(Wagner et al., 1981) 2 kb Pvu II fragment cloned into the Hinc II site of the
polylinker in pUC18 (obtained from Dr. R. Hill). The Bam HI site of the polylinker
is positioned 5' to the gene.
pBLCAT2 (Luckow and Schutz, 1987) contains the bacterial chloramphenical
acetyltransferase gene (CAT) attached to the HSV-f& promoter and SV40 t intron
and polyadenylation signal in pUC18. This vector was used for the construction of
CAT constructs to test for the regulatory effects of cloned DNA elements on a
heterologous eukaryotic promoter.
pBLCAT6 is different from pBLCAT2 in that it does not contain a promoter.
This vector was used for the construction of CAT constructs to test for promoter
function of cloned DNA.
Hox-2.1 subclones covering the region from the EcoRl site in Hox-2.2 to the
Bam HI site downstream of Hox-2.1 were available cloned into Bluescribe. The
subclones used throughout the project are shown in Figure 3.1.
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2.3.4 Preparation of competent JM83/GM161.
This method was obtained from Sambrook et al., (1989), pages 1.76-1.81.
Transformation efficiencies of 5 X 107 to 1 X 108 transformed colonies per jig
supercoiled plasmid DNA may be obtained by this method.
A single colony was used to inoculate a 10 ml overnight culture of L-Broth,
shaking 37°C. 0.4 ml of this culture was used to inoculate 20 ml L-Broth. This
culture was grown to OD530 = 0.3. 10 ml was used to inoculate 200 ml psi broth (L-
Broth containing 10 mM NaCl and 25 mM KC1). This culture was grown to OD530 =
0.48.
The culture was incubated on ice for 15 mins and centrifuged at 5K for 5
minutes at 4°C. The pellet was resuspended in 60 ml filter-sterilized TFB1 (100 mM
RbCl2; 50 mM MnCl2; 10 mM CaCl2; 35 mM NaOAc and 15% v/v glycerol) (pH
5.8) and incubated on ice for 15 minutes. The cells were pelleted as before and
resuspended in 8 ml filter-sterilized TFB2 (10 mM MOPs (pH 6.8), 10 mM RbCl2,
75 mM CaCl2 and 15% v/v glycerol). After incubation on ice for 20 mins 200 jll
aliquots were snap frozen in liquid nitrogen and stored at -70°C.
2.4 Manipulation of plasmid DNA.
2.4.1 Transformation of competent JM83/GM161.
An aliquot of frozen competent cells was thawed on ice. Plasmid DNA to be
transformed was added and the cells left on ice for 20 mins. The cells were then heat
shocked at 42°C for 90 sees, incubated on ice for 1 min and 0.5 ml L-Broth were
added. After 30 mins incubation at 37°C 100 jll aliquots were spread onto L-agar
plates containing ampicillin and if required X-gal.
2.4.2 Small scale plasmid DNA preparation (alkali lysis).
Adapted from Birnboim and Doly (1979).
5-10 ml Terrific Broth, containing ampicillin, was inoculated with a single
colony and incubated, shaking at 37°C for 6 hrs or overnight. Cells from 1.5 ml
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culture were pelleted in an eppendorf. (Remaining culture was stored at 4°C for
preparation of glycerol stock if necessary). The supernatant was discarded and the
pellet resuspended by vortexing in 100 jil solution 1 (50 mM glucose, 0.05 M EDTA
(pH 8) and 25 mM Tris-HCl (pH 8)), containing freshly added lysozyme at 2
mg/ml). The tube was incubated at room temperature for 10 mins. 200 fil solution 2
(0.2 M NaOH and 1% SDS) was added and the tube rocked gently from side to side
before incubation on ice for 10 mins. 150 |il 3 M NaOAc (pH 5.5) was added, the
tube vortexed and incubated on ice for 10 mins. After centrifugation for 10 mins the
supernatant was transferred to a fresh eppendorf and neutralised by the addition of 5
(il 5 M NaOH.
One phenol extraction, one phenolrchloroform (1:1) extraction and one
chloroform extraction was performed in succession. The resulting aqueous layer was
transferred to a fresh eppendorf and plasmid DNA precipitated by the addition of 1
ml ethanol. The DNA was pelleted by centrifugation at 4°C for 15 mins and washed
in 70% ethanol before drying under vacuum. The DNA was resuspended in 50 p.1 TE
and RNase (previously heat treated to destroy DNases) was added to a final
concentration of 0.2 mg/ml. 5 (J.1 was digested with the appropriate restriction
enzyme and visualised on an ethidium bromide-stained agarose gel.
Upon identification of a desired clone, a glycerol stock was prepared by
vortexing a 1:1 mixture of culture and sterile glycerol in a Nalgene cryotube. The
glycerol stock was stored at -70°C.
2.4.3 Large scale plasmid DNA preparation.
A single colony or 10 (il glycerol stock was used to inoculate 10 ml Terrific
Broth, containing ampicillin. After shaking at 37°C for at least 6 hrs this culture
was used to inoculate 200 ml Terrific Broth, containing ampicillin and the flask
shaken at 37°C overnight.
The cells were pelleted by centrifugation at 6000 rpm for 10 mins. The
supernatant was discarded and the pellet resuspended in 20 ml solution 1 (Section
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2.4.2), containing freshly added lysozyme at a concentration of 10 mg/ml. After
incubation at room temperature for 5 mins, 40 ml solution 2 was added and mixed in
gently by rocking from side to side. After incubation on ice for 10 mins 30 ml
solution 3 (3M KOAc, ph 4.8 with acetic acid) was added and the mixture vortexed.
A further incubation on ice for 30 mins was followed by centrifugation at 12000 rpm
for 30 mins. The supernatant was poured through muslin into a fresh centrifuge tube
and 0.6 volumes isopropanol added. After incubation at room temperature for 15
mins the precipitate was pelleted by centrifugation at 12000 rpm for 30 mins. The
pellet was washed in ether, dried under vacuum and resuspended in 3 ml TE. 3 g
CsCl and 120 |il (10 mg/ml) ethidium bromide were added and the mixture
transferred to a 3.5 ml ultracentrifuge tube. The tube was heat-sealed.
The plasmid DNA was banded by centrifugation on a Beckman tabletop
ultracentrifuge at 100000 rpm for at least 3 hours. The plasmid band (visible under
UV due to intercalation of ethidium bromide) was transferred using a syringe and
needle to an eppendorf tube. The volume was measured and named x.
The ethidium bromide was removed by a series of extractions with water-
saturated butan-2-ol, until the organic phase was colourless. The final volume of
aqueous phase was measured and named y. x volumes H20 and y volumes
isopropanol were added to precipitate the plasmid DNA. After incubation at -20°C
the DNA was pelleted by centrifugation, washed in 70% ethanol, dried under
vacuum and resuspended in 0.5 ml TE. DNA concentration was determined by OD
analysis as before (Section 2.2.2).
2.5 Manipulation of DNA by enzymes.
2.5.1 Restriction enzyme digestion of DNA.
Digestion of plasmid or genomic DNA by restriction enzymes was carried out
under the conditions (buffers provided and temperature) recommended for complete
digestion by the manufacturer (Boehringer Mannheim).
When DNA was to be double-digested with two enzymes an enzyme buffer
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favourable to both enzymes was used. If conditions required were dissimilar the
DNA was first digested with the enzyme requiring low salt and the concentration
adjusted by the addition of NaCl for the second enzyme digestion. One unit of
enzyme activity is defined as the amount of enzyme that will cut at all its specific
sites in 1 pg of lambda DNA in 1 hr.
5-10 pg genomic DNA was digested in a 40 pi volume with 3 units enzyme per
pg DNA for 4 hrs minimum.
Heat-sensitive enzyme reactions were stopped by heating to 65°C for 10
minutes while heat-stable enzyme activity was stopped by phenol extraction.
Digests to be loaded onto agarose gels were stopped by the addition of loading
dye, containing EDTA (100 mM EDTA (pH 8), 20% w/v Ficoll and orange G).
2.5.2 Dephosphorvlation of DNA.
Cloning vector linearised with a single enzyme for the ligation of an insert with
compatible ends was dephosphorylated using bacterial alkaline phosphatase (BAP)
to remove the 5' phosphates and thus prevent self-religation.
10 pg plasmid DNA was digested with the desired restriction enzyme in a 50 pi
volume. A 2 pi aliquot was visualised on an ethidium bromide-stained agarose gel to
ensure digestion was complete before the enzyme action was stopped. 5 or 10 pi 10
X BAP buffer (0.5 M Tris (pH 8) and 0.5 M NaCl) was added depending on whether
the digest had been heated or extracted on the previous step. 2 units BAP was added
and the volume made up to 100 pi with distilled H20. The reaction was incubated at
65°C for 1 hr. The BAP was destroyed by the addition of Proteinase K at a final
concentration of 100 pg/ml and incubation at 37°C for 30 mins. The DNA was
extracted once with phenol, once with chloroform and precipitated with 1/10 volume
3 M NaOAc (ph5.5) and 2.5 volumes ethanol. The DNA was pelleted by
centrifugation, washed in 70% ethanol, dried under vacuum and resuspended in 100
plTE.
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2.5.3 Conversion of 5' overhang to blunt end.
5' overhangs were filled in using the 5' to 3' polymerase activity of the Klenow
fragment of E. coli DNA polymerase I.
After digestion with the required restriction enzyme, the enzyme activity was
stopped either by heat or phenol extraction. 1 pi 200 |iM dNTPs, 1 pi 10 X Klenow
buffer (0.5 M Tris (pH7.6) and 0.1 M MgCl2) and 1 unit Klenow enzyme were
added to 1 pi digested DNA (lmg/ml) in a volume of 10 pi. The reaction was
incubated at 37°C for 30 mins. The Klenow activity was stopped by heat.
2.5.4 Phosphorylation of double-stranded oligonucleotide linker.
T4 polynucleotide kinase (PNK) catalyses the transfer of the y-phosphate from
ATP onto the terminal 5'-OH group of DNA.
The following were added to 1 pi linker (100 ng/pg): 1 pi 10 X PNK buffer
(50 mM Tris (pH 8), 10 mM MgCl2 and 5 mM DTT), 0.5 pi 0.5 mM ATP and 5
units PNK in a 10 pi volume. The reaction was incubated for 37°C and the kinase
destroyed by heat.
2.5.5 Ligation of DNA.
T4 DNA ligase catalyses the ligation of DNA ends by forming a
phosphodiester bond between the 3'-OH group of one end and the 5' phosphate of
another end (Weiss, 1968). This enzyme was therefore used to ligate DNA
molecules under conditions which preferentially generate self-ligated products
(inverse PCR) or the ligation of a DNA insert into plasmid.
The buffer conditions used were 66 mM Tris (pH 7.6), 5 mM MgCl2, 5 mM
DTT, and 1 mM ATP.
For inverse PCR ligations, 5 pg digested genomic DNA was ligated in a 1 ml
volume with 10 units ligase (Boehringer Mannheim) and the reaction incubated at
16°C overnight.
For insert into plasmid ligations, 100 ng insert and 20 ng plasmid were
45
incubated together in a 20 pi volume containing 1 unit ligase at 16°C overnight for
blunt-end ligation or room temperature for 2 hours for sticky-end ligation.
2.6 Amplification of DNA by the polymerase chain reaction (PCR).
PCR enables the selective amplification of a specific DNA sequence between
two hybridising oligonucleotides (Saiki et al., 1985). All PCRs were carried out
using Taq DNA polymerase (Promega), a thermostable DNA polymerase isolated
from Thermus aquaticus (Saiki et al., 1988).
2.6.1 PCR on plasmid or genomic DNA.
Reactions were carried out in a 50 pi volume containing: 5 pi 10 X buffer
(supplied by Promega), 50 pmoles of each oligonucleotide primer, 0.05 mM dNTPs,
1 pg genomic DNA template (or 10 ng plasmid DNA) and 1 unit Taq polymerase.
The reaction volume was overlaid with liquid paraffin.
The reactions were performed on a Techne PHC-2 PCR machine. The
reactions were heated to 94°C for 2 mins before 30 cycles of 94°C denaturing for
15 seconds, annealing at the calculated annealing temperature for 15 seconds and
72°C extending for 1 min/kb to be amplified. The annealing temperature was
determined by the GC richness of the oligonucleotides by the following equation:
5°C below the melting temperature (Tm) where Tm at 1 M Na+ concentration =
4(G+C) + 2(A+T) (Wedell et al., 1990). 5 pi product was visualised on an ethidium
bromide-stained agarose gel.
2.6.2 Inverse PCR.
This method allows the amplification of unknown sequence flanking known
sequence (Ochman et al., 1988). Linearised DNA is ligated under conditions which
promote the formation of circles and PCR primers orientated in opposite directions
on the linear DNA can now amplify across the junction of the circle.
5 pg genomic DNA was digested with the chosen restriction enzyme in a 30 pi
46
volume. The enzyme activity was stopped by heating to 65°C. The volume was
made up to 1 ml with ligation mix and 10 units T4 DNA ligase added. The reaction
was incubated at 16°C overnight. The ligase was destroyed by heating to 65°C for
10 mins. The DNA was ethanol precipitated, pelleted and dried under vacuum. 1 |ig
DNA was added to 50 jil PCR mix and 30 cycles PCR amplification were
performed.
10 pi product was visualised on an ethidium bromide-stained agarose gel. The
gel was blotted and the blot hybridised with an end-labelled oligonucleotide, internal
to the expected product. The band hybridising with the internal oligonucleotide was
cut from a LMT agarose gel and 30 cycles of PCR performed on 1 pi of the gel slice,
either between the original primers or between one primer internal to the product and
the second primer.
2.7 Gel electrophoresis of nucleic acid.
2.7.1 Solutions.
20 X TBE.
216 g Tris (1 M), 18.6 g EDTA (1M) and 110 g boric acid (20mM) made up
to 1 L with distilled H20 and autoclaved to prevent precipitation.
5 X MOPS buffer.
0.2M MOPS (pH 7)
50 mM sodium acetate
5 mM EDTA (pH 8)
made up to 1 L with distilled H20 and autoclaved.
DNA loading buffer/stop mix.
100 mM EDTA (pH 8), 20% ficoll and enough orange G for visualisation on
gel.
RNA loading buffer.




Water used for RNA was treated by adding diethyl pyrocarbonate (DEPC) to a
final concentration of 0.5 v/v and leaving overnight before autoclaving.
2.7.2 Agarose gel electrophoresis for resolving DNA molecules.
Agarose gels were used to resolve DNA fragments from 100 bp to 30 kb using
concentrations of agarose from 2% to 0.8% in 1 X TBE buffer. 4% Nusieve gels
were used to resolve 100 bp to 400 bp DNA fragments. Ethidium bromide was
added to the agarose at a concentration of 0.5 |ig/ml.
Samples were prepared by adding 1/10 volume loading buffer and loaded onto
the gel in the tank. Gels were run in 1 X TBE at 3-12 V/cm. Hind III digested
lambda DNA (BRL) or Hae III digested <J)X DNA (BRL) were used as molecular
weight markers.
DNA was fractionated on LMT agarose for the isolation of fragments for
ligation, further amplification by PCR, Genecleaning for direct PCR sequencing or
for random prime labelling as hybridisation probes
2.7.3 Purification ofDNA from agarose.
DNA was purified from LMT agarose by Geneclean (BIO 101 Inc.). The
procedure was as specified by the manufacturer.
DNA was recovered from type II agarose by centrifugation through blotting
paper (Weichenhan, 1991). This method was suitable for inserts for ligation. A
square piece of Whatman 3 MM paper (2x2 cm) was wrapped round the blunt end
of a micropipette tip to form a beaker and was inserted into a punctured eppendorf
tube. The agarose slice was placed inside the blotting paper. The tube was mounted
into a second eppendorf and centrifuged for 1 min. The DNA, in TBE, was collected
in the lower eppendorf. 1 p.1 of this was used for ligation reactions.
2.7.4 Formaldehyde gel electrophoresis of RNA.
RNA gels were run according to the method of Sambrook et al. (1989), 7.43-
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7.45.
1.2% agarose gels were prepared by melting 1.34 g agarose in 70 ml H20,
cooling to 60°C and adding 22.4 ml 5 X MOPs buffer and 20 ml deionised
formaldehyde.
RNA samples were prepared by incubation of 4.5 pi (up to 20 pg) in 2 pi 5 X
MOPS buffer, 3.5 pi formaldehyde and 10 pi deionised formamide, at 55°C for 15
mins. 2 pi loading buffer was added before loading onto the gel. Gels were run in 1
X MOPS buffer at 60 V.
1 pi of 1 mg/ml ethidium bromide was added to the RNA sample if
visualisation was required.
2.7.5 Polyacrvlamide gel electrophoresis.
Denaturing polyacrylamide/urea gels were used to resolve DNA sequencing
reactions. Polyacrylamide gels were used to resolve gel retarded products.
The glass plates for the sequencing gel were cleaned thoroughly in detergent
and water. The surface of the top/eared plate was wiped with distilled HzO and then
dimethyldichlorosilane. The plate was left to dry in the fume hood. The bottom plate
was wiped with ethanol and allowed to dry. Spacers were sandwiched between the
plates and the edges and bottom of the plates sealed with tape.
40 ml instagel (6% acrylamide:N,N'-methylenebisacrylamide (19:1)), 7.5 M
urea and 1 X TBE) was mixed with 0.33 ml 10% ammonium persulphate and 50 pi
TEMED. This mixture was poured between the plates and a sharkstooth comb
inserted before the gel was allowed to set. The gel was run at a limiting power of 26
W for 1 to 4 hrs.
Gel retard experiments were run on a Pharmacia LKB 2001 vertical 16 cm
(1.5 mm thickness) electrophoresis system. Plates were washed in ethanol before
assembling as manufacturers instruct.
40 ml 10%, 0.5 X TBE gels were made up from 19:1 stock acrylamide:N,N'
methylene bisacrylamide with 400 pi 10% ammonium persulphate, TBE and H20.
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The gel was run at a limiting voltage of 150-200 V in 0.5 X TBE.
After electrophoresis the tape and top plate were removed and the gel
immersed in fix (12% methanol and 10% acetic acid) for 10 mins. The fix was
drained from the plate and the gel transferred to a piece of 3MM paper by laying the
paper on top and peeling off slowly. The gel was covered with clingfilm and dried
under vacuum at 80°C on a gel drier. The gel, with clingfilm removed, was exposed
to X-ray fdm at room temperature.
2.8 Transfer of nucleic acid to nylon membrane.
2.8.1 Southern transfer of DNA.
DNA was transferred from agarose gels to nylon membranes (Hybond-N,
Amersham) by the capillary blotting method outlined by Southern (1975).
Gels, aligned with a ruler, were photographed on a UV transilluminator. The
DNA was denatured by shaking the gel in denaturing solution (1.5 M NaCl and 0.5
M NaOH) for 45 mins and neutralised by shaking in neutralising solution (1.5 M
NaCl, 0.5 M Tris and 1 mM EDTA) (pH 5.5) for 45 mins.
The gel was placed on a wick made from Whatman 3MM paper pre-soaked
with 20 X SSC (3 M NaCl and 0.3 M sodium citrate) (pH 7) and dipped into a
reservoir of 20 X SSC. Exposed regions of the wick were covered with clingfilm. A
piece of Hybond-N was cut and placed flat on top of the gel. 2 pieces of 3MM paper
were cut, presoaked in 20 X SSC and rolled flat on top of the Hybond-N. A 2 inch
layer of paper towels, a glass plate and a weight were placed on top.
Genomic DNA blots were left for a minimum of 5 hrs.
The DNA was cross-linked to the membrane by exposure to UV (3 mins on
UV transilluminator or 1200 pjoules from stratalinker (Stratagene)) and baking at
80°C for 30 mins.
Hybridised DNA may be removed from Hybond-N filters for re-probing.
Filters were stripped by immersing in boiling 0.01 M Tris (pH 8) and 0.1% SDS and
shaking until the solution had cooled to room temperature.
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2.8.2 Drv-blotting of DNA.
This method was used as a quick way of transferring plasmid or PCR product
from mini-gel to nylon. The mini-gel was denatured and neutralised as above and
placed on a piece of clingfilm. A piece of Hybond-N was laid on top, followed by
3MM paper and paper towels as before. The blot was left for a minimum of 1 hour.
DNA was crosslinked by exposure to UV (1200 (ijoules from the stratalinker).
2.8.3 Transfer of plasmid DNA from bacterial colonies to nvlon membrane.
This method is taken from Sambrook et al. (1989), pages 1.90-1.99. It was
used to screen large numbers of bacterial colonies for recombinant plasmid.
Bacterial colonies were streaked in duplicate, using sterile toothpicks, onto a
gridded master L-agar plate and onto a gridded circle of Hybond-N, which was laid
flat on an L-agar plate. Both plates were incubated at 37°C for a minimum of 6
hours until bacterial colonies were observed to grow. The master plate was stored at
4°C until required.
The Hybond-N circle was transferred to a piece of Whatman 3MM paper
presoaked in 10% SDS for 3 mins. Then it was transferred to a piece pre-soaked in
denaturing solution, left for 5 mins and transferred to a piece pre-soaked in
neutralising solution for 5 mins. The filter was rinsed in 3 X SSC. The DNA was
cross-linked as before and hybridised to an end-labelled oligonucleotide specific for
the insert in the recombinant plasmid. Upon identification of a recombinant clone a
culture was grown from the streak on the master plate corresponding to the positive
hybridising colony on the filter.
2.8.4 Northern blotting of RNA.
RNA formaldehyde gels were rinsed twice for 20 mins in H20. The RNA was
then capillary blotted onto Hybond-N, gel turned upside down, on an apparatus
similar to that described for Southern blotting. 10 X SSC was used for the transfer.
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2.9 Radiolabelling of DNA.
2.9.1 Random primed oligonucleotide-labelling with Klenow.
DNA probes excised from LMT gels were radiolabeled with [a-32P] dCTP by
random priming from hexadeoxyribonucleotides using the Klenow fragment of E.
coli DNA polymerase I (Feinberg and Vogelstein, 1983 and 1984).
I ml distilled H20 per gram of DNA agarose slice was added and boiled for 10
mins to denature. At this stage the DNA probe could be stored at -20°C and melted
at 65°C before subsequent labellings. Total plasmid probes (25 ng in 11 pi H20)
were boiled for 10 mins.
II pi (approximately 30 ng) DNA probe was labelled in a 20 pi volume using
the Boehringer Mannheim kit. 1 pi each dATP, dGTP, dTTP, 2 pi reaction mix
(containing hexanucleotides), 30 pCi [a-32P] dCTP and 2 units Klenow were added.
The reaction was incubated at 37°C for a minimum of 30 mins.
Unincorporated dCTP was removed by either spinning through a sephadex
G50 column (1600 rpm for 5 mins) in 3 X SSC or by passing through a Nick column
(Pharmacia) following the instructions given by the manufacturer.
2.9.2 End labelling of DNA oligonucleotides.
Oligonucleotides were end labelled by the transfer of the 32P-labelled y-
phosphate from [y-32P] ATP onto the terminal 5'-OH group.
50 ng oligonucleotide was labelled in a 20 pi volume containing 1 X PNK
buffer (5 mM Tris (pH 8), 1 mM MgC12 and 0.5 mM DTT), 50 pCi [y-32P] ATP and
10 units PNK. The reaction was incubated at 37°C for 30 mins and stopped by
heating to 65°C for 10 mins.
2.10 Nucleic acid hybridisation.
2.10.1 Hybridisation solutions.
Quick oligonucleotide hvb mix
5 X SSC, 0.05% w/v BSA, 0.05% w/v Ficoll, 0.1% w/v SDS, 0.05% w/v
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polyvinyl pyrrolididone, and 0.1% w/v sodium pyrophosphate.
Hybridisation fluid
4 X SSC, 0.2% w/v SDS, 0.1% w/v sodium pyrophosphate, 50 mg/ml
denatured salmon sperm DNA, 5 X Denhardts and 2 mM EDTA. This fluid was
stored as 50 ml aliquots at -20°C.
100 X Denhardts
2% w/v polyvinyl pyrrolidone, 2% w/v BSA and 2% w/v Ficoll.
Church buffer
(Church and Gilbert, 1984)
7% SDS, 0.5 M NaP04 (pH 7.2)
2.10.2 Hybridisation methods
Hybridisation of end labelled oligonucleotide was carried out in quick
oligonucleotide hyb mix at the Tm-5 of the oligonucleotide. Hybridisation of random
primed DNA probes was carried out in the above hybridisation fluid (Southerns) or
Church buffer (Northerns) at 68°C.
Filters were prehybed in hybridisation solutions in sealed plastic bags for a
minimum of 30 mins at 68°C, submerged in a shaking water bath.
End labelled oligonucleotide was added directly to the bag, the bag resealed
and the hybridisation incubated in a shaking water bath for a minimum of 4 hrs.
Filters were washed in 4 X SSC and 0.1% SDS, 2 washes of 10 mins at room
temperature and one wash for 2 mins at hybridisation temperature.
Random primed probes were boiled for 10 mins to denature before adding to
the bag. One random primed reaction was usually added to two large filters in 30 ml
hybridisation fluid. The hybridisation was incubated in a shaking water bath for a
minimum of 16 hrs. Filters were washed at 68°C once for 20 mins in 3 X SSC, 0.1%




Filters were dried on 3MM paper and wrapped in clingfilm.
32P labelled filters were exposed to Kodak X-AR5 autoradiograph film in
cassettes, which had tungsten intensifying screens, at -70°C. Filters were stored from
20 mins up to 2 weeks before developing the film using an automatic XI X-
OGRAPF1 processing machine.
2.12 DNA sequencing.
2.12.1 Double-stranded DNA sequencing of plasmid DNA.
DNA sequencing was performed using the chain termination method of
Sanger et al. (1977). The Sequenase version 2.0 kit (United States Biochemical) was
used to perform reactions on double-stranded DNA template.
1-2 jig miniprep or maxiprep plasmid DNA was denatured in the presence of
2.5 ng oligonucleotide primer in 0.2 M NaOH. After 2 mins this was neutralised by
the addition of 1.4 M ammonium acetate (pH 7.6) and the DNA precipitated with 4
volumes ethanol. After 15 mins at -20°C the DNA was pelleted, washed in 70%
ethanol and dried under vacuum. The primer will have become annealled to the
template.
The annealled template-primer was resuspended in 10 |il distilled H20. 2 jil 5
X sequenase buffer (200 mM Tris (pH7.5), lOOmM MgCl2 and 250 mM NaCl), 1 |il
0.1 M DTT, 2 |il 1 X labelling mix (0.75 jiM dGTP, dCTP and dTTP), 5 pCi [a-
35S] dATP and 2 jil Sequenase enzyme (diluted 1:8 in enzyme dilution buffer) were
added. The reaction was incubated at room temperature for 5 mins, during which
time primer is extended by the polymerase activity of Sequenase and 35S
incorporated into the newly synthesized strand. 3.5 |il aliquots were added to 4 tubes
labelled T,C,G and A, each of which contained 2.5 jil of the corresponding T,C,G or
A termination mix (50mM NaCl, 80 |iM of three dNTPs and 8 JiM of the limiting
ddNTP). The reactions were incubated at 37°C for 5 mins before the addition of 4 jil
stop mix. The newly synthesized strand of labelled DNA terminates with a ddNTP,
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which prevents further extension due to the lack of a 3'-OH. Each tube contains
varying lengths of labelled DNA molecules terminated at each complementary base
to the ddNTP in the sequence (within a few hundred bases of the primer).
The DNA was denatured by incubation at 80°C for 2 mins before running the
4 reactions side by side on a polyacrylamide/urea sequencing gel.
To obtain sequence information close to the primer 1 pi Mn buffer (0.15 M
sodium isocitrate and 0.1 M MnCl2) was added to the labelling reaction with the
Sequenase. The addition of Mn2+ to normal (Mg2+) sequencing reactions reduces the
length of DNA synthesized and therefore intensifies the bands corresponding to
sequence close to the primer. Sequencing gels for the visualisation of such reactions
were run until the bromophenol blue dye had run 3/4 the length of the gel.
2.12.2 Direct sequencing of PCR products.
2/5 PCR product (20 pi) was excised from an agarose gel and Genecleaned
prior to sequencing using the Sequenase version 2.0 kit (Winship, 1989).
3-5 pi Genecleaned PCR product was boiled for 3 minutes with 140 ng primer
(either PCR primer or one internal to amplified product), 2 pi sequenase buffer, 1 pi
DMSO in a 10 pi volume. The tube was snap-freezed by dropping into liquid
nitrogen.
The DDT, dilute labelling mix, [a-35S] ATP and sequenase were added as in
plasmid DNA sequencing and the labelling reaction incubated for a maximum of 90
seconds before the addition of 3.5 pi reaction to the four termination mixes. 10%
DMSO had been previously added to the termination mixes. The termination
reaction was incubated at 37°C for 5 mins as before.
2.13 CAT (chloroamphenical acetyltransferase) assays.
The ability of cis-acting elements to regulate gene expression may be assayed
by attachment to a reporter gene such as CAT (Gorman et al., 1982). CAT modifies
and inactivates chloramphenical by mono- and diacetylation. The CAT activity was
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assayed by thin-layer chromatography (TLC) (Sambrook et al., 1989; 16.56-16.61).
1 X 107 ES cells were electroporated with 40 (ig CAT construct under the
conditions described in section 2.2.3. The cells were plated onto two 10 cm diameter
dishes and incubated for 2 days. After two washes in PBS the cells were harvested
by scraping into 1 ml PBS. The cell suspension was transferred to an eppendorf and
the cells pelleted by centrifugation for 10 seconds. The cells were resuspended in
ice-cold PBS and repelleted. The PBS was aspirated from the eppendorf using a
vacuum line. The cells were resuspended in 100 (il 0.25 M Tris (pH 7.8) and
vortexed. The cells were disrupted by three cycles of freezing in a dry ice/ethanol
bath and thawing at 37°C. The cells were pelleted by centrifugation for 5 mins and
the supernatant transferred to a fresh eppendorf. 50 |il of the extract was stored at -
20°C.
The second 50 |il aliquot was incubated at 65°C for 10 mins to inactivate
deacetylases and any debris pelleted by centrifugation. 96 fil CAT reaction mix (56
(il 1 M Tris (pH 7.8), 20 p.1 0.25 M (57 |iCi/mmol) 14C-labelled chloramphenical and
20 p.1 3.5 mg/ml acetyl coenzyme A) was added to the supernatant and the reaction
incubated at 37°C for 2 hrs. 1 ml ethyl acetate was added and the mixture vortexed
for three periods of 10 seconds each. After centrifugation for 5 mins, 900 |il of the
upper phase (containing the acetylated forms of chloramphenicol) was transferred to
a fresh eppendorf. The ethyl acetate was evaporated by placing in a rotating
SpeedVac for 1 hr.
The reaction products were redissolved in 25 |il of ethyl acetate and applied
to the origin of a 25-mm silica gel TLC plate. The plate was placed in a TLC
chamber containing 200 ml chloroform :methanol (95:5) and allowed to run until the
solvent front had moved 75% of the distance to the top of the gel.
After air drying the plate was exposed to X-ray film at room temperature.
The chloramphenical acetylated spots were scraped from the plate and 5 ml
Aquasol 2 scintillation fluid added before liquid scintillation counting.
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2.14 Gel retardation.
2.14.1 Preparation of ES cell nuclear protein.
Cells were harvested by trypsinisation and the trypsin neutralised by washing
the cells twice in medium. The cells were washed three times in PBS and pelleted.
The pellet was resuspended in 2.5 ml lysis buffer (10 mM Tris (pH 7.5), 10
mM NaCl, 2 mM MgCl2 and 0.05% NP40). The lysate was incubated for 5 mins on
ice and forced up and down through a 21 gauge needle. Release of nuclei was
checked for by inspection under the microscope. The lysate was transferred to a
corex tube and the nuclei pelleted by centrifugation at 3000 rpm for 1 min.
Nuclear protein was extracted in the buffer used by Strauss and Varshavsky
(1984). The nuclear pellet was resuspended in 0.5 ml buffer (0.35 M NaCl, 5 mM
EDTA, 10 mM P-mercaptoethanol, 10 mM Tris-HCl (pH7.5) and 0.2 mM PMSF
(proteinase inhibitor). After incubation for 30 mins on ice with occasional vortexing,
the suspension was centrifuged for 15 mins and the supernatant transferred to a fresh
eppendorf. 15% glycerol was added and the protein extract stored at -70°C.
The protein concentration was measure using a Biorad dye-binding assay.
The acidic solution of Coomassie Brilliant Blue G-250 shifts absorbency from 465 to
595 nm in the presence of protein. Bovine gamma globulin was used as a protein
standard. The protein extract was found to have a concentration of 1.2 mg/ml.
2.14.2 Gel retardation.
Oligonucleotides were labelled with 32P as described previously and annealed
by cooling slowly from 65°C. Annealing was checked by running the
oligonucleotides on a 12% polyacrylamide gel.
5 |il proteins and 1 (il 1/100 dilution of labelled oligonucleotides (20000
counts per minute/ml) were incubated on ice for 1 hr in gel shift buffer (Frain et al.,
1989; gifted by Peter Budd) (20 mM Tris HC1 (pH 7.6), 12% glycerol, 25 mM KC1,
4 mM MgCl2, 4 mM spermidine, 1 Mm EDTA and 0.5 mM BSA) with 4 jig dldC
(non-specific competitor) before loading on a 10% polyacrylamide gel. Tracking dye
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(50% glycerol, 1 X TBE and 1% bromophenol blue) was loaded into the end tracks.
The gel was run at a limiting voltage of 150 V until the bromophenol blue had run
3/4 the length of the gel, fixed and dried as described previously.
2.15 Oligonucleotides.
Most oligonucleotides were synthesized by Doreen Chambers on an Applied
Biosystems 381A oligonucleotide synthesizer, with the exception of the forward and
reverse sequencing primers (Biolabs) and oligonucleotide 598 (Oswel DNA
Service).
Oligonucleotides were precipitated from ammonium stocks with 1/10 volume
3 M sodium acetate and 2.5 volumes ethanol at 20°C for 1 hr. The oligonucleotides
were pelleted by centrifugation for 15 mins, washed 3 times in 80% ethanol and
dried under vacuum. They were resuspended in 100 p.1 TE. The concentration was
determined by OD analysis, where OD260 = 1 at 20 |J.g/ml single-stranded DNA.
The oligonucleotides which were used for PCR, probes, sequencing, in CAT
constructs or gel retards are listed below:
neol8 CCTCTCCACCCAAGCGGC anti-sense neo
neol9 ACGATCCTCCTCCTGTCTC anti-sense neo
192 AAATCGTGAAGCACAGGG 39-56 Hox-2.1 cDNA sense
314 GCTACCAGACCCTGGAGC 711-729 Hox-2.1 cDNA sense
315 GTCAGGTAGCGATTGAAG 745-763 Hox-2.1 cDNA anti-sense
598 TCTTCAGAGAGATCTCCC spans Bglll site 3' to Hox-2.1
B2 GGTGGCTGCTGTGGGCTA 101 bp 3' to oligonucleotide 598
B85 GGACTGAGCCAGGCTGAG 5' insertion in 7B2: HTS sequence 40-58
B218 GGTGAACTCACAGCCTCC 3' insertion in 7B2: HTS sequence 435-417
B407 CCTAGGGTAGATATCAGA 3' insertion in 7B2: HTS 1177-1160
B460 GAGTCTCGGATATCATTC 3' insertion in 7B2: HTS sequence 481-496
B461 GGATGAGAAATGTGTTCC 3' insertion in 7B2: HTS sequence 922-905
-40 GT 1"1TCCCAGTCACGAC forward sequencing primer
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rev AACAGCTATGACCATG reverse sequencing primer
671 GTAAAACGACGGCCAGT Bluescribe primer:-41 to-25
B539 GATCCCAACCGCTCGCAG F2 locus: 193-209
B267 AGCAACAGTTTCCAGGCTTCCCC 7B2 direct repeat
B268 GGGGAAGCCTGGAAACTGTTGCT complement of B267
B277 AGCAACTGACTTCAGGCTTCCCC negative control for B267
B278 GGGGAAGCCTGAAGTCAGTTGCT complement of B277
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CHAPTER 3
TARGETING HOX-2.1 IN ES CELLS
3. TARGETING HOX-2.1 IN ES CELLS
3.1 Introduction.
The targeting frequency of a vector may be expressed as the number of
correctly targeted homologous recombination events as a fraction of the total number
of G418-resistant (G418r) clones. Targeting frequency is reduced by random
integration. Various parameters have been shown to affect targeting efficiency - in
particular the construct design.
There are two basic types of targeting vector - the replacement and the
insertion type. Their modes of action are described in Section 1.4 and illustrated in
Figure 1.2. Early studies by Thomas and Cappecchi (1987) showed that these vectors
had similar, but rather low targeting frequencies of 1/1000 G418r clones.
Homologous recombination occurs rarely against a large background of non¬
homologous integration events.
Two strategies have been used to enrich for homologous recombinant events
by reducing the amount of random insertion events surviving selection. By
introducing a promoterless neo into the construct (Doetschman et al., 1988; Dorin et
al., 1989 and Sedivy and Sharpe, 1989) only integration events that lie close to an
active promoter will allow neo expression. This strategy relies on expression of the
targeted gene in ES cells. In the alternative positive-negative selection (PNS)
strategy (Mansour et al., 1989) the HSV-r£ gene is introduced into the construct at
the end of target gene sequence homology. Upon homologous recombination and
replacement of target DNA, the HSV-r& gene is lost; while random integration of the
whole construct results in integration of the HSW-tk gene. Cells in which the HSV-tk
gene has integrated are sensitive to the base analogue, gancyclovir (ganc), and
therefore, may be selected against. These enrichment strategies have been discussed
in more detail in Section 1.4.
During this work, it was reported by Dr. Alan Bradley (personal
communication) that insertion vectors had high targeting frequency, comparable to
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those reported for PNS vectors. A recent paper by Hasty et al. (1991b) confirms that
insertion vectors may be up to 9-fold more efficient than replacement events (with
no enrichment). This may be because one cross-over is required instead of two, the
proximity of two adjacent homologous free ends or because of uninterrupted
homology.
Five different targeting vectors have been used in this project to target Hox-
2.1 in ES cells, based on the replacement, PNS and insertion vectors: a replacement
vector with promoterless neo (construct 2); two PNS vectors with either the Hox-
2.1 promoter driving neo expression (Hox2.1ptk) or a promoterless neo (Q2BBtk)
and two insertion vectors (construct 6 and HoxTneo).
L cells were transfected as a test system for the replacement vectors until ES
cells were being grown successfully in the laboratory. For the same reason one
transfection of ES cells with construct 2 was made in Dr. Robin Lovell-Badge's
laboratory. Clones were grown by Robin Lovell-Badge and Michaela Riddel, cells
pelleted and posted to Edinburgh for DNA extraction and analysis.
Initially G418r clones were analysed by PCR amplification between an
oligonucleotide (192) upstream of the Hox-2.1 sequence present in the replacement
targeting construct and the sense neo primer (neol8) on crude cell lysates prepared
from a few cells. Only cell lines in which homologous recombination between the
incoming vector and the endogenous locus has occurred will have the sequence
required for this amplification. However, in testing out the PCR primers on control
plasmid (£22) contamination from PCR product became a problem. Positives were
identified which upon further analysis of restriction fragment lengths were shown to
be random integration events and therefore false positives on the PCR screen. There
have been reports of PCR screens giving false negatives, where homologous
recombinants have failed to PCR amplify but have been identified on restriction
mapping. This may be caused by an inhibitor of PCR present in the crude cell lysate.
PCR may also be subject to artifact from random integration events (see Section 1.4,
Mansour, 1990 and Kim et al., 1991). It was decided that all subsequent clones
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should be analysed by restriction enzyme mapping at the Hox-2.1 locus to detect any
alteration due to insertion of neo. It was thought that enrichment for homologous
recombination events by the promoterless neo and PNS would reduce the numbers
needed for screening. Although this analysis is more time-consuming (since firstly
greater numbers of cells are needed and secondly the procedure is lengthier) the
results are more reliable.
All the vectors were designed to introduce a null mutation into one copy of
Hox-2.1.
3.2 Replacement vector with promoterless neo.
Construct 2 (Figure 3.2d) was cloned from a larger targeting construct, Q2
(Figure 3.1c/3.2c), which had been previously constructed and tested for targeting
efficiency by Dr. Ian Jackson. Q2 has 400 bp Hox-2.1 sequence (polylinker Eco R1
of cDNA clone (Figure 3.1b) (obtained from Dr. R Krumlauf) to Bam HI within
coding sequence) cloned upstream of a promoterless neo gene and 10 kb Hox-2.1
sequence (Hind III site within intron to 3' Bam HI) cloned downstream. The 1.2 kb
neo sequence replaces the 600 bp Bam HI to Hind III exon to intron fragment of
Hox-2.1. Thus a null mutaion is introduced into Hox-2.1 upon homologous
recombination.
It was thought at the time of study that the synthetic Bam HI site present at
the 5' end of the upstream Hox-2.1 sequence and that deletion of the 1 kb Hind III
fragment from within the 3' Hox-2.1 sequence in Q.2 might decrease or hinder
targeting by this vector. Therefore, the 5 kb Sst I fragment cut from Q2 and
identified as the rceo-containing fragment by hybridisation to the neo 18
oligonucleotide was cloned into the Sst I site of Bluescribe to generate the targeting
vector, construct 2. Construct 2 has 100 bp of Hox -2.1 sequence cloned upstream of
neo and 4 kb of sequence cloned downstream. Although it has a short region of
homology at the 5' end, the synthetic Bam HI site has been removed. Construct 2
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Enzymes are abbreviated as: E=EcoRI, H=Hind III, B=Bam HI, S=Sst I and Bg=Bgl II.
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£22 (and hence construct 2) contains a promoterless neo derived from the
SDM Blueneo of Dr. Julia Dorin (see Section 2.3.2). The stop codon immediately 5'
of the initiating codon of the neo has been mutated by site directed mutagenesis to
allow readthrough from upstream coding sequence. Q.2 was constructed by the
inframe fusion of neo 3' to 400 bp of Hox 2.1 sequence (ligation of Bam HI Hox-2.1
fragment to Bel I cut Blueneo). The fused sequence is presented in Figure 3.3. No
promoter activity has been identified from the 400 bp Hox-2.1 sequence. In order to
obtain neo expression the constructs (£22 or construct 2) must integrate close to an
active promoter and allow translation from the neo AUG or produce a functional neo
fusion protein.
It has been shown that Hox-2.1 is expressed at a low level in ES cells (Dr. R.
Krumlauf, personal communication) by nuclear run-off analysis. Homologous
recombination of construct 2 should therefore allow the transcription of Hox-2.1-neo
fusion transcript.
Translation may start from the neo AUG or from a 5' AUG if the open
reading frame into the neo is maintained. In order to generate G418-resistant clones
the latter event must produce a functional neo-fusion protein. The Hox-2.1 AUG is
present in £22 but is absent from construct 2 (see Figure 3.3). Upon homologous
recombination Hox-2.1-neo fusion protein should be generated.
In order to confirm that the Hox-2.1-neo fusion transcript could provide
G418r a third construct (Hox2.1pneo) was made. Hox2.1pneo (Figure 3.2e) contains
1.8 kb of Hox-2.1 sequence (1.7 kb 5' untranslated sequence and 100 bp of coding
sequence) fused inframe to the promoterless neo. This 1.8 kb fragment was thought
likely to contain the Hox-2.1 promoter function. Hox2.1pneo was constructed by
cloning the 1.8 kb Bam HI fragment (gel purified from subclone Hox2.1-2.2 (Figure
3.Id)) into Bel I linearised and BAP-treated SDM Blueneo. The orientation of the
insert in relation to neo was checked by double digestion with Bam HI and Hind III.
Numbers of G418r foci generated upon transfection of cells with Bam HI linearised
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GAA GTA CAG TGC ATC GCT ATA ATT CAT TAA TAC ATC ATA AAT CGT
GAA GCA CAG GGT TAT AAC GAC CAC GAT CCA CAA ATC AAG CCC
TCC AAA ATC ACC CAA ATG AGC TCG TAC TTT GTA AAC TCC TTC TCG
GGG CGT TAT CCA AAT GGC CCG GAC TAT CAG TTG CTA AAT TAT
GGC AGT GGC AGC TCT CTG AGC GGC TCT TAC AGG GAT CAA GAG
ACA £GA GGA GGA TCG TTT CGC ATG neo
Figure 3.3
Hox-2.1-neo sequence fusion in Q2. neo sequence is in
translation stop codon -15 bp from the neo initiation c
(underlined) to allow in-frame readthrough from the Hox-2.1
The Hox-2.1 initiation codon (underlined) has been deleted
to the GAGCTC Sst I site used to subclone construct 2 from I
bold print. The T of the TGA
odon has been mutated to a G
initiation codon.
:rom construct 2 since it is 2 bp 5'
712.
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Hox2.1pneo were compared to the numbers generated upon transfection with the
promoterless neo vector, construct 2 (tabulated as G418r frequency in Table 3.4).
The frequency of G418r induced by Hox2.1pneo was found to be 80-fold higher
than that induced by construct 2. It may be concluded from these data that
Hox2.1pneo contains promoter function and that either the Hox-2.1-neo fusion
protein is capable of neomycin phosphotransferase activity or that translation starts
from the neo AUG.
Construct 2 derived G418r clones were analysed for homologous
recombination by restriction mapping. The predicted alteration at the Hox-2.1 locus
due to the integration of neo and deletion of 600 bp of Hox-2.1 sequence upon
replacement of endogenous sequence with construct 2 is shown in Figure 3.4b. DNA
extracted from cell lines was restricted with EcoRI, Bam HI or Hind III and the blots
generated probed with the Hox-2.1 1 kb Sst I fragment (gel purified from Hox2.1-
2.2 subclone) from upstream of the construct sequence. Hybridisation to only the
endogenous/normal band indicates random integration of the construct.
Hybridisation to both the normal band and to the predicted diagnostic band would
indicate homologous recombination in that cell line. These two bands will be of
equal intensity and half as intense as the normal signal from the Hox-2.1 locus. The
predicted fragment band sizes are summarised in Table 3.1. The neo (insert gel
purified from pMClneo polyA) probe should hybridise to the same diagnostic band
in homologous recombinants since the neo and Hox-2.1 probes are separated by
DNA that is uncut by the chosen restriction enzymes. Upon hybridisation with a neo
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Predicted alteration to the restriction fragment lengths at the Hox-2.1 locus upon homologous
recombination with construct 2 (b), £22BBtk (c) or Hox2.1ptk (d) compared to the endogenous
Hox-2.1 restriction map (a). Construct sequence is represented by the thick line. The stippled
lines represent the probes used to detect the restriction fragments. The enzyme abbreviations








Eco RI 5.0 5.6
Hind III 2.0 2.6
Bam HI 1.8 14
Table 3.1
The restriction fragment lengths (kb) at the endogenous Hox-2.1 locus and the predicted
diagnostic fragment lengths for correct targeting of construct 2, upon hybridisation with the 1
kb Sst I probe 5' to the construct sequence. The same homologous recombinant diagnostic
bands will hybridise to the neo probe.
3.3 Replacement vector based on PNS.
Two PNS vectors were constructed.
Q2BBtk (Figure 3.2f) has the same 400 bp Hox-2.1 sequence segment as Q.2
fused 5' to the promoterless neo and 3.5 kb Hox-2.1 sequence (Hind III in intron to 3'
Bgl II) cloned downstream. The HSV-f& gene is positioned 5' to the upstream Hox-
2.1 sequence. Q2BBtk was constructed by cloning the 5.5 kb (neo-containing) Bam
HI to Bgl II fragment of Q2 into Bam HI and BAP-treated pUC18HSV-r&. Q2BBtk
was either linearised with Bam HI or Kpn I. Upon linearisation with Bam HI, the
HSV-r& gene and its promoter are positioned at the 3' end of the DNA molecule.
Upon linearisation with Kpn I, the HSV-tk gene is positioned centrally, immediately
5' to the promoterless neo. The position of the HSV-tk gene may be important since
upon random integration ends of the construct may be lost. HSV-T& positioned with
the transcription start site at the end of the molecule may become non-functional
upon integration and cell lines resistant to ganc will be generated.
Hox2.1ptk (Figure 3.2g) has the 1.5 kb (5' Hind III to Bam HI in coding
sequence) fragment of Hox-2.1 fused inframe with the promoterless neo and the 4
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kb (Bam HI in coding sequence to 3' Bgl II) Hox-2.1 fragment cloned downstream.
The HSW-tk gene is positioned 3' to the Hox-2.1 downstream sequence. The 1.5 kb
of sequence upstream of the neo has been shown to have promoter function (Table
3.4). The cloning steps involved in the construction of Hox2.1ptk are shown in
Figure 3.5. Hox2.1ptk was linearised prior to elecroporation by digestion with Kpn I.
The predicted alterations to the Eco RI restriction length fragments caused by
homologous recombination of Q2BBtk and Hox2.1ptk into the Hox-2.1 locus are
shown in Figure 3.4c and 3.4d. Homologous recombination leads to replacement of
endogenous Hox-2.1 by a null copy, disrupted by the neo gene (as Q2 and construct
2). G418r gancr cell line DNA was digested with EcoRI and the blots generated
hybridised to the 1.5 kb Eco RI to Hind III fragment of Hox-2.1 (purified from
Hox2.1-2.2) from upstream of the PNS construct sequences. Hybridisation to the
normal band only, indicates random insertion of the construct, while hybridisation to
the normal band and the predicted diagnostic band size, would indicate homologous
recombination. The fragment lengths are summarised in Table 3.2. Cell lines were




Enzyme Endogenous homologous homologous
Hox-2.1 recombinant recombinant
Eco RI 5 5.6 6.2
Table 3.2
The restriction fragment length (kb) at the endogenous Hox-2.1 locus and the predicted
diagnostic fragment lengths for correct targeting of Q2BBtk or Hox2.1ptk upon hybridisation
with the 1.5 kb Eco RI to Hind III probe 5' to the construct sequence. The same diagnostic
homologous recombinant bands will hybridise to the neo probe.
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Steps involved in the construction of the PNS construct, Hox2.1ptk. Vectors and subclones are
described in Section 2.3.3 or shown in Figure 3.1. A line across the enzyme name indicates the
site is not reconstituted after the cloning step.
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3.4 Insertion vectors.
Two insertion vectors had been previously constructed by Dr. Ian Jackson.
Construct 6 (Figure 3.2h) contains the 1.3 kb (Bam HI to Eco RI of exon 1-intron-
exon 2) fragment of Hox-2.1 cloned into the Bam HI and Eco RI sites of pSV2neo
(Southern and Berg, 1982). HoxTneo differs from construct 6 by absence of the 100
bp exon-intron Hind III fragment from the Hox-2.1 sequence and absence of the
Hind III to Bgl II fragment from the pSV2neo sequence.
Construct 6 was linearised through the Xho I site in the Hox-2.1 sequence
and HoxTneo was linearised through the Hox-2.1 Hind III site, prior to
electroporation. Construct 6 therefore has 360 bp 5' and 900 bp 3' and HoxTneo has
450 bp 5' and 700 bp 3' Hox-2.1 homology.
The predicted alterations in the Bgl II restriction fragment lengths at the Hox-
2.1 locus upon integration of construct 6 or HoxTneo are shown in Figures 3.6a and
3.6b. Integration leads to duplication of the construct Hox-2.1 sequence at the locus.
However, since the 5' copy of the gene is disrupted by plasmid/rceo sequence and
since the 3' copy lacks promoter/5' sequence, it is unlikely that functional Hox-2.1 is
produced by this locus.
Insertion vector derived G418r cell line DNA was digested with Bgl II and
the blots generated hybridised with the Hox-2.1 3 kb Eco RI to Bgl II fragment (gel-
purified from subclone pMl (Figure 3.1c)) downstream of Hox-2.1 sequence within
the construct (3' probe). Hybridisation to the normal band only, indicates random
integration of the construct, while hybridisation to the normal band and the predicted
novel band size, would indicate homologous recombination. The blots were stripped
and rehybridised with the neo probe to check for integration of the constmct. The
predicted fragment lengths are summarised in Table 3.3.
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Figure 3.6
Predicted restriction lengths upon homologous recombination into the Hox-2.1 locus by
construct 6 (b) or HoxTneo (c). Construct Hox-2.1 sequence is represented by a thick line,
plasmid sequence represented by a checked line and probe by a stippled line. The Hox-2.1
cDNA is illustrated as in Figure 3.1. The deleted regions of the gene upon integration of the




Enzyme Endogenous homologous homologous
Hox-2.1 recombinant recombinant
Bgl II 5 6 11
Table 3.3
The restriction fragment length (kb) for the endogenous Hox-2.1 locus and the diagnostic
fragment lengths for correct targeting of construct 6 or HoxTneo upon hybridisation with the 3
kb Eco RI to Bgl II probe from 3' to the construct sequence are shown in kb. The same
diagnostic homologous recombinant band will hybridise to the neo probe. The same diagnostic
band should hybridise to the 5' probe in HoxTneo homologous recombinants.
3.5 Frequencies of G418 resistance.
The required concentration of G418 for selection of ES cells was determined
for each batch of G418 by selection of cells on varying doses for 14 days. Plates
from such a selection and the resulting kill curve are shown in Figures 3.7 and 3.8.
400 |ig/ml G418 was chosen as the required dose for this batch. Too high a dose may
lead to death of cells containing neo but the expression of which is low.
The numbers of G418r (or G418r and gancr in the case of the PNS vectors)
foci produced after electroporation of L cells or ES cells with each of the targeting
constructs, Hox2.1pneo or pMClneo polyA were counted after 10-14 days selection.









Kill curve illustrating the % G418r after 10 days selection on varying concentrations of G418.
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Table 3.4
Construct L cell L cell ES cell ES cell
G418r G418r + gancr G418r G418r + gancr
construct 2 (-p) 3 x 10-6 3 x 10-6
Hox2.1pneo (+p) 2.5 x 10-4*
Q2BBtk (-p) 7 x 10-6 6 x 10-6 1.5 x 10-7
Hox2.1ptk (+p) 7 x 10-6 1.5 x 10-7
construct 6 (+p) 1.1 x 10-6
HoxTneo (+p) 1.3 x 10-6
pMClneo polyA 1 x 10-5
Table 3.4
The frequency of G418r or G418r + gancyclovirr (gancr) after 10-14 days selection is expressed
in number of surviving foci per number of cells transfected with the given construct.
*Transfection carried out by Dr. Sinead Jones. p=promoter.
Since frequencies may vary between experiments due to differences in cells
or batches of G418, it is difficult to make valid comparisons between construct
types. Also since the electroporation conditions etc. vary between laboratories it is
difficult to compare frequencies with those reported in the literature.
The reported G418r frequency for pMClneo polyA is 1 x 103 (expressed as
a fraction of the number of cells surviving electroporation) (Thomas and Capecchi,
1987). This frequency has not been reproduced. Other reports (Tybulewicz et al.,
1991) claim a frequency equal to pSV2neo (Southern and Berg, 1982). pSV2neo
induces a G418r frequency of 5 x lfr5 (Thomas and Capecchi, 1987).
The G418r frequency after transfection with Hox2.1pneo indicates the
presence of a strong promoter driving neo expression. This is in contrast to the
observed expression levels of Hox-2.1 in ES cells and may reflect the lack of
negative control regions from the Hox-2.1 locus in this vector or an increased
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stability of the Hox2.1neo mRNA over the natural Hox-2.1 mRNA. The Hox2.1 -neo
mRNA is functional and provides G418 resistance.
The G418r frequency for construct 2 is as expected for a promoterless neo
construct, being one third lower than the frequency obtained from pMClneo polyA
(comparable to the frequencies reported by Dorin et al. (1989)) and 80-fold lower
than the G418r conferred by Hox2.1pneo.. This indicates that selection for
integration next to an active promoter was relatively successful.
The G418r frequency obtained upon transfection with G2BBtk is similar to
that of construct 2, again indicating successful selection of integration into active
promoters. Double selection with G418 and ganc reduces the number of selected foci
by 40-fold. This is a considerably lower than the 2000-fold enrichment reported by
Mansour et al., 1988. However, there have been varying reports on enrichment
levels obtained by ganc selection of PNS vector derived clones (see Section 1.4) and
40-fold enrichment compares favourably with these. There is no difference in the
frequency of G418 and ganc resistant foci obtained from the promoterless neo
Q2BBtk construct or Hox2.1ptk (which contains the same upstream region as
Hox2.1pneo). This may suggest the presence of a negative enhancer element in the
intron or 3' untranslated region of Hox2.1 (regions present in Hox2.1ptk but not in
Hox2.1pneo).
The G418r frequencies for construct 6 and HoxTneo (pSV2neo encoded neo)
are 10-fold lower than the frequencies reported for pSV2neo. As transfections were
not carried out with pSV2neo alone it is not possible to comment on the apparent
reduction.
3.6 Screening of colonies by restriction mapping.
A number of G418r colonies were picked after transfection with the different
constructs. DNA was prepared for the analysis of restriction map alteration at the
Hox-2.1 locus. Digests and probes were used as described in Sections 3.2-3.5. Table
3.5 shows the number of clones analysed for homologous recombination and which
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the same integration event (ie. secondaries). None of the cell lines screened
contained the diagnostic band for homologous recombination. Examples of Southern
blot hybridisation analyses are presented in Figures 3.9, 3.10 and 3.11. By analysis
of the neo restriction fragment length (Figures 3.9b, 3.10b and 3.11b) it was
observed that most of the cell lines were derived from random integration of one
copy of the construct.
Table 3.5
Number of G418r cell lines analysed
Construct L cells ES cells
construct 2 5 31




The number of cell lines screened for homologous recombination at the Hox-2.1 locus by
restriction fragment length analysis.
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Southern blot of EcoRI/Hind III/Bam HI digested ES cell (E) DNA and G418r cell line DNAs
(1-7), hybridised to 5' probe (see text) (a) or neo probe (pMClneo polyA gel purified insert)
(b). Cell lines were derived from construct 2 transfection.
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Figure 3.10
Southern blot of Eco RI digested G418r cell line DNAs (1-4), hybridised to 5' probe (see text)
(a) or neo probe (b). Cell lines were derived from Hox2.1ptk PNS vector transfections.
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Figure 3.11
Southern blot of Bgl II digested G418r cell line DNAs (1-8), hybridised to the 3' probe (see
text) (a) or neo probe (b). Cell lines were derived from HoxTneo insertion vector transfections.
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3.7 Identification of a "pick-up" clone.
One G418r cell line (H4) derived from transfection with the insertion vector,
HoxTneo, had a novel Bgl II restriction fragment (20 kb) upon hybridisation to the 3'
Hox-2.1 probe (Figure 3.12a). The band also hybridises to the neo probe (figure
3.12b). However, this band is not indicative of correct homologous recombination
and insertion of the construct because it is larger than predicted and is half as intense
as the Hox-2.1 locus band (1 copy of new locus to 2 copies of endogenous locus). No
extra band hybridises to the 5' Hox-2.1 probe (1 kb Sst I fragment purified from
Hox2.1-2.2 subclone)(Figure 3.12c). Both 3' and 5' probes are expected to hybridise
the same diagnostic 11 kb Bgl II band in homologous recombinant.
It is likely that clone H4 is derived from a "pick-up" and random integration
event. Pick-up events have been reported to occur at equal frequency to homologous
recombination events (personal communication from Dr. Alan Clarke). Similar
events have been identified and reported by Adair et al. (1989); te Riele et al. (1990)
and Itzhaki and Porter (1991). It is proposed that the construct aligns with the region
of homology, picks up several kb of sequence from 5' or from 3' (not usually both)
by a process of gene conversion (strand invasion and replication followed by
breakage and joining), and integrates elsewhere in the genome.
Upon hybridisation of the 3' Hox-2.1 probe to a Hind III digest of H4, a
novel 4.5 kb band is identified (Figure 3.13a). Since this band does not hybridise to
the neo probe (Figure 3.13b) it may be concluded that the Hind ill site at the 3' end
of the construct has been reconstituted during the pick-up. Since the normal Hox 2.1
fragment length is 9 kb, this would suggest that less than 4.5 kb of Hox-2.1 sequence
has been transferred to the new locus by the targeting construct.
In situ hybridisation to metaphase spreads of H4 cells was carried out, by
Dianne Hanratty, in an attempt to map the integration site outside the Hox-2.1 locus.
Labelled insert from the subclone Hox2.1-2.2 correctly mapped Hox-2.1 to the distal
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Southern blot of Bgl II digested ES cell (E), H4 (1) and insertion vector derived G418r cell








Southern blot of Hind III digested ES (E) and H4 DNAs hybridised to 3' probe (see text) (a) or
neo probe (b).
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tips of two chromosomes (chromosome 11). No other hybridisation site was
identified. This may be due to rearrangement of targeting vector sequence upon
integration or integration of the targeting vector near the Hox-2.1 locus.
It is possible that during the pick-up event, a mutation was introduced into
the endogenous Hox-2.1 locus. However, the H4 cell line had the abnormal
karyotype of 44 chromosomes. Therefore, it was decided that characterisation of the
Hox-2.1 loci, to determine whether the pick-up process had created a mutation, was
not worthwhile in the context of this project.
No further pick-up clones were identified. However, only one third of the
insertion vector derived clones were screened with the 5' Hox-2.1 probe so there may
have been other pick-up events that were not detected.
3.8 Conclusions.
The reported targeting frequencies for replacement vectors containing a
promoterless neo vary from 3/11 (Dorin et al., 1989) to 1/100 G418r clones (Sedivy
and Sharpe, 1989). These frequencies may be expressed as a fraction of the total
integration events when the enrichment factor is taken into account, so that 3/11
becomes 1/11 (3-fold enrichment) and 1/100 becomes 1/10000 (100-fold
enrichment). 36 G418r cell lines were analysed for homologous recombination of
construct 2. None were homologous recombinants. If the enrichment factor is
assumed to be 80 (since Hox2.1pneo generated 80-fold more G418r colonies), 36
G418r clones is equivalent to 2880 total integrants. There are two possible reasons
for the low targeting efficiency of this vector. Firstly, the region of homology at the
5' end of the neo is small (100 bp). It has been demonstrated that targeting frequency
of a vector is increased by increasing the amount of homology to endogenous
sequence (Thomas and Capecchi, 1987; see Section 1.4). Secondly, Hox-2.1 is
expressed at a low level in ES cells - thus neo expression upon homologous
recombination into the Hox-2.1 locus may be too low to confer G418r. Homologous
recombinants may be selected against. The expression from the control vector,
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Hox2.1pneo, could be high due to loss of negative control regions influencing
endogenous Hox-2.1 expression. However, Hox-2.1 expression is believed to be low
due to mRNA instability rather than weak promoter function (Dr R. Krumlauf,
personal communication). An AU rich region similar to those leading to rapid
breakdown of c-fos (Wilson and Treisman, 1988) and rabbit (3-globin (Shaw and
Kamen, 1986) is present at the 3' end of the Hox-2.1 mRNA. The Hox-2.1-neo
fusion transcript does not contain the 3' AU region and therefore, is not subject to
rapid breakdown.
The reported targeting frequencies for PNS vectors, expressed as number of
homologous recombinants as a fraction of G418r gancr clones, vary from 19/24 for
hprt (Mansour et al., 1988), 1/38 for immunoglobulin p. gene (Kitamura et al., 1991)
to 1/500 for T-cell antigen receptor (Mombaerts et al., 1991). Taking into account
the reported ganc enrichment factors, the above targeting frequencies may be
expressed as a frequency of G418r clones: 1/2500 for Hprt, 1/304 for
immunoglobulin p., 1/1000 for T cell antigen receptor and 1/7150 for Wnt-1. The
variation in the reported targeting frequencies shows the extreme variation in locus
targetability. 27 L cell and 6 ES cell G418r Gancr clones were derived from the Hox-
2.1 construct transfections. This number is equivalent to 1320 G418r clones when
the ganc enrichment factor is taken into account.
Initial reports on targeting frequency for insertion vectors were in the order
of 1/1000 (Thomas and Cappecchi, 1987) but recently higher frequencies have been
obtained - 1/31 for Hox-2.6 (Hasty et al., 1991) and 1/170 for the CFTR locus (Dr.
Julia Dorin, personal communication). 216 Hox-2.1 insertion vector derived clones
were analysed. The identification of a pick-up clone indicates that HoxTneo is
capable of finding homology to the Hox-2.1 locus. HoxTneo, however, may be
incapable of homologous recombination because 100 bp have been deleted at the site
of linearisation, Hind III. Pick up clones are reported to occur at an equal frequency
to correctly targeted events (Alan Clarke, personal communication). However
properties of the Hox-2.1 locus (such as silencing of neo expression, to be discussed
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below) may lead to the identification of pick-up events rather than homologous
recombination events. Construct 6 may have a low targeting potential due to the
small region of Hox-2.1 homology 5' to the linearisation site.
The overall targeting frequency of Hox-2.1 may be stated as less than 1/4416
integration events (when enrichment factors are removed). Many genes have been
targeted at higher frequency than this. Equally many genes have been targeted at a
lower frequency.
Finally, it should be noted that the targeting literature is biased towards
genes which have been successfully targeted. Since no reports are published on the
unsuccessful targeting experiments it is difficult to tell whether the zero targeting
obtained for Hox-2.1 is unusual.
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CHAPTER 4
IDENTIFICATION OF A SITE OF
FREQUENT INTEGRATION IN ES CELLS
4. IDENTIFICATION OF A SITE OF FREQUENT INTEGRATION
IN ES CELLS.
4.1 Introduction.
Of the 31 G418r cell lines derived from transfection of ES cells with the
promoterless neo replacement vector, construct 2, two (5B2 and 7B2) were
identified as having the same integration sites. This was initially surmised from the
hybridisation pattern of the neo probe to the Eco RI, Hind III and Bam HI restriction
digests of the cell line DNAs - the band sizes were apparently equal for both the cell
lines in each of the digests (Figure 4.1). On close inspection there is observed to be a
slight variance in size between the band sizes, with the 5B2 band being slightly
smaller in each digest. 5B2 and 7B2 were clones picked from separate plates which
in turn had been plated from separate electroporation vials and are thus unlikely to
be derived from a single integration event. DNA was re-extracted from freshly
grown cells to confirm no mix-up had occurred during pelleting of cells or
preparation of DNA. These cell lines were derived from transfections carried out by
Dr. Robin Lovell-Badge.
It is proposed in this chapter that this site is a site of frequent integration
(SOFI) and shall henceforth be referred to as such.
4.2 Restriction site mapping at the integration sites of 5B2 and 7B2.
Various digests were performed on 5B2 and 7B2 DNA in order to map
restriction sites flanking the construct integration site. Sites were mapped 5' and 3' to
the Hind III site in the construct by performing double digests with Hind III and
various enzymes. The Southern blots were probed with the neo probe (5' to the
construct Hind III) or the 2.4 kb Eco RI to Bgl II fragment from subclone pMI (see
Figure 3.1) (3' to the construct Hind III). The hybridisation results are shown in
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Figure 4.1
Southern blot of Eco RI and Hind III digested G418r cell line DNAs (1-6), hybridised to neo




Southern blot of restriction enzyme digested 5B2 (5) and 7B2 (7) DNAs hybridised to neo
probe (a) or the pMI 3' Hox-2.1 probe (b). Enzymes are abbreviated as: B=Bam HI, K=Kpn I,
S=Sst I, H=Hind III and E=Eco RI.





























endogenous Hox-2.1 sequence - the construct sequence band was identified as the
band half the intensity of the Hox-2.1 band and by comparison to wild type DNA
digests. The hybridisation patterns confirm that 5B2 and 7B2 were indeed
integrations into similar loci. The restriction fragment lengths are tabulated in Table







Hind III 3.8 5.5
Eco RI4 2.9 4.0*
Eco RI and Hind III 2.0 4.0
Bgl II4 6.4 6.4
Bgl II and Hind III4 3.2 3.21
SstI >10 >10
Sst I and Hind III2'3 3.8 5.5
Kpn I >10 >10
Kpn I and Hind III3 3.8 5.5
Bam HI 10 10
Bam HI and Hind III3 3.8 5.5
Table 4.1
The band sizes (kb) at the 5B2 and 7B2 integration sites upon hybridisation to the probe 5' to
the construct Hind III site (neo) or to the probe 3' to the construct Hind III site (Eco RI to Bgl II
fragment from pMI).
* The 3' Eco RI site is mapped in relation to the Eco RI site in the construct.
1. The Bgl II site has been retained at the 3' end of the construct.
2. The Sst I sites have been lost from both ends of the construct.
3. The 5' and 3' SstI, Kpn I and Bam HI sites cannot be mapped since they are further 5' or 3'
than the Hind III sites.
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Figure 4.3
Restriction map of the 5B2/7B2 integration site. Bold line represents the integrated construct.
The Sst I sites at the ends of the construct have not been reconstituted and are represented by a
crossed "S". Enzymes are as abbreviated in Figure 4.2 and Bg=Bgl II. Neo probe is represented
by a stippled line and the 3' probe by a striped line.
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The restriction map was compared to the published maps for Hox gene loci
in case the construct had integrated into these genes due to homology. No map was
found to be similar.
4.3 Inverse PCR to obtain flanking sequence.
Flanking sequence, upstream and downstream of the construct sequence was
amplified by inverse PCR (Ochman et al., 1988) of 7B2 DNA. The steps involved
in amplification of DNA sequence by inverse PCR are shown in Figure 4.4.
Genomic DNA is linearised with a suitable restriction enzyme, the resulting
fragments are self-ligated to form circles and PCR amplification is carried out
between primers from the known sequence across the unknown junction sequence.
Eco RI was chosen as the enzyme for linearisation since the construct
contains an Eco RI site and since Eco RI sites had been mapped 600 bp upstream
and 1 kb downstream of the integration site.
The relative positions of the four primers involved in the amplification are
shown in Figure 4.4. Figure 4.5 shows sequence obtained from the 3' end of
construct 2 (Hox-2.1 locus genomic sequence). This sequence was required to
synthesize the oligonucleotide 598 for downstream amplification and
oligonucleotide B2 for hybridisation to the downstream product. 598 is derived
from sequence 1-18 and B2 from sequence 130-148. Since 598 spans the Bgl II site
and since this site is known to have been retained upon integration of the construct,
it was considered likely that 598 was present in the integrated sequence.
Upstream and downstream inverse PCR amplifications were carried out
separately on 7B2 DNA.
The specific bands were identified by hybridisation to the internal
oligonucleotides (neol9 for upstream and B2 for downstream products). Neol9
identified a 500 bp product amplified by the upstream oligonucleotides (neol8-


















Steps involved in inverse PCR amplification of flanking sequence. Construct sequence is
represented by a thick line. Arrows indicate a 5' to 3' direction of the PCR primers. The final
products of Upstream (314 to neol8) and downstream (598 to 315) amplification are
schematically presented.
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1 TCTTCAGAGA GATCTCCCTT AGTCCAGAAG AACTTATGGA ATTTGTTTGG
Bgl II 598
51 GGTGTGTTGG GCACACTCCG CCCCCCCCCC CCCGCAGGTC GTTTTTTACC
101 TGGATACATT TAGAGAAAAG GATAGGGAAG GTGGCTGCTG TGGGCTACCT
B2
151 GCCCTGAAAT GTTTTCTTGG GTTTTTAACG TCTGCCCCTG CACTCTCTAT
201 GGTCTCCCCA GGGTTATCCA GAATTCCGGG GAGCTC
Eco RI SstI
Figure 4.5
Sequence obtained from the 3' end of construct 2, by reading from the rev sequencing primer,
spans the Hox-2.1 sequence from Bgl II to Sst I sites (see Figure 3.1a). Sequences, from which
oligonucleotides 598 and B2 are derived, are underlined. Restriction enzyme sites are
underlined by double lines.
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amplified by the downstream oligonucleotides (598-315). The former is surmised to
be the endogenous Hox-2.1 sequence inverse PCR product which is amplified in
preference to the latter longer sequence. The latter sequence is surmised to be the
construct-flanking sequence inverse PCR product.
The construct-flanking sequence bands were gel-purified and re-amplified.
The re-amplified products were cut from LMT agarose and purified by Geneclean.
The upstream product ends were filled in with Klenow enzyme, digested with
Eco RI to remove the 314 oligonucleotide end (see Figure 4.4) and cloned into Sma
I-Eco RI cut Bluescribe. (From analysis of the cloned sequence it was discovered
that the PCR product had been cut successfully with Eco RI but that the overhang
had been filled in (presumably by residual Klenow, despite heat treatment) and the
blunt-ended molecule ligated into Sma I cut Bluescribe, with the insert orientated
with the neo end closest to the reverse sequencing primer).
The downstream product was digested with Bgl II (site within the 598
oligonucleotide) and Eco RI to remove the 315 oligonucleotide-end (see Figure 4.4).
This fragment was cloned into Bam HI and Eco RI cut Bluescribe.
Confirmation that the clones contained flanking sequence to the integrated
construct, was made by hybridisation of the cloned DNA to Eco RI or Hind III
restricted 7B2 DNA (Figures 4.6b and 4.7b) The neo probe and upstream inverse
PCR product clone hybridise to the same 2.9 kb Eco RI and 3.8 kb Hind III bands.
The 3' probe (see Section 4.2) and the downstream inverse PCR product clone
hybridise to the same 4.0 kb Eco RI and 5.5 kB Hind III bands. The bands observed
to hybridise to the downstream probe in ES cell DNA (Figure 4.7b) identify the
endogenous uninterrupted "target" locus. These bands are not clearly distinguishable
on hybridisation with the upstream probe (Figure 4.6b) because of multiple band
hybridisation. However, the same ES cell Eco RI and Hind III fragments should
hybridise to both the upstream and downstream probes.
The multiple bands hybridised by the upstream product suggest this sequence
is repeated several times in the genome. This raises the possibility that 5B2 and 7B2
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Figure 4.6
Southern blot of Eco RI (E) and Hind III (H) digested ES cell (ES) and 7B2 (7) DNAs
hybridised to neo (a) or upstream inverse PCR product clone (b) probes. The arrows indicates
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Southern blot of Eco RI (E) and Hind III (H) digested ES cell (ES) and 7B2 (7) DNAs
hybridised to 3' construct probe (a) or downstream inverse PCR product (b) probes. The
downstream product probe is the gel purified Pst I-Eco RI 250 bp fragment. The arrows
indicates the bands that are hybridised by both the probes.
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are integration events into the same sequence at different loci. However, since the
bands appear to be single-copy strength, and it is the same band that is altered upon
integration in both 5B2 and 7B2, it is likely that the events are into the same locus.
4.4 Sequencing of upstream flanking sequence.
The insert of the neol8-314 inverse PCR clone from 7B2 was sequenced
from both the forward, reverse and the neol9 primers. The neo-Hox-2.1 fusion was
identified and the construct-flanking junction sequenced through. 8 or 9 bp of 5'
construct sequence were deleted from the construct upon integration in 7B2 (the
exact number cannot be determined since bases at the site may be derived from
either genomic DNA or construct DNA).
An oligonucleotide (B85) was synthesized from the 7B2 upstream flanking
sequence and the B85-neol8 fragment was PCR amplified from 5B2 genomic DNA.
The product was directly sequenced using the neol9 primer. Mn buffer was included
in the sequencing buffer in order to read sequence close to the primer. 77 bp of 5'
construct sequence were deleted upon integration in 5B2.
Sequencing data presented in Figure 4.8 shows the difference between 7B2
and 5B2 at the 5' genomic-construct DNA junctions. The upstream flanking
sequence obtained from 5B2 and 7B2 is presented in Figure 4.9a .
4.5 Sequencing of downstream flanking sequence.
The insert of the 598-315 downstream inverse PCR product clone was
sequenced using forward, reverse and B2 primers. The insert was completely
sequenced from internal primers (B406, B460 and B461) prepared from the forward
and reverse sequence. The construct-downstream flanking sequence junction was
sequenced. 14-16 bp of 3' construct sequence were deleted upon integration of the
construct in 7B2.
An oligonucleotide (B218) was synthesized from 7B2 sequence and the 598-
B218 fragment PCR amplified from 5B2 genomic DNA. The product was
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Autoradiographs of DNA sequencing gels from reactions:
a. 7B2 upstream PCR product clone primed from rev sequencing primer.
b. B85-neol8 5B2 PCR product primed from neol9.
Integrated construct Hox-2.1 sequence reads into the integration site upstream flanking


















The upstream (a) and downstream (b) flanking sequence from 5B2 and 7B2 are shown in bold
print. Construct sequence is shown in non-bold print. The underlined sequence is shared by 5B2
and 7B2. The construct sequences not underlined are retained in 7B2 but are deleted from 5B2.
The target sequences CC (a) and T (b) are retained in 5B2 but deleted from 7B2.
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sequenced directly using the B2 primer, with Mn buffer in the sequencing reaction.
58 bp 3' construct sequence were deleted upon integration in 5B2.
In Figure 4.10 the sequencing data presented shows the difference between
7B2 and 5B2 at the 3' genomic-construct DNA junction. The downstream flanking
sequence obtained from 5B2 and 7B2 is presented in Figure 4.9b.
4.6 Sequencing of the SOFI.
In order to obtain the complete sequence at the integration site, PCR
amplification was carried out between the upstream flanking sequence primer, B85
and the downstream flanking sequence primer, B218, on ES cell genomic DNA. The
400 bp product was sequenced directly from the B85 and B218 primers. Sequencing
data showing the difference between unintegrated genomic DNA and the 5B2
integration site is presented in Figure 4.11.
The sequence obtained for the 7B2 upstream, 7B2 downstream and the ES
cell B85-B218 product combine to give 1.25 kb of sequence from the SOFI locus.
This sequence is presented in Figure 4.12.
3-6 bp of sequence were deleted from the locus upon integration of the
construct in 7B2. No sequence was deleted from the locus upon integration in 5B2.
The differences in the amount of construct or locus sequence lost or retained
in 5B2 and 7B2 confirm that these two cell lines are derived from separate
integration events. The 130 bp deleted from 5B2 and not from 7B2 would explain

















Autoradiographs of DNA sequencing gels from reactions:
a. 7B2 downstream PCR product clone primed from B2 primer.
b. 598-B218 5B2 PCR product primed from B2 primer.
Integrated construct Hox-2.1 sequence reads into the integration site downstream flanking














Autoradiographs of DNA sequencing gels from reactions:
a. ES cell B85-B218 PCR product primed from B218 primer.
b. 5B2 598-B218 downstream PCR product primed from B218 primer.
Downstream sequence reads into upstream sequence in the ES cell PCR product sequence (a).
Downstream flanking sequence reads into Hox-2.1 construct sequence in 5B2 PCR product (b).
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Figure 4.12
Sequence of the SOFI locus. The integration site of the construct in 5B2 is indicated by arrow
5. The integration region in 7B2 is highlighted in bold print. The possible integration sites in
7B2 are indicated arrows labelled 7. CCT is lost from the site upon integration in 7B2; the C
and AG on either side of the CCT may either be derived from the integration site or from the
incoming construct in 7B2. The Eco RI sites at ends of the upstream and downstream inverse
PCR products are underlined. The Pst I site used to generated the unique sequence probe from
the region is underlined. Sequence showing 72% homology to retroviral LTR sequence is


























AATTCTATGA ATTTATTTAT TTGTGCTTGC ATTTTGAAAG GACTGAGCCA
Eco RI
GGCTGAGTCA CTAGACAGGC TTCAAACTGA CAGTTCAGGT GAGTAGGCCT
AAGTTTCTGT TTCCCAGAAT TGAGCAAGTT TGGGAAAGTC AGTCTCTCAC
AGGGAAAAAA AAAAAGAAAA AAAAAACACA GTCCCTGGGC AGCCAATCAG
AGGCTGTCCA GACACTTAGC CTGAGGCAAG AGCAATGAGT TAGCAACAGT
TTCCAGGCTT CCCCAGCAAC AGTTTCCAGG TTTCCCCAGC AACAGTTCTG
GATTGTCCCC AGAGCCCTAG CCAATCCCAA AGACACCCAT
5
ACCAGACCAA CCAATCAAGA TAAAGGTTAC CCACTCCCTC CCTGGAATCC
CCTAATCTGC TTTAAATGGA GGCTGTGAGT TCACCTGGGC CTCTCCATCT
GAGTGAATGG TAGACCCCTG AATACTATTT GAGTCTCGGA TATCATTCTT
CACCCTTACA ATTTGTTACT TCATTGCTTT TTTTTTTTTT TAATGGTTTT
TTGAGACAGG GTTTCCTGTG TTACCCTGGC TATCTGACTN CTCTGTAGAT
TAGGCTGGTC TCAAATTTAA ACGATCTGCC TGCCTCTGCC TCATGAGTGC
TGGGATTAAA GACATGTGCT GACACTACCC GACTTCATTC GTTTATTTAT
TTGATCGTTT GTTTCAAACT CATATGTGGG TGTTCTGAGT CACATGGGTC
GATCAAAGAA AGAGGTACTC CAGAGTGTAA TCGTGCTCTG AGGCAGNAGA
GAGGAACAGT CTCAATGAAC TGAACCTGAA CCTGGGACAG ATGTACAGAC
GCACATCCAT TGAGTGTTAC ACAGTTTGTT TTGGTTTTTT TGGTGGGGGA
TAGGGGAACA CATTTCTCAT CCTAAAGCCC CTCATCTGAT CTGTTATGTT
TTATGAAGAA AAACACCATG CCCCTGNAAC TTCAATCCTT ACTGTCGACT
GTCTGCAGTG CCCAATAATG CAAGACATTC CGTCTTNGAG GAAAGTCACC
PstI
CATGGCTGTA AAGCTCCTTC AGGAAAACAA CATCATAGAT AATGGAAGAC
AAGCACTGTT CTATAGTGAT TCTTTCAGGG TCAAAGTACT TCTGAAAACA
ACTCTTCATT CTGATATCTA CCCTAGGATC ATTGAAAAAC AGCCTTTTCA
TTCTGATGTT TACCCTAGAT ACACTGATTC CACTAGAATT C
Eco RI
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4.7 Analysis of the SOFI Sequence.
Sequence analysis was carried out using the University of Wisconsin
Genetics Computer Group (UWGCG) software package (Devereux et al., 1984).
4.7.1 Search for DNA sequence homologies.
No extensive homology was found between the SOFI sequence and the ends
of the targeting vector using the UWGCG BestFit program. Figure 4.13 illustrates
the proposed sequence alignments of construct to genomic DNA prior to integration
in 5B2 and 7B2. 3bp at the 7B2 junction are homologous, none are homologous at
the 5B2 junction. It has been proposed that short sequence homologies (1-5 bp) may
direct "illegitimate" integration in mammalian cells (Roth and Wilson, 1986;
Murnane and Young, 1989 and Macleod et al., 1991). Since there is no sequence
specificity contributing to the integration event in 5B2 it is proposed that this region
possesses properties that enhance recombination.
Topoisomerase I cleavage sites AAT, CAT, CTC, CTT, GAT, GTC and GTT
have been shown to be over-represented around illegitimate integration points or
regions (Konopka, 1988). Two of these sites are present within 10 bp of the
integration regions in 5B2 and 7B2, as is shown in Figure 4.13.
The sequence was used to search the GenBank and EMBL sequence
databases, using UWGCG Wordsearch and FASTA programs. No significant
homology to the 1.25 kb SOFI sequence was found. Limited homology to sequences
in the databases was found to smaller regions of the sequence.
Sequence 241-295 shows 72% similarity to retroviral long terminal repeat
(LTR) sequence, such as the match shown in Figure 4.14. The sequence 243-310
contains three copies of a 23 bp repeat (the third copy is degenerate) and the
sequence 242-297 also contains two copies of an overlapping 27 bp direct repeat.
These repeats contain a 6 bp AGTTTC motif which is present in LTR sequences
(Golemis, et al., 1990). The AGTTTC motif is present twice at an interval of 23 bp,
which is also the case in some proviral LTRs. The function of this motif is unknown.




























The proposed alignment of construct DNA to endogenous SOFI locus DNA in the generation
of 7B2 (a) and 5B2 (b) integration sites. The construct sequence is represented by a box and the
direction of neo transcription is indicated by the arrow. Boxed sequence is lost by the incoming
construct. The bases homologous between construct and endogenous sequences are marked by
vertical lines. The C and AG flanking the construct sequence in 7B2 may be derived from the
endogenous or construct sequence. Underlined trinucleotide sequences are potential
Topoisomerase I cleavage sites.
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241 TAGCAACAGTTTCCAGGCTTCCCCAGCAACAGTTTCCAGGTTTCCCCAGC 290






An example of SOFI to retroviral LTR sequence homology found by the UWCGC FASTA
database search. The upper sequence is SOFI sequence (see Figure 4.12) and the lower
sequence is Murine Leukemia Virus RadLV variant LTR sequence (Rassart et al., 1986). Base
homologies are indicated by vertical lines. 72% similarity is observed across 55 bp of
sequence, with the introduction of one gap.
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The ladder of bands observed upon hybridisation of the upstream flanking
sequence to genomic DNA digests (Figure 4.6b) suggests this sequence is repeated
20-30 times in the mouse genome (strain 129). It may be concluded that the repeats
are dispersed since the bands on a number of different digests appear to be of single-
copy strength.
An enzyme cutting once in the LTR and once in the viral gene sequence of a
retroviral provirus will give rise to a fragment common to all proviral copies upon
hybridisation to the LTR probe. There is an Eco RI site in the SOFI 5' to the LTR-
like homology and an Eco RI site may be expected within about 4 kb. Since no
strongly hybridizing Eco RI band is observed upon hybridisation to the upstream
probe (Figure 4.6b) it is unlikely that this sequence identifies a novel retroviral
sequence.
The sequence 241-295 may retain some function similar to that of the
retroviral sequence.
Sequence 701-511 shows 76% similarity to the B1 SINE (short interspersed
element). The homology between the SOFI and the B1 SINE consensus is shown in
Figure 4.15. The B1 SINE, first characterised by Krayev, et al. (1980) and reviewed
by Hastie in Lyon and Searle (1988), is the most highly repeated element (130 000
to 180 000 copies) in the mouse genome. Hybridisation of the total downstream
sequence to genomic DNA digests resulted in hybridisation of the probe to total
DNA - this confirms the presence a highly repetitive sequence.
B1 SINES are believed to derive from short RNA molecules by a retroposan-
like reverse transcription and integration mechanism. A characteristic of the SINE is
an A-rich region in the region corresponding to the 3' terminus of the RNA
molecule. There is an A-rich region in the SOFI B1 element.
SINES are believed to be functionless but may have been important in the
restructuring of the genome during evolution.
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511 ATTTGTTACTTCATTGCTTTTTTTTTTTTTTAATGGTTTTTTGAGACAGG 560
I II I III II III I I I I I I I I I I I I I I I I I I I I I I I I I I II
701 ATTTTTTATTTTATTTTGTTTTATTTTTTTT.TTGGTTTTTCGAGACAGG 653
561 GTTTCCTGTGTTACCCTGGCTATC....TGACTNCTCTGTAGATTAGGCT 606
III I I I I I I I I I I I I I I I I I : I I I I II I I I I I I I
652 GTTCTCTGTGTAGCCCTGGCTGTCCTGGAGCTCACTTTGTAGACCAGGCT 603
607 GGTCTCAAATTTAAACGATCTGCCTGCCTCTGCCTCATGAGTGCTGGGAT 656
II III I I I I I I III I I I I I I I III II I I I I I I I I I I I I
602 GGCCTCGAATTCAGA.AATCCACCTGCCTTTGCTTCCCGAGTGCTGGGAT 554
657 TAAAGACATGTGCTGACACTACCCGACTTCATTCGTTTATTTATT 701
I I I I I I I I I I I II I I I I I I I I I I I I I I I I I I
553 TAAAGGCGTGTGC.CACCATGCCCGGC..CATTTCTGTATTTTTT 512
Figure 4.15
The B1 consensus sequence to SOFI sequence homology. The upper sequence is SOFI sequence
(see Figure 4.12) and the lower sequence is B1 consensus sequence (Hastie, 1989). Base
homologies are indicated by vertical lines. 76% similarity is observed across 195 bp of
sequence, with the introduction of 5 gaps.
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4.7.2 Translation of the SOFI sequence.
Upon translation of the sequence in all six reading frames using the UWGCG
program Frames (Figure 4.16), no extensive open reading frames (ORF) are
identified.
It was noted that in both 5B2 and 7B2 the neo sequence has integrated into
frame 2 of the SOFI sequence (4.16b). This frame has no AUG initiating codon. It is
possible that the sequence is spliced.
However, on the basis of the UWGCG Testcode plot (Figure 4.17) the
sequence is unlikely to be coding. Testcode scores sequence coding potential on the
basis of A, C, T, G content or codon position. The Testcode plot of SOFI sequence
lies below the midline indicating the sequence is probably non-coding.
The peptide sequence translated from the six frames was used to search the
EMBL and Genbank protein sequence databases using UWGCG Wordsearch and
Fasta programs. The sequence from frame 2 was used to search the NBRF, Swissport
databases and the translation of the EMBL database sequences (search carried out by
Dr. D. Kipling). No extensive homology was found.
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4.7.3 Attempt to map the SOFI.
The position on the genetic map of a cloned piece of DNA may be
determined by the use of recombinant inbred (RI) strains (Taylor in Morse, 1978).
The BXD RI strains result from a cross between two progenitor inbred strains,
C57BL/6J and DBA/2J.
The method relies on the presence of a polymorphic site which varies
between the parental strains and is identified by the cloned DNA. Segregation of the
polymorphic site in the RI strains allows the locus to be mapped in respect to
previously mapped loci.
The unique sequence probe (Pst I to Eco RI fragment from the downstream
inverse PCR product clone) from the SOFI was hybridised to a panels of C57 and
DBA DNAs digested with 12 restriction enzymes (Taq I, Mspl, Hind III, Bam HI,
Bgl II, Pst I, Eco RI, Sph I, Xba I, Sac I, Pvu II and Stu I). No polymorphic site was
identified.
4.8 Identification of the SOFI locus promoter function.
The upstream flanking sequence is expected to contain promoter elements,
necessary for the expression of the neo gene and selection of 5B2 and 7B2.
No consensus TATA box sequences (Corden et al, 1980) are present in the
350 bp of cloned upstream sequence.
Promoter function was tested for directly by two methods: 1. by attachment
of the cloned upstream sequence to a promoterless neo and transfection into ES cells
to test for G418 resistance and 2. by attachment of the cloned upstream sequence to
the chloramphenical transferase (CAT) gene and transfection into ES cells for the
assay of CAT activity.
To identify protein binding sites that may be associated with promoter
sequence, gel retardation experiments with oligonucleotides derived from the
upstream sequence were carried out.
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4.8.1 Promoter elements from the SOFT locus drive neo expression.
The upstream inverse PCR product clone was digested with Eco RI and Bam
HI to release the insert. The insert was gel-purified, Genecleaned and digested with
Sau 3A. Sau 3A cuts at the Hox-2.1-neo junction. This fragment was cloned into Eco
RI and Bel I cut SDM Blueneo to recreate the SOFI-rceo sequence fusion of 5B2/7B2
(construct named SOFIneo). SOFIneo was digested with Eco RI and Hind III to
release total insert, prior to electroporation into ES cells.
The G418r frequency generated by SOFIneo is compared to that obtained
from the promoterless neo vector SDM Blueneo and is tabulated in Table 4.2.
Table 4.2
Construct G418r frequency
SOFIneo 3.8 x 10"6
SDM Blueneo 1.5 X 10-6
Table 4.2
G418r frequency expressed as the number of resistant foci as a fraction of the number of ES
cells electroporated.
The G418r frequency obtained from the SOFIneo construct is 2.5 fold higher
than that of the the promoterless neo vector. It may be concluded that the cloned
SOFI sequence has some, though perhaps weak promoter function.
4.8.2 CAT assays.
The Eco RI to Sau 3A fragment from the upstream inverse PCR clone was
cloned 5' to the CAT gene in pBLCAT2 (contains the HSW-tk promoter) and
pBLCAT6 (promoterless) to generate the constructs SOFICAT2 and SOFICAT6.
The double-stranded (ds) B267-B268 oligonucleotide was also cloned into the
CAT vectors to give the constructs 267CAT2 and 267CAT6. B267 is derived from
the sequence 242-274 of the SOFI, shows homology to retroviral LTR and contains
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the motif AGTTTC.
The cloning steps involved in the construction of the CAT constructs are
presented in Figure 4.18. 267CAT2 and 267CAT6 were sequenced to check for
correct insertion of the oligonucleotide sequence.
A plasmid containing the p-galactosidase gene driven by the P-actin
promoter was transfected into ES cells by electroporation to test the efficiency of
uptake. However, on staining the cells in situ with X-gal to monitor P-galactosidase
activity, no cells stained blue. Other people in the lab have reported failure of this
plasmid to express in mammalian cells. Therefore, no suitable transfection control
was available in these experiments and the results must be regarded as preliminary.
pBLCAT2, 267CAT2, SOFICAT2, pBLCAT6, 267CAT6 and SOFICAT6
were electroporated into ES cells. 48 hrs later the cells were harvested and CAT
assays performed. No chloramphenicol acetylation was observed when the cells were
electroporated at 3 jiF and 800 V. CAT assay results from cells electroporated at 960
|lF and 200 V are presented in Figure 4.19 and the scintillation counts obtained from
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Autoradiograph of CAT assay TLC plate. Numbers denote plasmid transfections:
1 = no plasmid; 2 = pBLCAT2; 3 = 267CAT2; 4 = SOFICAT2; 5 = pBLCAT6; 6 = 267CAT6
and 7 = SOFICAT6. The spot that has migrated the least distance from the origin is that of
nonacetylated chloramphenical. Acetylated chloramphenical forms (acetylated at one or other
of the potential acetylation sites) migrate to the higher positions on the TLC plate.
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Table 4.3





The scintillation counts per minute obtained from the CAT2 construct chloramphenical
acetylation spots.
The level of chloramphenical acetylation obtained is 4-fold higher from cells
transfected with SOFICAT2 and 2-fold reduction from cells transfected with
267CAT2 constructs than from cells transfected with the control pBLCAT2. None of
the other constructs show an increase in chloramphenicol acetylation over the control
vectors. It may be concluded from these data that the cloned SOFI sequence contains
an enhancer element but does not possess complete promoter function and that the
267-268 oligonucleotide sequence possesses no enhancer or promoter function and
may even have a silencing effect on expression.
4.8.3 Gel retardation of sequence from the SOFI locus.
It was suggested by Dr. Jonathan Stoye that the AGTTTC motif from the
LTR sequence that shows homology to the SOFI sequence might have enhancer
activity and therefore might bind a transcriptional control protein. Gel retardation
experiments were therefore carried out on the ds oligonucleotide sequence 267-268
(see Figure 4.12) with nuclear protein extracted from ES cells. Control ds
oligonucleotide sequence 277-278, in which the AGTTTC motif was replaced by
random sequence, was included in the experiments as a negative control.
The results of a gel retardation experiment are shown in Figure 4.20. Some of
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A B C D
Figure 4.20
Autoradiograph of 32P-labelled ds oligonucleotides 267-268 or 277-278, alone (A and C,
respectively) or retarded by ES cell nuclear protein extract (B and D).
121
the labelled 267-268 oligonucleotide has been shifted to a higher molecular weight
position in the presence of protein. No shift in the control oligonucleotide is
observed.
Gel retardation experiments carried out in the presence of cold ds
oligonucleotide as competitor gave unconvincing results. These results may be
regarded as preliminary.
4.9 Analysis of expression from the SOFI locus.
The Pst I-Eco RI unique sequence downstream probe was hybridised to
RNA from various tissues (kidney, liver, ovary, brain, salivary gland, heart, lung,
small intestine, testes and spleen)(Northern kindly provided by Jane McConnel) and
ES cells. The probe failed to hybridise. The upstream inverse PCR probe was also
hybridised to ES cell RNA. The probe hybridised to the total RNA track (data not
shown), suggesting identification of multiple transcripts.
4.10 Search for other integration events into the same sequence.
It is predicted that if this sequence has been targeted in 2 events out of 31 and
if this site is indeed a site of frequent integration, similar integration events may be
detected upon analysis of more G418rcell lines. Also if the upstream sequence is
repeated 20-30 times in the genome that similar sequence at different loci may be
targeted in different cell lines.
PCR amplification between the primer B85 (upstream of 5B2 and 7B2
integrated sequence) and the neo primer neol8 was performed on DNA from the 34
cell lines derived from the integration of construct 2 (including secondaries, in pools
of 6) and 5 cell lines derived from integration of a second Hox-2.1 promoterless neo
construct (obtained from Dr. Donald Macleod). The PCR products were hybridised
to the internal oligonucleotide, neol9. One cell line, 7B3 gave a positive band of the
same size as 7B2. Sequencing of the product confirmed the integration site was
identical to that of 7B2. Since these clones were picked from the same plate, 7B2
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and 7B3 are likely to derive from the same integration event (i.e. sibling clones).
Sst I cut construct 2 was transfected into ES cells to generate more G418r
clones for SOFI PCR analysis. PCR amplification between primers B85 and neol8
was carried out on the DNA from 15 clones (analysed in pools of 3 or 4). No
positive was identified.
The overall frequency of targeting of the SOFI locus by the Hox-2.1
promoterless neo vector is therefore 2/46 G418r clones. Repeat copies of the same
sequence have not been targeted.
Stu I cut SOFIneo (described in Section 4.8.1) was transfected into ES cells.
This construct is expected to behave like an promoterless neo insertion vector and
target the endogenous SOFI sequence by homologous recombination. However, on
analysis of 11 G418r clones by PCR amplification between B461 primer
(oligonucleotide made from 3' SOFI sequence not in targeting vector) and 671
primer (Bluescribe oligonucleotide, see Section 2.15), no correctly targeted events
were identified.
4.11 Search for integration into the F2 locus.
The mouse F2 locus defines a region where three recombinant M-MuLV
retroviruses have inserted into the genome of F9 EC cells (Barklis et al., 1986;
Peckham et al., 1989 and Peterson et al., 1991). Barklis et al. suggest integration
into this locus is selected for since specific cellular sequence at this locus promotes
viral neo activity. Peckham et al. demonstrate that sequence flanking the proviral
insert is normally expressed, readthrough from the endogenous promoter into viral
sequence takes place and that the mRNA product is spliced from a cellular splice
donor to a proviral splice acceptor. The three proviral insertions map to intronic
sequences at varying distances (500-1500 bp) from the F2 promoter. The F2 locus
has been cloned and sequenced, but the function is unknown (Peterson et al., 1991).
No homology between F2 and SOFI sequences was found by the UWCGC
BestFit program.
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An oligonucleotide (B539) was made from the published F2 locus sequence
(193-209; Peterson et al., 1991) and PCR amplification between B539 and neol8
was carried out on the 46 construct 2 derived G418r cell line DNAs. No positives
were identified. Therefore, the integration into the F2 locus has not been
preferentially selected for.
4.12 Conclusions.
The SOFI locus is defined as a region where the promoterless neo Hox-2.1
construct has integrated twice, in two independent events, to generate the ES cell
lines 5B2 and 7B2. The overall targeting frequency is 2/46 G418r clones.
The sequence flanking the construct in 5B2 and 7B2 has been sequenced.
This has enabled the SOFI to be sequenced. The integration points are within 3-6 bp
and varying amounts of incoming vector have been deleted in the separate events.
In some cases of illegitimate recombination small regions of homology have
been found at the cross-over junction and these are thought to promote
recombination (reviewed by Roth and Wilson in Kucherlapati and Smith, 1988). 3
bp of homology between the construct and SOFI sequences are observed at the
proposed construct-SOFI junction in 7B2. No homology is observed at the proposed
junction in 5B2. Therefore, homology to SOFI sequence is not assumed to promote
integration of vector into this locus.
Topoisomerase I has been implicated in the formation of some illegitimate
recombination events (reviewed by Champoux and Bullock in Kucherlapati; Smith,
1988; Konopka, 1988 and Macleod et al., 1991). Topoisomerase I introduces a
transient break into one of the two DNA strands and can join DNA strands from
different molecules. Topoisomerase I sites are present in the vicinity of 92%
illegitimate cross-over points (Konopka, 1988). It is proposed that Topoisomerase I
may cause a break in DNA at the region, ends may be filled in or trimmed (since the
recognition site is often a few bp away from the integration point), before
recombination occurs. There are three Topoisomerase I recognition sites within 10
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bp of the integration region in 5B2 and 7B2 - CAT (position -6); GTC (+6) and GTC
(+11). These are not the preferred positions for these sites at illegitimate integration
regions (Konopka, 1988) and they may be present by chance.
Barklis et al (1986) have described the F2 locus - a site for integration and
expression of proviral sequence. Three retroviral integrations out of 17 were into the
F2 locus. Barklis et al. propose that the F2 locus provides strong promoter function
and a splice donor site for the expression of viral neo. Integration events into this
locus are thus selected for on G418.
In contrast to the F2 locus, the promoter function of cloned SOFI sequence is
found to be weak. Comparing G418r frequency with that of a promoterless neo
construct a 2.5-fold increase is observed. The sequence is also observed to have a
moderate enhancer activity from the analyses of CAT construct activity. It is
unlikely that this site acts as a strong promoter (although this cannot be ruled out
since only 350 bp from the locus was used in this study), and it is therefore unlikely
that this integration event is enriched for by G418 selection, as is proposed for the
identification of the F2 integrants. Also enrichment for promoter activity would not
be expected to select for integration into such a specific (6 bp) region. The described
integration events into the F2 locus vary by several hundred base pairs.
It is proposed that other properties of the SOFI sequence promote integration.
It is possible that aspects of the secondary structure enhance recombination. Short
indirect repeats, longer direct repeats and stretches of AT sequence are present.
These sequences may form single-stranded bubbles which could increase the
likelihood of recombination. The 55 bp retroviral homology may also be significant.
It is possible that the sequence retains some LTR properties or functions, such as the
binding of protein or promotion of recombination. The function of the retrovirally
conserved motif, AGTTTC, present in the SOFI sequence, is unknown. Preliminary
gel retardation results showed that this sequence may bind weakly to an ES cell
protein. However, no enhancer or promoter activity was displayed by the sequence
in CAT constructs.
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No motif associated with recombinational hotspots was identified in the
SOFI sequence (reviewed by Fischer Lindahl, 1991 and Steinmetz et al., 1987). This
will be discussed further in Section 5.4.
Searches of the Genbank/EMBL sequence databases revealed no significant
homology over the entire SOFI sequence. Two smaller regions of homology were
found - 55 bp homology to retroviral LTR sequence and 190 bp homology to the B1
repeat sequence. There are no long ORFs present and the sequence is unlikely to be
coding. No transcript was detected on a Northerns of RNA from various tissues and
ES cells when the 250 bp unique sequence probe from 650 bp downstream of the
integration site was used as a probe. It is possible that this sequence is intronic and
not detectable on Northerns. The probe from upstream of the integration point
detects multiple transcripts in ES cell RNA. These transcripts are probably derived
from several loci (Figure 4.6b).
The function of the SOFI promoter and the properties that make the SOFI





5.1 Targeting Hox-2.1 in ES cells.
The aim of this project was to produce a mouse mutant for Hox-2.1. The
mutant would be useful for the functional analysis of Hox-2.1 - to determine its
developmental importance or role and determine its interaction with developmental
control and downstream "regulated" genes.
The overall procedure for producing a mouse mutant for Hox-2.1 is presented
in Figure 1.4. The first step in the procedure is the mutation of the gene in ES cells.
ES cells were successfully cultured during the project. Culture conditions
were devised by myself, Dr. Julia Dorin, Dr. Sinead Jones and Wendy Kimber, such
that the ES cells appeared to be healthy and in an undifferentiated state. Julia Dorin
has recently shown that ES cells cultured under these conditions are capable of
forming highly chimaeric mice, with ES cell germ line contribution. ES cells of an
early passage number (20-22) were used for transfections.
L cells were initially used as a test system until ES cells were being grown
successfully. However, it is thought that genes target with different efficiencies in
different cell types. This may be due to different availability of enzymes for
recombination or difference in expression or accessibility of the gene.
Five targeting vectors have been used to target Hox-2.1 during this project.
PCR amplification between flanking endogenous and vector sequence was
initially devised as the strategy for rapid screening of homologous recombinant
clones against the background of random integration events. However,
contamination from control plasmid amplified products became a problem during the
first transfection analyses and other vectors contained too large a region of Hox-2.1
sequence for reliable amplification by PCR. All clones were therefore analysed by
Southern blot hybridisation.
The first targeting attempts were made with a promoterless neo replacement
vector. No homologous recombinants were obtained after isolation of 5 L cell and 31
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ES cell G418r clones. 36 clones are equivalent to 2880 total integration events if the
80-fold enrichment factor for integration into active promoter sites is taken into
account. Promoterless neo targeting vectors have been successfully used to target
expressed genes at high frequency e.g. SV40 at 3/11 G418r clones (1/11 total
integration events)(Dorin et al., 1989) and pim at 34/40 G418r clones (te Riele et al.,
1990). However, some lower frequencies have been reported e.g. polyoma middle T
antigen at 1/100 G418r clones (1/10000 total integration events)(Sedivy and Sharpe,
1989) or c-abl at 1/34 G418r clones (Schwarzberg et al., 1989). Analysis of 36
clones may be too low a number to conclude that this targeting vector is incapable of
targeting Hox-2.1. However, it is possible to speculate that the size (100 bp) of the 5'
Hox-2.1 homology is a limiting factor. Decreased regions of homology decrease
targeting frequency (Thomas and Capecchi, 1987). Also it is possible that the
selectable marker, neo, is not expressed at a high enough level to confer G418
resistance on homologous recombinants. Negative control regions at the Hox-2.1
locus may have an inhibitory affect on neo expression from the Hox-2.1 promoter. It
was shown that the construct, Hox2.1pneo, containing 1.5 kb upstream Hox-2.1
sequence fused inframe with the neo, was capable of conferring G418 resistance on
ES cells.
Two PNS vectors were constructed. One was designed to act like a
promoterless neo vector with 400 bp of Hox-2.1 homology at the 5' end; the second
contained 1.5 kb 5' Hox-2.1 homology and therefore Hox-2.1 promoter function.
Surprisingly the latter generated no more G418r colonies than the former, which
should enrich for promoter integrations. This may suggest the presence of a negative
control region in the 3' Hox-2.1 sequence (sequence not present in the Hox2.1pneo)
inhibiting expression of neo. The HSW-tk gene was cloned onto the end of the
vectors so that random integration events could be selected against by sensitivity to
the base analogue, gancyclovir. Gancyclovir selection reduced the number of G418r
colonies by 40-fold. This compares favourably with the level of enrichment reported
in the literature. 25 L cell and 6 ES cell G418r gancr clones were analysed
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(equivalent to 1320 G418r clones). None were homologous recombinants. Again it is
not possible to say whether these vectors are incapable or capable of targeting Hox-
2.1. There is considerable variability in the reported targeting frequencies obtained
with PNS vectors. Some of the frequencies published are: 1/38 G418r gancr clones
(1/304 G418r clones) for immunoglobulin p. gene (Kitamura et al., 1991) and with
double tk for enrichment 1/500 (1/1000) for T-cell antigen receptor (Mombaerts et
al., 1991) or 1/275 (1/7150) for Wnt-1 (McMahon and Bradley, 1990). It must be
noted again that both vectors rely on the expression of the Hox-2.1 promoter at the
Hox-2.1 locus for expression of neo.
Finally, two insertion vectors were used to target Hox-2.1 in ES cells. These
vectors contain the same region of Hox-2.1 but 100 bp is deleted from the Hox-2.1
sequence at the linearisation site of HoxTneo. Construct 6 has a smaller region of 5'
Hox-2.1 homology (360 bp) upon linearisation. No homologous recombinants were
detected in 226 G418r clones analysed. It is not possible to say whether these vectors
can function to target Hox-2.1. Targeting frequencies reported for insertion vectors
are variable: 1/31 for Hox-2.6 (Hasty et al., 1991) to 1/1000 G418r clones for Hprt
(Thomas and Capecchi, 1987). It is possible that the 360 bp of Hox-2.1 homology at
the 5' end of construct 6 limits targeting potential of this vector and it is possible that
HoxTneo is incapable of homologous recombination due to deletion of Hox-2.1
sequence at the linearisation site. However, HoxTneo did generate a pick-up clone. It
is thought that the targeting vector found homology to the target sequence but
instead of undergoing homologous recombination, picked up adjacent sequence from
the locus by a process of gene conversion, before randomly integrating into the
genome.
Hox-2.1 has not been successfully targeted. A total of 253 ES cell and 32 L
cell selected clones were analysed. It is not possible to say whether the failure to
target is due to low targeting potential of the targeting vectors used (discussed
above) or because of inherent low targetability of the Hox-2.1 locus. There is
obviously a wide range in the targeting frequencies obtained for targeting of
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different loci/sequences, as reported in the literature (or not reported in the
literature!). These differences are not always due to vector design since very similar
vectors have been used to target different genes with different targeting frequencies,
e.g. PNS vectors. It may be that sequence at the Hox-2.1 locus has low
recombinogenic potential. The same 6 kb of sequence was used to construct the
different targeting vectors. Also it may be that the Hox-2.1 locus has an inhibitory
effect on neo expression, such that any homologous recombinants are selected
against by G418. This negative influence may be affecting neo expression from the
Hox-2.1 promoter in the case of the replacement/PNS vectors or from the SV40
early region promoter of SV2neo in the case of the insertion vectors.
285 clones have been screened in this study. This number is equivalent to
4416 integration events. This is not a large number when compared to some of the
numbers screened for the successful targeting of other genes. Many more clones
need to be analysed before any firm conclusions may be drawn.
5.2 Future prospects for targeting Hox-2.1.
In order to screen larger numbers of clones more quickly a more rapid
screening procedure needs to be devised. Two recent techniques, one for freezing
cells and one for DNA isolation from cells, allow the growth of more clones to the
DNA preparation stage more quickly. Both techniques require fewer numbers of
cells than the standard techniques. Chan and Evans (1991) describe a technique for
freezing of ES cells in situ in 2 cm2 wells of a 24 well plate (see Section 2.1.7).
Laird et al. (1991) describe a procedure for the isolation of DNA from a confluent
layer of ES cells in a 2cm2 well. This method also has the advantage of having fewer
steps, with no centrifugation, so that large numbers of clones may be processed at
once. The DNA is extracted by layering lysis buffer onto the cells and precipitating
the DNA with isopropanol. The DNA is claimed to be of sufficient yield and quality
for digestion by restriction enzymes for Southern blot analysis.
PCR amplification allows the screening of large numbers of clones, more
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rapidly than Southern blot analysis. However, PCR amplification is subject to
contamination and generation of false positives (as previously discussed, found by
myself and Kim et al., 1991). Kim et al. suggest the generation of a pseudo-
recombinant cell line for use as a positive control along with PCR screening. This
cell line has an integrated plasmid containing the diagnostic PCR product fragment
for some of the PCR primers but not all (so that PCR contamination may be
detected). Pseudo-recombinant cell line PCR amplification will enable the
identification of the correctly sized product and provides an intensity comparison for
amplification in pools of non-recombinant clones. It is wise to take extra care when
setting up PCR reactions so as to avoid contamination. Kwok and Higuchi (1989)
outline some precautions which ought to be taken.
It is possible that the use of isogenic DNA between ES cell and targeting
vectors will increase the targeting frequency obtained in some targeting experiments
(te Riele, personal communication). There may be small sequence differences
between different strains. Thus construction of a Hox-2.1 targeting vector from 129
strain DNA (isogenic with E14 ES cell line) may increase the likelihood of targeting.
The strength of the neo selectable marker gene in the targeting vector may
also have a significant effect on targeting frequency. Tybulewitcz et al. (1991) report
a 13-fold increase in G418r colonies with a neo attached to the mouse
phosphoglycerate kinase-1 (PGK-1) (Adra et al., 1987) compared to pMClneo
polyA and SV2neo. A strong promoter may allow neo expression independent of
chromosomal integration site.
Thomas and Capecchi (1987) found that insertion and replacement vectors
were equally efficient at targeting the Hprt gene. Recent data, of Hasty et al.
(1991b), suggest that insertion vectors are 9-fold more efficient than replacement
vectors (Section 3.1). Replacement vectors may also integrate into the target locus
upon recircularisation or concatemerisation. Negative selection against integration
events (ganc selection against HSV-tk) may thus eliminate 95% of targeted events
(Hasty et al., 1991b). It may therefore be advisable to continue with the insertion
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vector in future Hox-2.1 targeting experiments. However, a potential problem with
insertion vectors is reversion of the introduced mutation - duplicated sequence at the
insertion site may undergo a single intrachromasomal recombination event such that
the normal gene sequence is restored.
It is possible that the Hox-2.1 locus sequence is refractory to homologous
recombination either because of low recombinogenic nature or due to silencing of
neo expression. Therefore, it may be useful to construct a targeting vector similar to
that used by Mombaerts et al. (1991). A large region (10 kb) of Hox-2.1
endogenous locus sequence may be deleted by targeting with a replacement vector
containing DNA from upstream and downstream of the locus. In this way, different
DNA sequence is required for recombination and any negative transcription control
region may be deleted from the site.
5.3 Future prospects for the study of Hox-2.1 function.
Once the targeting of Hox-2.1 has been achieved in ES cells, the cells will be
used to generate a mouse mutant for Hox-2.1. The study of the Hox-2.1 mutant
phenotype is a project in itself!
If a Hox-2.1 mutation causes an early embryonic lethality it may be necessary
to create a double knock-out ES cell line for the analysis of contribution to chimaeric
mouse development (te Riele et al., 1990). Alternatively a less severe phenotype
may be observed due to redundancy of function between related gene products. Hox-
2.1 mutants may be crossed to Hox-1.3 mutants to create double homozygous
mutants. Since Hox-1.3 is the paralogue of Hox-2.1 a more severe phenotype may be
observed in these mice.
The generation of cell lines or mice overexpressing Hox-2.1 may also be
useful in the study of Hox-2.1 function.
5.4 Identification of a site of frequent integration.
The SOFI of ES cells is a site which has been integrated into twice by a
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promoterless neo targeting vector. The insert flanking sequences, for one clone
(7B2), were amplified by inverse PCR and sequenced. The flanking sequence from
the second clone (5B2) and the uninterrupted target sequence from ES cells were
sequenced directly from PCR products. In the different integration events, different
amounts of targeting construct sequence have been lost - therefore, different regions
of the targeting vector were involved in the cross-over event. However, the construct
has integrated into the same 6 bp region in both the clones. There are 3 bp homology
between vector and endogenous sequence at the proposed cross-over junction in
7B2, but no homology in 5B2. It is unlikely that the vector integrated into this
specific sequence due to homology.
The promoter function of the cloned upstream region has been tested in ES
cells by measuring G418r conferred by an attached neo gene and by CAT assay.
Weak promoter function is observed. It is therefore unlikely that integration into this
sequence has been selected for due to high expression of neo from the endogenous
promoter. This is believed to be the reason for the isolation and identification of
viral integrations into the F2 locus of EC cells (Barklis et al., 1986).
There are several sequence motifs found to be associated with hotspots for
homologous recombination (reviewed by Fischer Lindahl, 1991 and Steinmetz et al.,
1987). The Chi sequence, GCTGGTGG, enhances homologous recombination in E.
coli and bacteriophage X. Chi is a recognition site for the RecBC enzyme, which cuts
3' to the Chi site as it unwinds DNA. Short repeated sequences similar to Chi
(CAGA and CAGG) have been found to be associated with the mouse major
histocompatibility complex (MHC) hotspots for recombination. Middle-repetitive
elements (MT) (Heinlein et al., 1986), LTR-like sequences (Uematsu et al., 1986
and Edelman et al., 1989), a 57 bp direct repeat (Uematsu et al., 1986) and binding
motifs for transcription factors (Shenkar et al., 1991) are also associated with
recombinational hotspots. Solitary LTR elements (Wirth et al., 1983) are hotspots
for recombination (Edelman et al., 1989). Edelman et al. tested LTR recombination
in vitro and found two cis-acting sequences required for recombination. It is assumed
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that DNA at the recombination hotspot interacts with proteins which regulate the
rate-limiting step of recombination. Proteins may stabilise single-stranded DNA
regions required for recombination.
It is not known what properties of the SOFI sequence promote the integration
into this site. No motif associated with recombinational hotspots was identified in the
SOFI sequence. However, there is a 55 bp of sequence present upstream of the
integration site, which is 72% homologous to proviral LTR sequence and contains
two copies of an AGTTTC LTR motif. It is possible that this sequence retains some
LTR function and is associated with promotion of recombination.
Aspects of secondary structure may also contribute to the recombination at
the SOFI locus. Indirect repeats and AT rich regions may form single-stranded DNA
regions.
The function of the SOFI sequence and promoter in ES cells is unknown. No
transcript was detected on a Northern blot of RNA from various tissues when the
250 bp unique sequence from 650 bp downstream of the integration site was used as
a probe. It is possible that the sequence is intronic and not detectable on Northerns.
Computer analysis of the sequence shows it is unlikely to be coding.
5.4 Application of inverse PCR.
The isolation of sequence from promoter-trap and enhancer-trap integration
sites is necessary for the molecular characterisation of the gene. This may be
achieved by screening lambda libraries cloned from cell line genomic DNA. Inverse
PCR amplification of flanking sequence offers a more rapid method which can be
applied to large numbers of clones. The use of inverse PCR amplification in the
cloning and sequencing of flanking sequences to the insert in the cell line 7B2, has
shown the power of this method for such applications.
A second method for PCR amplification of flanking sequence was initially
tried. Vectorette PCR is described by Riley et al. (1990). Sequence between vector
and an upstream/downstream restriction site may be amplified by digestion of DNA
134
with the restriction enzyme, attachment of synthetic linkers and PCR amplification
between a vector-specific primer and a linker-specific primer. The method has been
used to isolate terminal sequences from YACs (Riley et al., 1990). However, when I
applied it to the amplification of flanking sequences from 7B2, no specific sequence
was amplified. The added complexity of mouse genomic DNA over yeast DNA is
probably the reason for this lack of amplification.
5.4 Future prospects for the analysis of the SOFI.
There are several lines of research that may be pursued for the
characterisation of the SOFI.
In order to obtain a larger region from the SOFI locus a lambda library of
mouse genomic DNA should be screened with the unique downstream flanking
inverse PCR product clone probe (Pst I to Eco RI fragment). Subcloning and
sequencing of sequence further upstream from the integration point will help
characterise the promoter. A larger upstream region may be tested for promoter
function in ES cells as before.
The SOFI locus may be mapped to the mouse genetic map using RI strains
(Section 4.7.3; Taylor in Morse, 1978). The search for polymorphic sites around the
locus may be continued with different enzyme digests and the unique sequence probe
available or by isolation of and screening with new probes.
Probes around the region may also be used to hybridise Northern blots of ES
cell and tissue mRNAs in order to detect a transcript from the locus. If a probe
recognises a transcript, then a cDNA clone may be pulled out from a cDNA library.
More information on the function of the SOFI sequence may be obtained from
sequencing of a cDNA clone.
Chimaeric mice may be generated from the ES cell lines 5B2, 7B2 and 7B3
(secondary of 7B2). This has been attempted once by Robin Lovell-Badge.
However, no extensive chimaerism was observed in the chimaeras born and none
were germ-line. If these cells cannot form germ-line chimaeras (due to genetic
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defects accumuled during culturing), it may be possible to generate new cell lines by
targeting the SOFI locus homologously or again with the promoterless neo vector. If
chimaeric mice are produced, homozygous mice for the SOFI integration may be
studied for any phenotypic effects.
If the locus is indeed a site of frequent integration, it is predicted that
integration into this locus may be repeated. Integration events into the locus may be
detected by PCR as in Section 4.9. It is possible that other targeting vectors integrate
into this locus - since no homology to the Hox-2.1 vector is observed. Analysis of
other targeting vector illegitimate integration events can easily be carried out by
PCR amplification on pools of DNA. It may be that random integration is not
random at all, but into a few specific regions.
If the properties that make this sequence a site of frequent integration (e.g.
sequence content or structure) can be characterised, useful information may be
obtained for the targeting of other regions. If a specific gene is to be targeted,
sequences in or around the gene may be analysed for similar sequence or structure to
the SOFI sequence. Any region that shows similarity may be used to construct the





Accili, D., and Taylor, S. I. (1991). Targeted inactivation of the insulin receptor
gene in mouse 3T3-L1 fibroblasts via homologous recombination. Proc. Natl. Acad.
Sci. USA 88, 4708-4712.
Adair, G. M., Nairn, R. S., Wilson, J. H., Seidman, M. M., Brotherman, K. A.,
MacKinnon, C., and Scheerer, J. B. (1989). Targeted homologous recombination at
the endogenous adenine phosphoribosyltransferase locus in Chinese hamster cells.
Proc. Natl. Acad. Sci. USA 86, 4574-4578.
Adra, C. N., Boer, P. H., and McBurney, M. W. (1987). Cloning and expression of
the mouse pgk-1 gene and the nucleotide sequence of its promoter. Gene 60, 65-74.
Akam, M. (1987). The molecular basis for metameric pattern in the Drosophila
embryo. Development 101, 1-22.
Balling, R., Mutter, G., Gruss, P., and Kessel, M. (1989). Craniofacial abnormalities
induced by ectopic expression of the homeobox gene Hox 1.1 in transgenic mice.
Cell 58, 337-347.
Barklis, E., Mulligan, R. C., and Jaenisch, R. (1986). Chromosomal position or virus
mutation permits retrovirus expression in embryonal carcinoma cells. Cell 47, 391-
399.
Birnboim, H. C., and Doly, J. (1979). A rapid alkaline extraction method for
screening recombinant plasmid DNA. Nucl. Acids Res. 7, 1513-1516.
Bolivar, F., Rodriguez, R.L., Greene, P.J., Betlach, M.C., Heyneker, H. L. and
Boyer, H.W. (1977). Construction and characterisation of new cloning vehicles. II.
A multipurpose cloning system. Gene 2, 95-113.
Bradley, A., Evans, M., Kaufman, M. H., and Robertson, E. (1984). Formation of
germ-line chimaeras from embryo-derived teratocarcinoma cell lines. Nature 309,
255-556.
Brinster, R. L. (1974). The effect of cells transferred into the mouse blastocyst on
subsequent development. J. Exp. Med. 140, 1049-1056.
Brinster, R. L., Braun, R. E., Lo, D., Avarbock, M. R., Oram, F., and Palmiter, R. D.
(1989). Targeted correction of a major histocompatibility class II Ea gene by DNA
microinjected into mouse eggs. Proc. Natl. Acad. Sci. USA 86, 7087-7091.
Budd, P. S., and Jackson, I. J. (1991). What do the regulators regulate? First
glimpses downstream. Trends Genet. 7, 74-76.
Capecchi, M. R. (1989). Altering the genome by homologous recombination.
Science 244, 1288-1292.
137
Chan, S. Y., and Evans, M. J. (1991). In situ freezing of embryonic stem cells in
multiwell plates. Trends Genet. 7, 76.
Chang, X.-B., and Wilson, J. H. (1987). Modification of DNA ends can decrease end
joining relative to homologous recombination in mammalian cells. Proc. Natl. Acad.
Sci. USA 84, 4959-4963.
Charron, J., Malynn, B. A., Robertson, E. J., Goff, S. P., and Alt, F. W. (1990).
High-frequency disruption of the N-myc gene in embryonic stem cell and pre-B cell
lines by homologous recombination. Mol. Cell Biol. 10, 1799-1804.
Chisaka, O., and Capecchi, M. R. (1991). Regionally restricted developmental
defects resulting from targeted disruption of the mouse homeobox gene hox-1.5.
Nature 350, 473-479.
Church, G.M. and Gilbert, W. (1984). Genomic sequencing. Proc. Natl. Acad.
Sci.USA 81, 1991-1995.
Conlon, F. L., Barth, K. S., and Robertson, E. J. (1991). A novel retrovirally induced
embryonic lethal mutation in the mouse: assessment of the developmental fate of
embryonic stem cells homozygous for the 413.d proviral integration. Development
111,969-981.
Corden, J., Wasylyk, B., Buchenwalder, A., Sassone-Corci, P., Kedinger, C., and
Chambon, P. (1980). Promoter sequences of eukaryotic protein-coding genes.
Science 209,1405-1414.
Craig Barton, M., Hoekstra, M. F., and Emerson, B. M. (1990). Site-directed,
recombination-mediated mutagenesis of a complex gene locus. Nucl. Acids Res. 18,
7349-7355.
DeChiara, T. M., Efstratiadis, A., and Robertson, E. (1990). A growth-deficiency
phenotype in heterozygous mice carrying an insulin-like growth factor II gene
disrupted by targeting. Nature 345, 78-80.
DeChiara, T. M., Robertson, E. J., and Efstratiadis, A. (1991). Parental imprinting of
the mouse insulin-like growth factor II gene. Cell 64, 849-859.
Deurson, J. van, Lovell-Badge, R., Oerlemans, F., Schepens, J., and Wieringa, B.
(1991). Modulation of gene activity by consecutive gene targeting of one creatine
kinase M allele in mouse embryonic stem cells. Nucl. Acids Res. 19, 2637-2643.
Devereux, J., Haeberli, P., and Smithies, O. (1984). A comprehensive set of
sequence analysis programs for the VAX. Nucl. Acids Res. 12, 387-395.
Doetschman, T., Gregg, R. G., Maeda, N., Hooper, M. L., Melton, D.W.,
Thompson, S., and Smithies, O. (1987). Targetted correction of a mutant HPRT
gene in mouse embryonic stem cells. Nature 330, 576-578.
138
Doetschman, T., Maeda, N., and Smithies, O. (1988). Targeted mutation of the Hprt
gene in mouse embryonic stem cells. Proc. Natl. Acad. Sci. USA 85, 8583-8587.
Dorin, J. R., Inglis, J. D., and Porteous, D. J. (1989). Selection for precise
chromosomal targeting of a dominant marker by homologous recombination.
Science 243,1357-1360.
Duboule, D., and Dolle, P. (1989). The structural and functional organisation of the
murine HOX gene family resembles that of Drosophila homeotic genes. EMBO J. 8,
1497-1505.
Edelman, W., Kroger, B., Goller, M., and Horak, I. (1989). A recombination hotspot
in the LTR of a mouse retrotransposan identified in an in vitro system. Cell 57, 937-
946.
Evans, M. H., and Kaufman, M. H. (1981). Establishment in culture of pluripotential
cells from mouse embryos. Nature 292, 154-156.
Feinberg, A. P., and Vogelstein, A. (1983). A technique for radiolabeling DNA
restriction endonuclease fragments to high specific activity. Anal. Biochem. 132, 6-
13.
Feinberg, A. P., and Vogelstein, A. (1984). A technique for radiolabeling DNA
restriction endonuclease fragments to high specific activity. Anal. Biochem. 137,
266-267.
Fischer Lindahl, K. (1991). His and hers recombinational hotspots. Trends Genet. 7,
273-276.
Frain, M., Swart, G., Monaci, P., Nicosia, A., Stampfii, S., Frank, R., and Cortese,
R. (1989). The liver-specific transcription factor LF-B1 contains a highly diverged
homeobox DNA binding domain. Cell 59, 145-157.
Friedrich, G. and Soriano, P. (1991). Promoter traps in embryonic stem cells: a
genetic screen to identify and mutate developmental genes in mice. Genes Dev. 5,
1513-1523.
Gaunt, S. J., Krumlauf, R., and Duboule, D. (1989). Mouse homeo-genes within a
subfamily, Hox-1.4, -2.6 and -5.7, display similar anteroposterior domains of
expression in the embryo, but show stage- and tissue-dependent differences in their
regulation. Development 107, 131-141.
Gaunt, S. J., and Singh, P. B. (1990). Homeogene expression patterns and
chromosomal imprinting. Trends Genet. 6, 208-212.
Gehring, W. J. (1987). Homeo boxes in the study of development. Science 236,
1245-1251.
139
Golemis, E. A., Speak, N. A., and Hopkins, N. (1990). Alignment of U3 region
sequences of mammalian type C viruses: Identification of highly conserved motifs
and implications for enhancer design. J.Virol 64, 534-542.
Gorman, C. M., Moffat, L. F., and Howard, B. H. (1982). Recombinant genomes
which express chloramphenical acetyltransferase in mammalian cells. Mol. Cell Biol.
2, 1044-1051.
Gossler, A., Joyner, A. L., Rossant, J., and Skarnes, W. C. (1989). Mouse embryonic
stem cells and reporter constructs to detect developmentally regulated genes. Science
244, 463-465.
Graham, A., Papalopulu, N., and Krumlauf, R. (1989). The murine and Drosophila
homeobox gene complexes have common features of organisation and expression.
Cell 57, 367-378.
Handyside, A. H., O'Neill, G. T., Jones, M., and Hooper, M. L. (1989). Use of BRL-
conditioned medium in combination with feeder layers to isolte a diploid embryonal
stem cell line. Roux's Arch. Dev. Biol. 198, 48-55.
Hart, C. P., Awgulewitsch, A., Fainsod, A., McGinnis, W., and Ruddle, F. H.
(1985). Homeo box gene complex on mouse chromosome 11: molecular cloning,
expression in embryogenesis, and homology to a human homeo box locus. Cell 43,
9-18.
Hasty, P., Ramirez-Solis, R., Krumlauf, R., and Bradley, A. (1991a). Introduction of
a subtle mutation into the Hox-2.6 locus in embryonic stem cells. Nature 350, 243-
247.
Hasty, P., Rivera-Perez, J., Chang, C., Bradley, A. (1991b). Target frequency and
integration pattern for insertion and replacement vectors in embryonic stem cells.
Mol. Cell Biol. 11, 4509-4517.
Hattman, S., Brooks, J. E., and Masurekar, M. (1978). Sequence specificity of the PI
modification methylase (M.Eco PI) and the DNA methylase (Ni.Eco dam) controlled
by Escherichia coli dam gene. J. Mol. Biol. 126, 367-380.
Hayashi, S., and Scott, M. P. (1990). What determines the specificity of action of
Drosophila homeodomain proteins? Cell 63, 883-894.
Heath, J. K., and Smith, A. G. (1989). Growth factors in embryogenesis. Brit. Med.
Bull. 45, 319-336.
Heinlein, U. A. O., Lange-Sablitzky, Schaal, H and Wille, W. (1986). Molecular
characterizition of the MT-family of dispersed middle-repetitive DNA in rodent
genomes. Nucl. Acids Res. 14, 6403-6416.
Hinnen, A., Hicks, J. B., and Fink, G. R. (1978). Transformation of yeast. Proc.
Natl. Acad. Sci. USA 75, 1929-1933.
140
Hogan, B., Costantini, F., and Lacy, E. (1986). Manipulating the mouse embryo: a
laboratory manual., 1st ed. (New York: Cold Spring Harbor Laboratory).
Holland, P. W. H., and Hogan, B. L. M. (1986). Phylogenetic distribution of
Antennapedia-like homeo boxes. Nature 321, 251-253.
Holland, P. W. H., and Hogan, B. L. M. (1988a). Expression of homeo box genes
during mouse development: a review. Genes Dev. 2, 773-782.
Holland, P. W. H., and Hogan, B. L. M. (1988b). Spatially restricted patterns of
expression of homeobox-containing gene Hox-2.1 during mouse embryogenesis.
Development 102, 159-174.
Hooper, M., Hardy, K., Handyside, A., Hunter, S., and Monk, M. (1987). HPRT-
deficient (Lesch-Nyan) mouse embryos derived from germline colonisation of
cultured cells. Nature 326, 292-295.
Hunt, P., Wilkinson, D., and Krumlauf, R. (1991). Patterning the vertebrate head:
murine Hox 2 genes mark distinct subpopulations of premigratory and migrating
cranial neural crest. Development 112, 43-50.
Ingham, P. (1988). The molecular genetics of embryonic pattern formation in
Drosophila. Nature 335, 25-33.
Itzhaki, J. E., and Porter, A. C. G. (1991). Targeted disruption of a human
interferon-inducible gene detected by secretion of human growth hormone. Nucl.
Acids Res. 19, 3835-3842.
Jackson, I. J., Schofield, P., and Hogan, B. (1985). A mouse homeo box gene is
expressed during embryogenesis and in adult kidney. Nature 317, 745-748.
Jaenisch, R. (1988). Transgenic animals. Science 240, 1468-1475.
Jaenisch, R., Breindl, L. M., Harbers, K., Jahner, D., and Lohler, J. (1985).
Retroviruses and insertional mutagenesis. Cold Spring Harbor Symp. Quant. Biol.
50, 439-445.
Jaenisch, R., Harber, K., Schnieke, A., Lohler, J., Chumakov, I., Jahner, D.,
Grotkopp, D., and Hoffman, E. (1983). Germline integration of Moloney murine
leukemia virus at the Movl3 locus leads to recessive lethal mutation and early
embryonic death. Cell 32, 209-216.
Jasin, M., and Berg, P. (1988). Homologous integration in mammalian cells without
target gene selection. Genes Dev. 2, 1353-1363.
Jasin, M., Elledge, S. J., Davis, R. W., and Berg, P. (1990). Gene targeting at the
human CD4 locus by epitope addition. Genes Dev. 4, 157-166.
141
Jenkins, N. A., Copeland, N. G., Taylor, B. A., and Lee, B. K. (1981). Dilute (d)
coat colour mutation of DBA/2J mice is associated with the site of integration of an
ecotropic MuLV genome. Nature 293, 370-374.
Johnson, A. D., and Heskowitz, I. (1985). A repressor (Mat a2 product) and its
operator control expression of a set of cell type specific genes. Cell 42, 237-247.
Johnson, R. S., Sheng, M., Greenberg, M. E., Kolodner, R. D., Papaioannou, V. E.,
and Spiegelman, B. M. (1989). Targeting of nonexpressed genes in embryonic stem
cells via homologous recombination. Science 245, 1234-1236.
Joyner, A. L., Herrup, K., Auerbach, B. A., Davis, C. A., and Rossant, J. (1991).
Subtle cerebellar phenotype in mice homozygous for a targeted deletion of the En-2
homeobox. Science 251, 1239-1243.
Joyner, A. L., Lebo, R. V., Kan, Y. W., Tjian, R., Cox, D. R., and Martin, G. R.
(1985). Comparitive chromosome mapping of a conserved homoeo box region in
mouse and man. Nature 314, 173-175.
Joyner, A. L., Skarnes, W. C., and Rossant, J. (1989). Production of a mutation in
mouse En-2 gene by homologous recombination in embryonic stem cells. Nature
338, 153-156.
Kay, R., and McPherson, J. (1987). Hybrid pUC vectors for addition of new
restriction enzyme sites to the ends of DNA fragments. Nucl. Acids Res. 15, 2778.
Kessel, M., Balling, R., and Gruss, P. (1990). Variations of cervical vertebrae after
expression of a Hox-1.1 transgene in mice. Cell 61, 301-308.
Kessel, M., and Gruss, P. (1990). Murine developmental control genes. Science 249,
374-379.
Kim, H.-S., Popovich, B. W., Shehee, W. R., Shesely, E. G., and Smithies, O.
(1991). Problems encountered in detecting a targeted gene by the polymerase chain
reaction. Gene 103, 227-233.
Kim, H.-S., and Smithies, O. (1988). Recombinant fragment assay for gene
targetting based on the polymerase chain reaction. Nucl. Acids Res. 16, 8887-8893.
Kit, S., Dubbs, D. R., Piekarski, L. J., and Hsu, T. C. (1963). Deletion of thymidine
kinase activity from L cells resistant to bromodeoxyuridine. Exp. Cell. Res. 31, 297-
312.
Kitamura, D., Roes, J., Kuhn, R., and Rajewsty, K. (1991). A B cell-deficient mouse
by targeted disruption of the membrane exon of the immunoglobulin (i chain gene.
Nature 350, 423-426.
142
Koller, B. H., Hagemann, L. J., Doetschman, T., Hagaman, J. R., Huang, S.,
Williams, P. J., First, N. L., Maeda, N., and Smithies, O. (1989). Germ-line
transmission of a planned alteration made in a hypoxanthine
phosphoribosyltransferase gene by homologous recombination in embryonic stem
cells. Proc. Natl. Acad. Sci. USA 86, 8927-8931.
Konopka, A. K. (1988). Compilation of DNA strand exchange sites for non¬
homologous recombination in somatic cells. Nucl. Acids Res. 16, 1739-1758.
Koopman, P., and Cotton, R. G. H. (1984). A factor produced by feeder cells which
inhibits embryonal carcinoma cell differentiation. Exp. Cell. Res. 154, 233-242.
Krayev, A. S., Kramerov, D. A., Skiryabin, K. G., Ryskov, A. P., Bayev, A. A., and
Georgiev, G. P. (1980). The nucleotide sequence of the ubiquitous repetitive DNA
sequence B1 complementary to the most abundant class of mouse fold-back RNA.
Nucl. Acids Res. 8, 1201-1215.
Krumlauf, R., Holland, P. W. H., McVey, J. H., and Hogan, B. L. M. (1987).
Developmental and spatial patterns of expression of the mouse homeobox gene, Hox
2.1. Development 99, 603-617.
Kucherlapati, R. and Smith, G.R. eds.(1988). Genetic Recombination., 1st edition.
(Am. Soc. Microbiol.).
Kuehn, M. R., Bradley, M. R., Robertson, E. J., and Evans, M. J. (1987). A potential
animal model for Lesch-Nyhan Syndrome through introduction of HPRT mutations
into mice. Nature 326, 295-298.
Kwok, S., and Higuchi, R. (1989). Avoiding false positives with PCR. Nature 339,
237-238.
Laird, P.W., Zijderveld, A., Linders, K., Rudnicki, M.A., Jaenisch, R., and Berns, A.
(1991). Simplified mammalian DNA isolation procedure. Nucl. Acids Res. 19, 4293.
Laughon, A., and Scott, M. P. (1984). Sequence of a Drosophila segmentation gene:
protein structure homology with DNA-binding proteins. Nature 310, 25-30.
Le Mouellic, H., Lallemand, Y., and Brulet, P. (1990). Targeted replacement of the
homeobox gene Hox 3.1 by the Escherichia coli lac z in mouse chimeric embryos.
Proc. Natl. Acad. Sci. USA 87, 4712-4716.
Levine, M., Rubin, G. M., and Tjian, R. (1984). Human DNA sequences
homologous to a protein coding region conserved between homeotic genes in
Drosophila. Cell 38, 667-673.
Lin, F.-L., Sperle, K., and Sternberg, N. (1984). Model for homologous
recombination during transfer of DNA into mouse L cells: role for DNA ends in the
recombination process. Mol. Cell Biol. 4, 1020-1034.
143
Lin, F.-L., Sperle, K., and Sternberg, N. (1985). Recombination in mouse L cells
between DNA introduced into cells and homologous chromosomal sequences. Proc.
Natl. Acad. Sci. USA 82, 1391-1395.
Luckow, B., and Schutz, G. (1987). CAT constructions with multiple unique
restriction sites for the functional analysis of eukaryotic promoters and regulatory
elements. Nucl. Acids Res. 15, 5490.
Lumsden, A., and Keynes, R. (1989). Segmental patterns of neuronal development
in the chick hindbrain. Nature 337, 424-428.
Lyon, M. F., and Searle, A. G., eds. (1989). Genetic variants and strains of the
laboratory mouse., 2nd ed. (New York: Oxford University Press).
Macleod, D., Lovell-Badge, R., Jones, S., and Jackson, I. (1991). A promoter trap in
embryonic stem (ES) cells selects for integration of DNA into CpG islands. Nucl.
Acids Res. 19, 17-23.
Mansour, S. L. (1990). Gene targeting in murine embryonic stem cells: introduction
of specific alterations into the mammalian genome. Genet. Anal. Tech. Appl. 7, 219-
227.
Mansour, S. L., Thomas, K. R., and Capecchi, M. R. (1988). Disruption of the
proto-oncogene int-2 in mouse embryo-derived stem cells: a general strategy for
targeting mutations to non-selectible genes. Nature 336, 348-352.
Mansour, S. L., Thomas, K. R., Deng, C., and Capecchi, M. R. (1990). Introduction
of a lacZ reporter gene into the mouse int-2 locus by homologous recombination.
Proc. Natl. Acad. Sci. USA 87, 7688-7692.
Martin, G. A., and Evans, M. J. (1975). Differentiation of clonal lines of
teratocarcinoma cells: formation of embryoid bodies in vitro. Proc. Natl. Acad. Sci.
USA 72, 1441-1445.
Martin, G. R. (1981). Isolation of a pluripotent cell line from early mouse embryos
cultured in medium conditioned by teratocarcinoma stem cells. Proc. Natl. Acad.
Sci. USA 78, 7634-7638.
Matthews, B. W., Ohlendorf, D. H., Anderson, W. F., Fisher, R. G., and Takeda, Y.
(1982). Cro repressor protein and its interaction with DNA. Cold Spring Harbor
Symp. Quant. Biol. 47, 427-432.
McGinnis, W., Hart, C. P., Gehring, W. J., and Ruddle, F. H. (1984a). Molecular
cloning and chromosome mapping of a mouse DNA sequences homologous to
homeotic genes of Drosophila. Cell 38, 675-680.
McGinnis, W., Levine, M.S., Hafen, E., Kuroiwa, A., and Gehring, W.J. (1984b). A
conserved DNA sequence in homeotic genes of Drosophila Antennapedia and
bithorax complexes. Nature 308, 428-433.
144
McMahon, A. P., and Bradley, A. (1990). The Wnt-1 (int-1) proto-oncogene is
required for development of a large region of the mouse brain. Cell 62, 1073-1085.
Melton, D. W., Konecki, D. S., Brennand, J., and Caskey, C. T. (1984). Structure,
expression, and mutation of the hypoxanthine phosphoribosyltransferase gene. Proc.
Natl. Acad. Sci. USA 81, 2147-2151.
Mintz, B., and Illmensee, K. (1975). Normal genetically mosiac mice produced from
malignant teratocarcinoma cells. Proc. Natl. Acad. Sci. USA 72, 3585-3589.
Mombaerts, P., Clarke, A., Hooper, M. L., and Tonegawa, S. (1991). Creation of a
large genomic deletion at the T-cell antigen receptor (3-subunit locus in mouse
embryonic stem cells by gene targeting. Proc. Natl. Acad. Sci. USA 88, 3084-3087.
Moreau, J.-F., Donaldson, D. D., Bennet, F., Witek-Giannotti, J., Clark, S. C., and
Wong, G. G. (1988). Leukaemia inhibitory factor is identical to the myeloid growth
factor human interleukin for DA cells. Nature 336, 690-692.
Morse, H. C., ed. (1978). Origins ofInbred Mice. (London: Academic Press).
Murnane, J. P., and Young, B.R. (1989). Nucleotide sequence analysis of novel
junctions near an unstable integrated plasmid in human cells. Gene 84, 201-205.
Murphy, P., Davidson, D. R., and Hill, R. E. (1989). Segment-specific expression of
a homeobox-containing gene in the mouse hindbrain. Nature 341, 156-159.
Murphy, P., and Hill, R. E. (1991). Expression of mouse labial-like, homeobox-
containing genes, Hox-2.9 and Hox-1.6, during segmentation of the hindbrain.
Development 111, 61-74.
Nasmyth, K. A. (1982). Molecular genetics of yeast mating type. Ann.Rev.Genet. 16,
439-500.
Nichols, J., Evans, E. P., and Smith, A. G. (1990). Establishment of germ-line-
competent embryonic stem (ES) cells using differentiation inhibiting activity.
Development 110, 1341-1348.
Nusslein-Volhard, C., Frohnhoffer, H. G., and Lehmann, R. (1987). Determination
of anteroposterior polarity in Drosophila. Science 238, 1675-1681.
Ochman, H., Gerber, A. S., and Hard, D. L. (1988). Genetic applications of an
inverse polymerase chain reaction. Genetics 120, 621-623.
Orr-Weaver, T. L., Szostak, J. W., and Rothstein, R. J. (1981). Yeast transformation:
A model system for the study of recombination. Proc. Natl. Acad. Sci. USA 78,
6354-6359.
145
Palmiter, R. D., Behringer, R. R., Quaife, C. J., Maxwell, F., Maxwell, I. H., and
Brinster, R. (1987). Cell lineage ablation in transgenic mice by cell-specific
expression of a toxin gene. Cell 50, 435-443.
Palmiter, R. D., and Brinster, R. L. (1985). Transgenic mice. Cell 41, 343-345.
Pavan, W. J., Hieter, P., and Reeves, R. H. (1990). Modification and transfer into an
embryonal carcinoma cell line of a 360-kilobase human-derived Yeast Artificial
Chromosome. Mol. Cell Biol. 10, 4163-4169.
Peabody, D. S., and Berg, P. (1986). Termination-reinitiation occurs in the
translation of mammalian cell mRNAs. Mol. Cell Biol. 6, 2695-2703.
Peckham, I., Sobel, S., Comer, J., Jaenisch, R., and Barklis, E. (1989). Retroviral
activation in embryonal carcinoma cells by cellular promoters. Genes Dev. 3, 2062-
2071.
Peters, J. (1985). Ethylnitrosourea as a mouse mutagen. Trends Genet. 1, 5-6.
Peterson, R., Sobel, S., Wang, C., Jaenisch, R., and Barklis, E. (1991). Cellular
transcripts encoded at a locus which permits retrovirus expression in mouse
embryonic cells. Gene 101, 177-183.
Pevny, L., Simon, M. C., Robertson, E., Klein, W. H., Tsai, S.-F., D'Agati, V.,
Orkin, S. H., and Costantini, F. (1991). Erythroid differentiation in chimaeric mice
blocked by a targeted mutation in the gene for transcription factor GATA-1. Nature
349, 257-260.
Porter, S. D., and Smith, M. (1986). Homoeo-domain homology in yeast MATa2 is
essential for repressor activity. Nature 320, 766-768.
Puschel, A. W., Balling, R., and Gruss, P. (1990). Position-specific activity of the
Hox-l.l promoter in transgenic mice. Development 108, 435-442.
Puschel, A. W., Balling, R., and Gruss, P. (1991). Separate elements cause lineage
restriction and specify boundaries of Hox-l.l expression. Development 112, 279-
287.
Radice, G., Lee, J. J., and Costantini, F. (1991). Hp58, an insertional mutation
affecting early postimplantation development of the mouse embryo. Development
111,801-811.
Rassart, E., Shang, M., Boie, Y, and Jolicoeur, P. (1986). Studies on emerging
radiation leukemia virus variants in C57BL/Ka mice. J. Virol. 58, 96-106.
Riele, H. te, Robanus Maandag, E., Clarke, A., Hooper, M., and Berns, A. (1990).
Consecutive inactivation of both alleles of the pim-1 proto-oncogene by homologous
recombination in embryonic stem cells. Nature 348, 649-651.
146
Riley, J., Butler, R., Ogilvie, D., Finniear, R., Jenner, D., Powell, S., Anand, R.,
Smith, J. C., and Markham, A. F. (1990). A novel, rapid method for the isolation of
terminal sequences from yeast artificial chromosome (YAC) clones. Nucl. Acids Res.
18, 2887-2890.
Robertson, E., Bradley, A., Kuehn, M., and Evans, M. (1986). Germ-line
transmission of genes introduced into cultured pluripotential cells by retroviral
vector. Nature 323, 445-447.
Robertson, E. J. (1986). Pluripotential stem cell lines as a route into the mouse germ
line. Trends Genet. 2, 9-13.
Robertson, E. J., ed. (1987). Teratocarcinomas and embryonic stem cells: a practical
approach., 1st ed. (1RL Press).
Robertson, M. (1987). A genetic switch in Drosophila morphogenesis. Nature 327,
556-557.
Roth, D. B., Porter, T. N., and Wilson, J. H. (1985). Mechanisms of nonhomologous
recombination in mammalian cells. Mol. Cell Biol. 5, 2599-2607.
Roth, D. B., and Wilson, J. H. (1986). Nonhomologous recombination in
mammalian cells: role for short sequence homologies in the joining reaction. Mol.
Cell Biol. 6, 4295-4304.
Rothstein, R. J. (1983). One-step gene disruption in yeast. Meth. Enzym. 101, 202-
211.
Russel, W. L. (1951). X-ray induced mutation in mice. Cold Spring Harbor Symp.
Quant. Biol. 16, 327-336.
Saiki, R. K., Gelfand, D. H., Stoffel, S., Scharf, S. J., Higuchi, R., Horn, G. T.,
Mullis, K. B., and Erlich, H. A. (1988). Primer-directed enzymatic amplification of
DNA with a thermostable DNA polymerase. Science 239, 487-491.
Saiki, R. K., Scharf, S., Faloona, F., Mullis, K. B., Horn, G. T., Erlich, H. A., and
Arnheim, N. (1985). Enzymatic amplification of (3-globin genomic seqences and
restriction site analysis for diagnosis of sickle cell anaemia. Science 230, 1350-1354.
Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989). Molecular cloning: a
laboratory manual., 2nd ed., vol. 1-3. (New York: Cold Spring Harbor Laboratory
Press).
Sanger, F., Nicklen, S., and Coulson, A. R. (1977). DNA sequencing with chain-
terminating inhibitors. Proc. Natl. Acad. Sci. USA 74, 5463-5467.
Schnieke, A., Harbers, K., and Jaenisch, R. (1983). Embryonic lethal mutation in
mice induced by retroviral insertion into the al(I) collagen gene. Nature 304, 315-
320.
147
Schughart, K., Kappen, C., and Ruddle, F. H. (1989). Duplication of large genomic
regions during the evolution of vertebrate homeobox genes. Proc. Natl. Acad. Sci.
USA 86, 7067-7071.
Schwartzberg, P. L., Goff, S. P., and Robertson, E. J. (1989). Germ-line
transmission of a c-abl mutation produced by targeted gene disruption in ES cells.
Science 246, 799-803.
Schwartzberg, P. L., Robertson, E. J., and Goff, S. P. (1990). Targeted gene
disruption of the endogenous c-abl locus by homologous recombination with DNA
encoding a selectable fusion protein. Proc. Natl. Acad. Sci. USA 87, 3210-3214.
Schwartzberg, P. L., Stall, A. M., Hardin, J. D., Bowdish, K. S., Humaran, T.,
Boast, S., Harbison, M. L., Robertson, E. J., and Goff, S. P. (1991). Mice
homozygous for the ablml mutation show poor viability and depletion of selected B
and T cell populations. Cell 65, 1165-1175.
Sedivy, J. M., and Sharp, P. A. (1989). Positive genetic selection for gene disruption
in mammalian cells by homologous recombination. Proc. Natl. Acad. Sci. USA 86,
227-231.
Shaw, G., and Kamen, R. (1986). A conserved AU sequence from the 3' untranslated
region of GM-CSF mRNA mediates selective rnRNA degradation. Cell 46, 659-667.
Shenkar, R., Shen, M., and Arnheim, N. (1991). DNase I-hypersensitive sites and
transcription factor-binding motifs within mouse E(3 meiotic recombination hot spot.
Mol. Cell Biol. 11, 1813-1819.
Shepherd, J. C. W., McGinnis, W., Carrasco, A. E., De Robertis, E. M., and
Gehring, W. (1984). Fly and frog homeo domains show homologies with yeast
mating type regulatory proteins. Nature 310, 70.
Shesely, E. G., Kim, H.-S., Shehee, W. R., Papayannopoulou, T., Smithies, O., and
Popovich, B. W. (1991). Correction of a human (3s-globin by gene targeting. Proc.
Natl. Acad. Sci. USA 88, 4294-4298.
Smith, A. G., Heath, J. K., Donaldson, D. D., Wong, G. G., Moreau, J., Stahl, M.,
and Rogers, D. (1988). Inhibition of pluripotential embryonic stem cell
differentiation by purified polypeptides. Nature 336, 688-690.
Smith, A. G., and Hooper, M. L. (1987). Buffalo rat liver cells produce a diffusible
activity which inhibits the differentiation of murine embryonal carcinoma and
embryonic stem cells. Dev. Biol. 121, 1-9.
Smith, G.R., and Stahl, F.W. (1985). Homologous recombination promoted by Chi
sites and RecBC enzyme of Escherichia coli. Bioessays 2, 244-249.
148
Smithies, O., Gregg, R. G., Boggs, S. S., Koralewski, M. A., and Kucherlapati, R. S.
(1985). Insertion of DNA sequences into the human chromosomal P-globin locus by
homologous recombination. Nature 317, 230-234.
Soriano, P., Montgomery, C., Geske, R., and Bradley, A. (1991). Targeted
disruption of the c-src proto-oncogene leads to osteopetrosis in mice. Cell 64, 693-
702.
Southern, E. M. (1975). Detection of specific sequences among DNA fragments
separated by gel electrophoresis../. Mol. Biol. 98, 503-517.
Southern, P. J., and Berg, P. (1982). Transformation of mammmalian cells to
antibiotic resistance with a bacterial gene under control of the SV40 early region
promoter. J. Mol. Appl. Genet. 1, 327-341.
Steinmetz, M., Uematsu, Y., and Fischer Lindahl, K. (1987). Hotspots of
homologous recombination in mammalian genomes. Trends Genet. 3, 7-10.
Stoye, J. P., Fenner, S., Greenoak, G. E., Moran, C., and Coffin, J. M. (1988). Role
of endogenous retrovirus as mutagens: the hairless mutation of mice. Cell 54, 383-
391.
Strauss, F., and Varshavsky, A. (1984). A protein binds to a satellite DNA repeat at
three specific sites that would be brought into mutual proximity by DNA folding in
the nucleosome. Cell 37, 889-901.
Thomas, B.J., and Rothstein, R. (1989). Elevated recombination rates in
transcriptionally active DNA. Cell 56, 619-630.
Thomas, K. R., and Capecchi, M. R. (1987). Site-directed mutagenesis by gene
targeting in mouse embryo-derived stem cells. Cell 51, 503-512.
Thomas, K. R., and Capecchi, M. R. (1990). Targeted disruption of the murine int-1
proto-oncogene resulting in severe abnormalities in midbrain and cerebellar
development. Nature 346, 847-850.
Thomas, K. R., Folger, K. R., and Capecchi, M. R. (1986). High frequency targeting
of genes to specific sites in the mammalian genome. Cell 44, 419-428.
Thompson, S., Clarke, A. R., Pow, A. M., Hooper, M. L., and Melton, D. W.
(1989). Germ line transmission and expression of a corrected HPRT gene produced
by gene targeting in embryonic stem cells. Cell 56, 313-321.
Tybulewicz, V. L. J., Crawford, C. E., Jackson, P. K., Bronson, R. T., and Mulligan,
R. C. (1991). Neonatal lethality and lymphopenia in mice with a homozygous
disruption of the c-ahl proto-oncogene. Cell 65, 1153-1163.
149
Uematsu, Y., Kiefer, H., Schulze, R., Fischer-Landahl, K., and Steinmetz, M.
(1986). Molecular characterization of a meiotic recombinational hotspot enhancing
homologous equal crossing-over. EMBO J. 5, 2123-2129.
Vieira, J., and Messing, J. (1982). The pUC plasmids, an M13mp7-derived system
for insertion mutagenesis and sequencing with universal primers. Gene 19, 259-269.
Wagner, M.J., Sharp, J.A., and Summers, W.C. (1981). Nucleotide sequence of the
thymidine kinase gene of herpes simplex virus type I. Proc. Natl. Acad. Sci. USA 78,
1441-1445.
Wake, C. T., Vernaleone, F., and Wilson, J. H. (1985). Topological requirements for
homologous recombination among DNA molecules transfected into mammalian
cells. Mol. Cell Biol., 2080-2089.
Wedell, A., Datta, S., Andersson, B., and Luthman, H. (1990). A modified
procedure for polymerase chain reaction amplification of single stranded DNA
improves direct sequencing. Technique 2, 23-26.
Weichenham, D. (1991). Fast recovery of DNA from agarose gels by centrifugation
through blotting paper. Trends Genet. 7, 109.
Weiss, B., Jacquenun-Sabon, A., Live, T. R., Fareed, G. C., and Richardson, C. C.
(1968). Enzymatic breakage and joining of deoxyribonucleic acid. J. Biol. Chem.
243, 4543-4555.
White, R. A. H., and Wilcox, M. (1984). Protein products of the Bithorax complex
in Drosophila. Cell 39, 163-171.
Wilkinson, D. G., Bhatt, S., Cook, M., Boncinelli, E., and Krumlauf, R. (1989).
Segmental expression of Hox-2 homeobox-containing genes in developing mouse
hindbrain. Nature 341, 405-409.
Williams, R. L., Hilton, D. J., Pease, S., Willson, T. A., Stewart, C. L., Gearing, D.
P., Wagner, E. F., Metcalf, D., Nicola, N. A., and Gough, N. M. (1988). Myeloid
leukaemia inhibitory factor maintains the developmental potential of embryonic stem
cells. Nature 336, 684-687.
Wilson, T., and Treisman, R. (1988). Removal of poly(A) and consequent
degradation of c-fos mRNA faciltated by 3' AU-rich sequences. Nature 336, 396-
399.
Winship, P. R. (1989). An improved method for directly sequencing PCR amplified
material using dimethyl sulphoxide. Nucl. Acids Res. 17, 1266.
Wirth, T., Gloggler, K., Baumruker, T., Schmidt, M., and Horak, I. (1983). Family
of middle repetitive DNA sequences in the mouse genome with structural features of
solitary retroviral long terminal repeats. Proc. Natl. Acad. Sci. USA 80, 3327-3330.
150
Wolgemuth, D. J., Behringer, R. R., Mostoller, M. P., Brinster, R. L., and Palmiter,
R. D. (1989). Transgenic mice overexperessing the mouse homeobox-containing
gene Hox-1.4 exhibit abnormal gut development. Nature 337, 464-467.
Yagi, T., Ikawa, Y., Yoshida, K., Shigetani, Y., Takeda, N., Mabuchi, I.,
Yamamoto, T., and Aizawa, S. (1990). Homologous recombination at c-fyn locus of
mouse embryonic stem cells with use of diphtheria toxin A-fragment gene in
negative selection. Proc. Natl. Acad. Sci. USA 87, 9918-9922.
Zijlsra, M., Li, E., Sajjadi, F., Subramani, S., and Jaenisch, R. (1989). Germ-line
transmission of a disrupted (32-microglobulin gene produced by homologous
recombination in embryonic stem cells. Nature 342, 435-437.
Zijlstra, M., Bix, M., Simister, N. E., Loring, J. M., Raulet, D. H., and Jaenisch, R.
(1990). P2-microglobulin deficient mice lack CD4~8+ cytolytic T cells. Nature 344,
742-746.
Zimmer, A., and Gruss, P. (1989). Production of chimaeric mice containing
embryonic stem (ES) cells carrying a homoeobox Hoxl.l allele mutated by
homologous recombination. Nature 338, 150-155.
151
